|
OMIM |
Link |
Information gain |
01 |
|
APOE
|
[NCBI]
|
0.0101649
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.0094186
|
|
|
VRNI
|
[NCBI]
|
0.00607214
|
|
|
MAFD6
|
[NCBI]
|
0.00484315
|
|
|
MAFD1
|
[NCBI]
|
0.00326503
|
|
|
VDR
|
[NCBI]
|
0.00250912
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00212734
|
|
|
IDDM
|
[NCBI]
|
0.0020736
|
|
|
RA
|
[NCBI]
|
0.00152523
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00149685
|
|
|
COMT
|
[NCBI]
|
0.00148476
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.00147756
|
|
|
EGF
|
[NCBI]
|
0.00141894
|
|
|
ACE
|
[NCBI]
|
0.00123926
|
|
|
HPCX
|
[NCBI]
|
0.00121345
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.00106236
|
|
|
SLEB3
|
[NCBI]
|
0.00106236
|
|
|
myopia 9
|
[NCBI]
|
0.000984732
|
|
|
DFNB13
|
[NCBI]
|
0.000984732
|
|
|
myopia 7
|
[NCBI]
|
0.000984732
|
|
|
BMND2
|
[NCBI]
|
0.000984732
|
|
|
SLI2
|
[NCBI]
|
0.000984732
|
|
|
myopia 8
|
[NCBI]
|
0.000984732
|
|
|
SLI1
|
[NCBI]
|
0.000984732
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.000984732
|
|
|
HDL3
|
[NCBI]
|
0.000984732
|
|
|
myopia 5
|
[NCBI]
|
0.000984732
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000984732
|
|
|
RCM2
|
[NCBI]
|
0.000984732
|
|
|
GLC1I
|
[NCBI]
|
0.000984732
|
|
|
SLI3
|
[NCBI]
|
0.000984732
|
|
|
myopia 10
|
[NCBI]
|
0.000984732
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.000984732
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000970244
|
|
|
IS1
|
[NCBI]
|
0.000935769
|
|
|
IBD2
|
[NCBI]
|
0.000863395
|
|
|
SLE
|
[NCBI]
|
0.000844919
|
|
|
AD
|
[NCBI]
|
0.000833137
|
|
|
NGFB
|
[NCBI]
|
0.000811541
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.000755609
|
|
|
HPC10
|
[NCBI]
|
0.000727294
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000727294
|
|
|
NIDDM2
|
[NCBI]
|
0.000727294
|
|
|
IBD5
|
[NCBI]
|
0.000697017
|
|
|
AUTS6
|
[NCBI]
|
0.000697017
|
|
|
MBL2
|
[NCBI]
|
0.000657122
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
0.000634562
|
|
|
bruck syndrome 1
|
[NCBI]
|
0.000634562
|
|
|
IDDM18
|
[NCBI]
|
0.000634562
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
0.000634562
|
|
|
myopia 6
|
[NCBI]
|
0.000634562
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
0.000634562
|
|
|
IDDM11
|
[NCBI]
|
0.000634562
|
|
|
PEE1
|
[NCBI]
|
0.000626228
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.00062353
|
|
|
ECA1
|
[NCBI]
|
0.00062353
|
|
|
VEGF
|
[NCBI]
|
0.000612195
|
|
|
PRL
|
[NCBI]
|
0.000586539
|
|
|
IDDM4
|
[NCBI]
|
0.000571551
|
|
|
neuroticism
|
[NCBI]
|
0.000540683
|
|
|
AVP
|
[NCBI]
|
0.000535067
|
|
|
TPMT
|
[NCBI]
|
0.000529029
|
|
|
FMF
|
[NCBI]
|
0.000520852
|
|
|
PCNA
|
[NCBI]
|
0.000511508
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000510996
|
|
|
VIP
|
[NCBI]
|
0.000494644
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000492212
|
|
|
creatinine clearance quantitative trait locus
|
[NCBI]
|
0.000492212
|
|
|
unique green phenomenon
|
[NCBI]
|
0.000492212
|
|
|
FEB7
|
[NCBI]
|
0.000492212
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.000492212
|
|
|
RP32
|
[NCBI]
|
0.000492212
|
|
|
BMND4
|
[NCBI]
|
0.000492212
|
|
|
FMTLE
|
[NCBI]
|
0.000492212
|
|
|
panic disorder 2
|
[NCBI]
|
0.000492212
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000492212
|
|
|
XGR
|
[NCBI]
|
0.000492212
|
|
|
IS2
|
[NCBI]
|
0.000492212
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000492212
|
|
|
stature quantitative trait locus 7
|
[NCBI]
|
0.000492212
|
|
|
IBD8
|
[NCBI]
|
0.000492212
|
|
|
body mass index quantitative trait locus on chromosome 7
|
[NCBI]
|
0.000492212
|
|
|
GINGF2
|
[NCBI]
|
0.000492212
|
|
|
SPG24
|
[NCBI]
|
0.000492212
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000492212
|
|
|
SPG30
|
[NCBI]
|
0.000492212
|
|
|
circulating adiponectin quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000492212
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000492212
|
|
|
DYTCA
|
[NCBI]
|
0.000492212
|
|
|
MRX53
|
[NCBI]
|
0.000492212
|
|
|
DFN6
|
[NCBI]
|
0.000492212
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000492212
|
|
|
STHAG5
|
[NCBI]
|
0.000492212
|
|
|
restless legs syndrome, susceptibility to, 5
|
[NCBI]
|
0.000492212
|
|
|
psoriasis susceptibility 7
|
[NCBI]
|
0.000492212
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000492212
|
|
|
DFNB40
|
[NCBI]
|
0.000492212
|
|
|
RP25
|
[NCBI]
|
0.000492212
|
|
|
EIG2
|
[NCBI]
|
0.000492212
|
|
|
BMND7
|
[NCBI]
|
0.000492212
|
|
|
circulating adiponectin quantitative trait locus on chromosome 5
|
[NCBI]
|
0.000492212
|
|
|
DFNA16
|
[NCBI]
|
0.000492212
|
|
|
SPG27
|
[NCBI]
|
0.000492212
|
|
|
DFNA30
|
[NCBI]
|
0.000492212
|
|
|
DFNB55
|
[NCBI]
|
0.000492212
|
|
|
cataract, crystalline coralliform
|
[NCBI]
|
0.000492212
|
|
|
atypical mycobacteriosis, familial, x-linked 2
|
[NCBI]
|
0.000492212
|
|
|
cataract, nuclear progressive
|
[NCBI]
|
0.000492212
|
|
|
body mass index quantitative trait locus on chromosome 13
|
[NCBI]
|
0.000492212
|
|
|
major depressive disorder 2
|
[NCBI]
|
0.000492212
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000492212
|
|
|
mycobacterium tuberculosis, susceptibility to, 1
|
[NCBI]
|
0.000492212
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000492212
|
|
|
lung cancer 1
|
[NCBI]
|
0.000492212
|
|
|
myopia 11
|
[NCBI]
|
0.000492212
|
|
|
aortic aneurysm, familial abdominal 1
|
[NCBI]
|
0.000492212
|
|
|
AMCX5
|
[NCBI]
|
0.000492212
|
|
|
SPG32
|
[NCBI]
|
0.000492212
|
|
|
mammographic density
|
[NCBI]
|
0.000492212
|
|
|
hypertension, essential, susceptibility to, 3
|
[NCBI]
|
0.000492212
|
|
|
hyperlipidemia, combined, 2
|
[NCBI]
|
0.000492212
|
|
|
DFNA43
|
[NCBI]
|
0.000492212
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000492212
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000492212
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000492212
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 3
|
[NCBI]
|
0.000492212
|
|
|
GLC1H
|
[NCBI]
|
0.000492212
|
|
|
high density lipoprotein deficiency 3
|
[NCBI]
|
0.000492212
|
|
|
CATCN1
|
[NCBI]
|
0.000492212
|
|
|
bone size quantitative trait locus 3
|
[NCBI]
|
0.000492212
|
|
|
ETM3
|
[NCBI]
|
0.000492212
|
|
|
OTSC5
|
[NCBI]
|
0.000492212
|
|
|
alzheimer disease 9
|
[NCBI]
|
0.000492212
|
|
|
GINGF3
|
[NCBI]
|
0.000492212
|
|
|
dyskeratosis, hereditary benign intraepithelial
|
[NCBI]
|
0.000492212
|
|
|
schizophrenia 11
|
[NCBI]
|
0.000492212
|
|
|
FEB6
|
[NCBI]
|
0.000492212
|
|
|
myopia 12
|
[NCBI]
|
0.000492212
|
|
|
aortic aneurysm, familial abdominal 2
|
[NCBI]
|
0.000492212
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000492212
|
|
|
prostate cancer, hereditary, 4
|
[NCBI]
|
0.000492212
|
|
|
FEB9
|
[NCBI]
|
0.000492212
|
|
|
HDLCQ1
|
[NCBI]
|
0.000492212
|
|
|
DFNB68
|
[NCBI]
|
0.000492212
|
|
|
CCV
|
[NCBI]
|
0.000484603
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
0.000484603
|
|
|
MYP3
|
[NCBI]
|
0.000484603
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000484603
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000484603
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
0.000484603
|
|
|
HBFQTL4
|
[NCBI]
|
0.000484603
|
|
|
OFC1
|
[NCBI]
|
0.000482359
|
|
|
CF
|
[NCBI]
|
0.000472579
|
|
|
SCZD7
|
[NCBI]
|
0.000472384
|
|
|
PCOS1
|
[NCBI]
|
0.000470163
|
|
|
CEACAM5
|
[NCBI]
|
0.000448454
|
|
|
SCZD
|
[NCBI]
|
0.000434773
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000431926
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.00041482
|
|
|
IBD1
|
[NCBI]
|
0.000413139
|
|
|
MG
|
[NCBI]
|
0.000391891
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000390128
|
|
|
GFAP
|
[NCBI]
|
0.000389965
|
|
|
CELIAC2
|
[NCBI]
|
0.000386412
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000386412
|
|
|
ETM2
|
[NCBI]
|
0.000386412
|
|
|
AUTS5
|
[NCBI]
|
0.000386412
|
|
|
CORD7
|
[NCBI]
|
0.000386412
|
|
|
IBD3
|
[NCBI]
|
0.000386412
|
|
|
HTC2
|
[NCBI]
|
0.000386412
|
|
|
HFM
|
[NCBI]
|
0.000382246
|
|
|
MAOA
|
[NCBI]
|
0.000363468
|
|
|
PON1
|
[NCBI]
|
0.000358521
|
|
|
KLK3
|
[NCBI]
|
0.000354734
|
|
|
EPO
|
[NCBI]
|
0.000352347
|
|
|
ACHE
|
[NCBI]
|
0.000338386
|
|
|
LEPR
|
[NCBI]
|
0.000331646
|
|
|
PTH
|
[NCBI]
|
0.000329064
|
|
|
SCZD3
|
[NCBI]
|
0.000326684
|
|
|
amyloidosis vi
|
[NCBI]
|
0.000321346
|
|
|
MTHFR
|
[NCBI]
|
0.000317134
|
|
|
PFHB1B
|
[NCBI]
|
0.000314708
|
|
|
RNANC
|
[NCBI]
|
0.000314708
|
|
|
ATOD6
|
[NCBI]
|
0.000314708
|
|
|
NNO1
|
[NCBI]
|
0.000314708
|
|
|
NPY
|
[NCBI]
|
0.000303913
|
|
|
EGFR
|
[NCBI]
|
0.000302229
|
|
|
CFH
|
[NCBI]
|
0.000300779
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000298957
|
|
|
EIG
|
[NCBI]
|
0.000278262
|
|
|
ARMD4
|
[NCBI]
|
0.00027741
|
|
|
NIDDM
|
[NCBI]
|
0.000272921
|
|
|
CRH
|
[NCBI]
|
0.000265198
|
|
|
APS2
|
[NCBI]
|
0.000259311
|
|
|
BRCD1
|
[NCBI]
|
0.000259311
|
|
|
SHFM2
|
[NCBI]
|
0.000259311
|
|
|
mental health wellness 1
|
[NCBI]
|
0.000259311
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000259311
|
|
|
MTR
|
[NCBI]
|
0.000255351
|
|
|
CCK
|
[NCBI]
|
0.000255222
|
|
|
AFP
|
[NCBI]
|
0.000252564
|
|
|
CFTR
|
[NCBI]
|
0.00024799
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
0.000246146
|
|
|
NAT1
|
[NCBI]
|
0.000245905
|
|
|
CLN9
|
[NCBI]
|
0.000242172
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.000242172
|
|
|
esophagitis, eosinophilic
|
[NCBI]
|
0.000242172
|
|
|
EA3
|
[NCBI]
|
0.000242172
|
|
|
CMD1H
|
[NCBI]
|
0.000242172
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.000242172
|
|
|
HRPT3
|
[NCBI]
|
0.000242172
|
|
|
CHNG3
|
[NCBI]
|
0.000242172
|
|
|
WS2B
|
[NCBI]
|
0.000242172
|
|
|
AIS3
|
[NCBI]
|
0.000242172
|
|
|
FSHMD1B
|
[NCBI]
|
0.000242172
|
|
|
LGMD1F
|
[NCBI]
|
0.000242172
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000242172
|
|
|
DFNA18
|
[NCBI]
|
0.000242172
|
|
|
cone-rod dystrophy and amelogenesis imperfecta
|
[NCBI]
|
0.000242172
|
|
|
BMND5
|
[NCBI]
|
0.000242172
|
|
|
hyperaldosteronism, familial, type ii
|
[NCBI]
|
0.000242172
|
|
|
myopathy, hyaline body, autosomal recessive
|
[NCBI]
|
0.000242172
|
|
|
CELIAC5
|
[NCBI]
|
0.000242172
|
|
|
NEM6
|
[NCBI]
|
0.000242172
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.000242172
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000242172
|
|
|
PEE2
|
[NCBI]
|
0.000242172
|
|
|
obesity, susceptibility to, on chromosome 4
|
[NCBI]
|
0.000242172
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.000242172
|
|
|
SCA21
|
[NCBI]
|
0.000242172
|
|
|
myopia 14
|
[NCBI]
|
0.000242172
|
|
|
CCAL1
|
[NCBI]
|
0.000242172
|
|
|
MPD3
|
[NCBI]
|
0.000242172
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000242172
|
|
|
alacrima, congenital
|
[NCBI]
|
0.000242172
|
|
|
hypertension, essential, susceptibility to, 2
|
[NCBI]
|
0.000242172
|
|
|
ENUR2
|
[NCBI]
|
0.000242172
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant, with thyroid disease
|
[NCBI]
|
0.000242172
|
|
|
AIS2
|
[NCBI]
|
0.000242172
|
|
|
IDDM8
|
[NCBI]
|
0.000242172
|
|
|
IDDM6
|
[NCBI]
|
0.000242172
|
|
|
porokeratosis, disseminated superficial actinic, 2
|
[NCBI]
|
0.000242172
|
|
|
asparagus, specific smell hypersensitivity
|
[NCBI]
|
0.000242172
|
|
|
intelligence quantitative trait locus 1
|
[NCBI]
|
0.000242172
|
|
|
DYX8
|
[NCBI]
|
0.000242172
|
|
|
myopia 4
|
[NCBI]
|
0.000242172
|
|
|
ichthyosis prematurity syndrome
|
[NCBI]
|
0.000242172
|
|
|
ENUR1
|
[NCBI]
|
0.000242172
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.000242172
|
|
|
IBD7
|
[NCBI]
|
0.000242172
|
|
|
DYX9
|
[NCBI]
|
0.000242172
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.000242172
|
|
|
LGMD2A
|
[NCBI]
|
0.000239904
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.000231427
|
|
|
LPL
|
[NCBI]
|
0.000231231
|
|
|
HGF
|
[NCBI]
|
0.000227437
|
|
|
ESR1
|
[NCBI]
|
0.000218436
|
|
|
NPPA
|
[NCBI]
|
0.000217764
|
|
|
AUTS9
|
[NCBI]
|
0.000215014
|
|
|
EKD1
|
[NCBI]
|
0.000212106
|
|
|
PTK2
|
[NCBI]
|
0.0002117
|
|
|
APOB
|
[NCBI]
|
0.000209752
|
|
|
hypertension, essential
|
[NCBI]
|
0.000208749
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.000208426
|
|
|
GBA
|
[NCBI]
|
0.000207516
|
|
|
TH
|
[NCBI]
|
0.000202342
|
|
|
OCD1
|
[NCBI]
|
0.000200423
|
|
|
autism
|
[NCBI]
|
0.00019804
|
|
|
DRD4
|
[NCBI]
|
0.000195119
|
|
|
obesity
|
[NCBI]
|
0.000189329
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
0.000187235
|
|
|
HFE
|
[NCBI]
|
0.000186793
|
|
|
CAT
|
[NCBI]
|
0.000186371
|
|
|
DYX2
|
[NCBI]
|
0.000185053
|
|
|
HPC1
|
[NCBI]
|
0.000185053
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.000178777
|
|
|
CGF1
|
[NCBI]
|
0.000178777
|
|
|
GCY
|
[NCBI]
|
0.000178777
|
|
|
IGES
|
[NCBI]
|
0.000178777
|
|
|
SCZD6
|
[NCBI]
|
0.000178777
|
|
|
alcohol dependence
|
[NCBI]
|
0.000174432
|
|
|
MBP
|
[NCBI]
|
0.000173424
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000167877
|
|
|
cystinuria
|
[NCBI]
|
0.000165429
|
|
|
LPG
|
[NCBI]
|
0.000164183
|
|
|
SCZD9
|
[NCBI]
|
0.000164183
|
|
|
BL
|
[NCBI]
|
0.00016178
|
|
|
RTT
|
[NCBI]
|
0.000160755
|
|
|
mental retardation, congenital heart disease, blepharophimosis, blepharoptosis, and hypoplastic teeth
|
[NCBI]
|
0.000157247
|
|
|
USH1E
|
[NCBI]
|
0.000157247
|
|
|
IDDM17
|
[NCBI]
|
0.000157247
|
|
|
AUTS7
|
[NCBI]
|
0.000157247
|
|
|
cerebellar atrophy with progressive microcephaly
|
[NCBI]
|
0.000157247
|
|
|
OPA2
|
[NCBI]
|
0.000157247
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.000157247
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.000157247
|
|
|
erythrokeratodermia variabilis 3
|
[NCBI]
|
0.000157247
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000157247
|
|
|
SPG15
|
[NCBI]
|
0.000157247
|
|
|
alzheimer disease 11
|
[NCBI]
|
0.000157247
|
|
|
MCOPS4
|
[NCBI]
|
0.000157247
|
|
|
IDDM3
|
[NCBI]
|
0.000157247
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal recessive
|
[NCBI]
|
0.000157247
|
|
|
ALSFTD2
|
[NCBI]
|
0.000157247
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000157247
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000157247
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.000157247
|
|
|
auditory neuropathy, x-linked, 1, with peripheral sensory neuropathy
|
[NCBI]
|
0.000157247
|
|
|
myasthenia gravis with thymus hyperplasia
|
[NCBI]
|
0.000157247
|
|
|
PSORS5
|
[NCBI]
|
0.000157247
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.000157247
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000157247
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
0.000157247
|
|
|
IDDM13
|
[NCBI]
|
0.000157247
|
|
|
PFHB2
|
[NCBI]
|
0.000157247
|
|
|
HHC2
|
[NCBI]
|
0.000157247
|
|
|
CRCS2
|
[NCBI]
|
0.000157247
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.000157247
|
|
|
CHDS8
|
[NCBI]
|
0.000157247
|
|
|
xm system
|
[NCBI]
|
0.000157247
|
|
|
IBD6
|
[NCBI]
|
0.000157247
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
0.000157247
|
|
|
dianzani autoimmune lymphoproliferative disease
|
[NCBI]
|
0.000157247
|
|
|
IDDM15
|
[NCBI]
|
0.000157247
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
0.000157247
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000157247
|
|
|
ORW3
|
[NCBI]
|
0.000157247
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000157247
|
|
|
CMD1F
|
[NCBI]
|
0.000157247
|
|
|
IBD9
|
[NCBI]
|
0.000157247
|
|
|
GIST
|
[NCBI]
|
0.000156497
|
|
|
IGAN1
|
[NCBI]
|
0.000153099
|
|
|
SHFM3
|
[NCBI]
|
0.000153099
|
|
|
PARK3
|
[NCBI]
|
0.000148665
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000146024
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000145875
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000145361
|
|
|
CYP2D6
|
[NCBI]
|
0.000141527
|
|
|
MEFV
|
[NCBI]
|
0.000139909
|
|
|
PSNP1
|
[NCBI]
|
0.00013956
|
|
|
graves disease
|
[NCBI]
|
0.000138856
|
|
|
IL10
|
[NCBI]
|
0.000138608
|
|
|
MS
|
[NCBI]
|
0.000138296
|
|
|
NPC1
|
[NCBI]
|
0.000134696
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.000131047
|
|
|
FIDD
|
[NCBI]
|
0.000129318
|
|
|
PBD
|
[NCBI]
|
0.000128038
|
|
|
CCR5
|
[NCBI]
|
0.000126461
|
|
|
NOS3
|
[NCBI]
|
0.000126076
|
|
|
ALDH2
|
[NCBI]
|
0.000124993
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
0.000124437
|
|
|
BMND1
|
[NCBI]
|
0.000124437
|
|
|
WDM
|
[NCBI]
|
0.000123369
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
0.000123369
|
|
|
OTSC1
|
[NCBI]
|
0.000123369
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000123369
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
0.000122762
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000121601
|
|
|
NOD2
|
[NCBI]
|
0.000120693
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.000120375
|
|
|
prostate cancer
|
[NCBI]
|
0.000119174
|
|
|
TNF
|
[NCBI]
|
0.000117907
|
|
|
PARK8
|
[NCBI]
|
0.000117883
|
|
|
MCDR1
|
[NCBI]
|
0.000117589
|
|
|
VHL
|
[NCBI]
|
0.000117588
|
|
|
PRNP
|
[NCBI]
|
0.000117434
|
|
|
GNRH1
|
[NCBI]
|
0.000117226
|
|
|
LGMD2I
|
[NCBI]
|
0.000116316
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
0.000115481
|
|
|
bruck syndrome 2
|
[NCBI]
|
0.000115481
|
|
|
arteriovenous malformations of the brain
|
[NCBI]
|
0.000115481
|
|
|
MMP3
|
[NCBI]
|
0.000114741
|
|
|
TG
|
[NCBI]
|
0.000114636
|
|
|
CRC
|
[NCBI]
|
0.0001142
|
|
|
TNFSF6
|
[NCBI]
|
0.000113494
|
|
|
CCND1
|
[NCBI]
|
0.000112943
|
|
|
LTA
|
[NCBI]
|
0.000109053
|
|
|
LMS
|
[NCBI]
|
0.000108993
|
|
|
MDD
|
[NCBI]
|
0.000108511
|
|
|
SCZD8
|
[NCBI]
|
0.00010812
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
0.00010812
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.00010742
|
|
|
EXT3
|
[NCBI]
|
0.00010742
|
|
|
restless legs syndrome, susceptibility to, 6
|
[NCBI]
|
0.00010742
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.00010742
|
|
|
DYT6
|
[NCBI]
|
0.00010742
|
|
|
RP6
|
[NCBI]
|
0.00010742
|
|
|
DYX3
|
[NCBI]
|
0.00010742
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.00010742
|
|
|
candidiasis, familial chronic mucocutaneous, autosomal dominant
|
[NCBI]
|
0.00010742
|
|
|
arrhythmogenic right ventricular dysplasia, familial, 6
|
[NCBI]
|
0.00010742
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.00010742
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.00010742
|
|
|
EA4
|
[NCBI]
|
0.00010742
|
|
|
DYX5
|
[NCBI]
|
0.00010742
|
|
|
ALS5
|
[NCBI]
|
0.00010742
|
|
|
CELIAC6
|
[NCBI]
|
0.00010742
|
|
|
ALSFTD1
|
[NCBI]
|
0.00010742
|
|
|
RP24
|
[NCBI]
|
0.00010742
|
|
|
dupuytren contracture
|
[NCBI]
|
0.00010742
|
|
|
PARK11
|
[NCBI]
|
0.00010742
|
|
|
SCA19
|
[NCBI]
|
0.00010742
|
|
|
ARVD5
|
[NCBI]
|
0.00010742
|
|
|
DYX6
|
[NCBI]
|
0.00010742
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.00010742
|
|
|
PTOS1
|
[NCBI]
|
0.00010742
|
|
|
MCDU
|
[NCBI]
|
0.00010742
|
|
|
PN
|
[NCBI]
|
0.00010742
|
|
|
speech-sound disorder
|
[NCBI]
|
0.00010742
|
|
|
AXPC1
|
[NCBI]
|
0.00010742
|
|
|
OB10P
|
[NCBI]
|
0.00010742
|
|
|
MYP1
|
[NCBI]
|
0.00010742
|
|
|
DSMA3
|
[NCBI]
|
0.00010742
|
|
|
noonan syndrome 2
|
[NCBI]
|
0.00010742
|
|
|
BRCA3
|
[NCBI]
|
0.00010742
|
|
|
A2M
|
[NCBI]
|
0.000105987
|
|
|
TCF7L2
|
[NCBI]
|
0.000105921
|
|
|
PDS
|
[NCBI]
|
0.000104822
|
|
|
BRIC1
|
[NCBI]
|
0.000103071
|
|
|
PKD3
|
[NCBI]
|
0.000103071
|
|
|
ADCYAP1
|
[NCBI]
|
0.000102509
|
|
|
CHAT
|
[NCBI]
|
0.00010153
|
|
|
ARMD1
|
[NCBI]
|
0.000101439
|
|
|
F3
|
[NCBI]
|
0.000101397
|
|
|
LDLR
|
[NCBI]
|
0.000100828
|
|
|
ADH2
|
[NCBI]
|
0.000100794
|
|
|
isoniazid inactivation
|
[NCBI]
|
9.96718e-05
|
|
|
DRD3
|
[NCBI]
|
9.9271e-05
|
|
|
APC
|
[NCBI]
|
9.78382e-05
|
|
|
HP
|
[NCBI]
|
9.76577e-05
|
|
|
MC1R
|
[NCBI]
|
9.74232e-05
|
|
|
ZS
|
[NCBI]
|
9.7084e-05
|
|
|
osteoporosis
|
[NCBI]
|
9.68789e-05
|
|
|
ELAC2
|
[NCBI]
|
9.65335e-05
|
|
|
CYP2C9
|
[NCBI]
|
9.65335e-05
|
|
|
FCHL
|
[NCBI]
|
9.63165e-05
|
|
|
longevity
|
[NCBI]
|
9.62578e-05
|
|
|
FABP2
|
[NCBI]
|
9.61382e-05
|
|
|
PAI1
|
[NCBI]
|
9.56442e-05
|
|
|
CMM
|
[NCBI]
|
9.4572e-05
|
|
|
DWS
|
[NCBI]
|
9.44116e-05
|
|
|
CAPN10
|
[NCBI]
|
9.37367e-05
|
|
|
PTHLH
|
[NCBI]
|
9.2569e-05
|
|
|
DRD2
|
[NCBI]
|
9.13676e-05
|
|
|
HNMT
|
[NCBI]
|
9.03832e-05
|
|
|
MFS
|
[NCBI]
|
9.01078e-05
|
|
|
SMA2
|
[NCBI]
|
8.81824e-05
|
|
|
osteoarthritis
|
[NCBI]
|
8.81824e-05
|
|
|
GJB2
|
[NCBI]
|
8.71362e-05
|
|
|
HSCR1
|
[NCBI]
|
8.5658e-05
|
|
|
GSTM1
|
[NCBI]
|
8.43521e-05
|
|
|
LRRK2
|
[NCBI]
|
8.41002e-05
|
|
|
FEB1
|
[NCBI]
|
8.37551e-05
|
|
|
ST8
|
[NCBI]
|
8.37551e-05
|
|
|
CBBM
|
[NCBI]
|
8.37551e-05
|
|
|
FRAP1
|
[NCBI]
|
8.3692e-05
|
|
|
AGT
|
[NCBI]
|
8.36449e-05
|
|
|
phenylketonuria
|
[NCBI]
|
8.34062e-05
|
|
|
OPA1
|
[NCBI]
|
8.24307e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
8.24307e-05
|
|
|
FMO2
|
[NCBI]
|
8.20738e-05
|
|
|
HMS
|
[NCBI]
|
8.20738e-05
|
|
|
body mass index
|
[NCBI]
|
8.20738e-05
|
|
|
CORD3
|
[NCBI]
|
8.20738e-05
|
|
|
ARMD7
|
[NCBI]
|
8.20738e-05
|
|
|
RYR1
|
[NCBI]
|
8.11121e-05
|
|
|
SHEP1
|
[NCBI]
|
8.06083e-05
|
|
|
adult syndrome
|
[NCBI]
|
8.06083e-05
|
|
|
GDNF
|
[NCBI]
|
7.98075e-05
|
|
|
IL1RN
|
[NCBI]
|
7.91922e-05
|
|
|
abdominal body fat distribution
|
[NCBI]
|
7.83788e-05
|
|
|
CMD3A
|
[NCBI]
|
7.83788e-05
|
|
|
HMERF
|
[NCBI]
|
7.83788e-05
|
|
|
ABO
|
[NCBI]
|
7.78177e-05
|
|
|
NPC1
|
[NCBI]
|
7.6604e-05
|
|
|
MYOC
|
[NCBI]
|
7.59459e-05
|
|
|
MECP2
|
[NCBI]
|
7.52431e-05
|
|
|
UBQLN1
|
[NCBI]
|
7.52153e-05
|
|
|
ACP5
|
[NCBI]
|
7.48651e-05
|
|
|
IL1A
|
[NCBI]
|
7.48643e-05
|
|
|
WGN1
|
[NCBI]
|
7.47178e-05
|
|
|
CAST
|
[NCBI]
|
7.46832e-05
|
|
|
FECD2
|
[NCBI]
|
7.42638e-05
|
|
|
syndactyly, type i
|
[NCBI]
|
7.42638e-05
|
|
|
SPG12
|
[NCBI]
|
7.42638e-05
|
|
|
OPA4
|
[NCBI]
|
7.42638e-05
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
7.42638e-05
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
7.42638e-05
|
|
|
AD14
|
[NCBI]
|
7.42638e-05
|
|
|
CMD1B
|
[NCBI]
|
7.42638e-05
|
|
|
SCA4
|
[NCBI]
|
7.42638e-05
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
7.42638e-05
|
|
|
pelizaeus-merzbacher-like disease, autosomal recessive, 2
|
[NCBI]
|
7.42638e-05
|
|
|
leptin, serum levels of
|
[NCBI]
|
7.42638e-05
|
|
|
HBD
|
[NCBI]
|
7.42638e-05
|
|
|
DYT7
|
[NCBI]
|
7.42638e-05
|
|
|
USH2B
|
[NCBI]
|
7.42638e-05
|
|
|
OFC3
|
[NCBI]
|
7.42638e-05
|
|
|
anosmia, congenital
|
[NCBI]
|
7.42638e-05
|
|
|
AD13
|
[NCBI]
|
7.42638e-05
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
7.42638e-05
|
|
|
oca2 gene
|
[NCBI]
|
7.31923e-05
|
|
|
PGL4
|
[NCBI]
|
7.29676e-05
|
|
|
vitiligo
|
[NCBI]
|
7.29676e-05
|
|
|
BRCA1
|
[NCBI]
|
7.24521e-05
|
|
|
ABCA4
|
[NCBI]
|
7.20981e-05
|
|
|
wilson disease
|
[NCBI]
|
7.13826e-05
|
|
|
LMNA
|
[NCBI]
|
7.05468e-05
|
|
|
FCMD
|
[NCBI]
|
7.00487e-05
|
|
|
MUC1
|
[NCBI]
|
6.99411e-05
|
|
|
ADLTE
|
[NCBI]
|
6.94019e-05
|
|
|
PALS
|
[NCBI]
|
6.94019e-05
|
|
|
PPARG
|
[NCBI]
|
6.8921e-05
|
|
|
EPHX1
|
[NCBI]
|
6.85382e-05
|
|
|
CYP2A6
|
[NCBI]
|
6.85382e-05
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
6.82438e-05
|
|
|
USH2A
|
[NCBI]
|
6.82438e-05
|
|
|
MYP2
|
[NCBI]
|
6.82374e-05
|
|
|
SMN1
|
[NCBI]
|
6.81506e-05
|
|
|
GAPDH
|
[NCBI]
|
6.81063e-05
|
|
|
PYY
|
[NCBI]
|
6.79126e-05
|
|
|
RNASE3
|
[NCBI]
|
6.71357e-05
|
|
|
PF4
|
[NCBI]
|
6.71238e-05
|
|
|
SCA1
|
[NCBI]
|
6.68754e-05
|
|
|
ABCB1
|
[NCBI]
|
6.66333e-05
|
|
|
IL2
|
[NCBI]
|
6.65634e-05
|
|
|
breast cancer
|
[NCBI]
|
6.60196e-05
|
|
|
SRF
|
[NCBI]
|
6.57051e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
6.53846e-05
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
6.46042e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
6.45732e-05
|
|
|
SOD2
|
[NCBI]
|
6.44088e-05
|
|
|
SMAX1
|
[NCBI]
|
6.41091e-05
|
|
|
CVID
|
[NCBI]
|
6.40832e-05
|
|
|
MB
|
[NCBI]
|
6.35805e-05
|
|
|
apc gene
|
[NCBI]
|
6.32664e-05
|
|
|
FBN1
|
[NCBI]
|
6.29802e-05
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
6.25371e-05
|
|
|
DPYD
|
[NCBI]
|
6.22492e-05
|
|
|
VAMAS1
|
[NCBI]
|
6.22427e-05
|
|
|
AIS1
|
[NCBI]
|
6.22427e-05
|
|
|
platelet disorder, familial, with associated myeloid malignancy
|
[NCBI]
|
6.22427e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
6.22427e-05
|
|
|
FHCA
|
[NCBI]
|
6.22427e-05
|
|
|
cardiomyopathy, dilated, autosomal recessive
|
[NCBI]
|
6.22427e-05
|
|
|
varicose veins
|
[NCBI]
|
6.22427e-05
|
|
|
SLC6A4
|
[NCBI]
|
6.17532e-05
|
|
|
EVA
|
[NCBI]
|
6.1379e-05
|
|
|
MHA
|
[NCBI]
|
6.11845e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
6.11845e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
6.01631e-05
|
|
|
CTLA4
|
[NCBI]
|
5.9365e-05
|
|
|
INSIG2
|
[NCBI]
|
5.90143e-05
|
|
|
PEX1
|
[NCBI]
|
5.90143e-05
|
|
|
trifunctional protein deficiency
|
[NCBI]
|
5.89257e-05
|
|
|
USH1D
|
[NCBI]
|
5.89257e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
5.8705e-05
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
5.77382e-05
|
|
|
hla modifier
|
[NCBI]
|
5.77382e-05
|
|
|
ECYT4
|
[NCBI]
|
5.77382e-05
|
|
|
USH2D
|
[NCBI]
|
5.77382e-05
|
|
|
IDDM19
|
[NCBI]
|
5.77382e-05
|
|
|
CISS1
|
[NCBI]
|
5.77382e-05
|
|
|
RDC
|
[NCBI]
|
5.77382e-05
|
|
|
NEM5
|
[NCBI]
|
5.77382e-05
|
|
|
PMSE
|
[NCBI]
|
5.77382e-05
|
|
|
cutis verticis gyrata, retinitis pigmentosa, and sensorineural deafness
|
[NCBI]
|
5.77382e-05
|
|
|
DFNB30
|
[NCBI]
|
5.77382e-05
|
|
|
CATCN2
|
[NCBI]
|
5.77382e-05
|
|
|
anemia, congenital hypoplastic, with multiple congenital anomalies/mental retardation syndrome
|
[NCBI]
|
5.77382e-05
|
|
|
immunodeficiency due to defect in mapbp-interacting protein
|
[NCBI]
|
5.77382e-05
|
|
|
ectrodactyly-cleft palate syndrome
|
[NCBI]
|
5.77382e-05
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
5.77382e-05
|
|
|
coronary heart disease, susceptibility to, 7
|
[NCBI]
|
5.77382e-05
|
|
|
DFNB22
|
[NCBI]
|
5.77382e-05
|
|
|
kleine-levin hibernation syndrome
|
[NCBI]
|
5.77382e-05
|
|
|
taurodontism
|
[NCBI]
|
5.77382e-05
|
|
|
hyperlipoproteinemia, type v
|
[NCBI]
|
5.77382e-05
|
|
|
fascial dystrophy, congenital
|
[NCBI]
|
5.77382e-05
|
|
|
cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome
|
[NCBI]
|
5.77382e-05
|
|
|
cd8 deficiency, familial
|
[NCBI]
|
5.77382e-05
|
|
|
COFS4
|
[NCBI]
|
5.77382e-05
|
|
|
blood group--en
|
[NCBI]
|
5.77382e-05
|
|
|
myopathy, early-onset, with fatal cardiomyopathy
|
[NCBI]
|
5.77382e-05
|
|
|
craniosynostosis syndrome, autosomal recessive
|
[NCBI]
|
5.77382e-05
|
|
|
low density lipoprotein cholesterol, mild elevation of
|
[NCBI]
|
5.77382e-05
|
|
|
microcephaly with simplified gyral pattern
|
[NCBI]
|
5.77382e-05
|
|
|
immunoglobulin d level in plasma, low
|
[NCBI]
|
5.77382e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
5.76598e-05
|
|
|
DBA
|
[NCBI]
|
5.71125e-05
|
|
|
SHH
|
[NCBI]
|
5.66567e-05
|
|
|
FMO3
|
[NCBI]
|
5.66138e-05
|
|
|
HTR2A
|
[NCBI]
|
5.60243e-05
|
|
|
CBP
|
[NCBI]
|
5.55313e-05
|
|
|
asthma, susceptibility to
|
[NCBI]
|
5.53992e-05
|
|
|
DURS1
|
[NCBI]
|
5.50062e-05
|
|
|
twinning, dizygotic
|
[NCBI]
|
5.50062e-05
|
|
|
PAND1
|
[NCBI]
|
5.50062e-05
|
|
|
DFNB1
|
[NCBI]
|
5.493e-05
|
|
|
SRS
|
[NCBI]
|
5.45121e-05
|
|
|
SLC22A5
|
[NCBI]
|
5.44659e-05
|
|
|
LEP
|
[NCBI]
|
5.44589e-05
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
5.3788e-05
|
|
|
ADRB3
|
[NCBI]
|
5.35325e-05
|
|
|
CASR
|
[NCBI]
|
5.35187e-05
|
|
|
LGMD1A
|
[NCBI]
|
5.33319e-05
|
|
|
SCA14
|
[NCBI]
|
5.33319e-05
|
|
|
BBS
|
[NCBI]
|
5.31449e-05
|
|
|
SLC11A1
|
[NCBI]
|
5.28455e-05
|
|
|
IBM2
|
[NCBI]
|
5.23884e-05
|
|
|
galactosemia
|
[NCBI]
|
5.20796e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
5.20633e-05
|
|
|
OPTN
|
[NCBI]
|
5.17401e-05
|
|
|
DHCR7
|
[NCBI]
|
5.16614e-05
|
|
|
NCSTN
|
[NCBI]
|
5.16614e-05
|
|
|
CCZS
|
[NCBI]
|
5.15276e-05
|
|
|
schindler disease, type i
|
[NCBI]
|
5.15276e-05
|
|
|
IDDM10
|
[NCBI]
|
5.15276e-05
|
|
|
IDDM12
|
[NCBI]
|
5.15276e-05
|
|
|
CTPP3
|
[NCBI]
|
5.15276e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
5.15276e-05
|
|
|
JAE
|
[NCBI]
|
5.15276e-05
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
5.15276e-05
|
|
|
PC2
|
[NCBI]
|
5.15276e-05
|
|
|
ARSA
|
[NCBI]
|
5.11864e-05
|
|
|
ITGB3
|
[NCBI]
|
5.11678e-05
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
5.09271e-05
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
5.09271e-05
|
|
|
MCOPS6
|
[NCBI]
|
5.09271e-05
|
|
|
SCAX1
|
[NCBI]
|
5.09271e-05
|
|
|
STHAG4
|
[NCBI]
|
5.09271e-05
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
5.09271e-05
|
|
|
CLN4A
|
[NCBI]
|
5.09271e-05
|
|
|
CNC2
|
[NCBI]
|
5.09271e-05
|
|
|
BCNS
|
[NCBI]
|
5.05371e-05
|
|
|
TPH2
|
[NCBI]
|
5.03885e-05
|
|
|
CTSD
|
[NCBI]
|
4.99038e-05
|
|
|
LAM
|
[NCBI]
|
4.97101e-05
|
|
|
ATP7B
|
[NCBI]
|
4.95358e-05
|
|
|
STGD1
|
[NCBI]
|
4.93524e-05
|
|
|
OSM
|
[NCBI]
|
4.91927e-05
|
|
|
CPB2
|
[NCBI]
|
4.89507e-05
|
|
|
SCA10
|
[NCBI]
|
4.89421e-05
|
|
|
CST3
|
[NCBI]
|
4.88889e-05
|
|
|
TLR4
|
[NCBI]
|
4.868e-05
|
|
|
ABCC1
|
[NCBI]
|
4.86371e-05
|
|
|
CTGF
|
[NCBI]
|
4.85981e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
4.84252e-05
|
|
|
LIS1
|
[NCBI]
|
4.84252e-05
|
|
|
LGMD2H
|
[NCBI]
|
4.84252e-05
|
|
|
GALT
|
[NCBI]
|
4.82507e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
4.78305e-05
|
|
|
MAPT
|
[NCBI]
|
4.75763e-05
|
|
|
homocystinuria
|
[NCBI]
|
4.72828e-05
|
|
|
SMEI
|
[NCBI]
|
4.69791e-05
|
|
|
AACT
|
[NCBI]
|
4.66832e-05
|
|
|
MAOB
|
[NCBI]
|
4.64302e-05
|
|
|
LRP1
|
[NCBI]
|
4.63156e-05
|
|
|
MAS
|
[NCBI]
|
4.58949e-05
|
|
|
BCHE
|
[NCBI]
|
4.52633e-05
|
|
|
SHBG
|
[NCBI]
|
4.52394e-05
|
|
|
IGER
|
[NCBI]
|
4.49207e-05
|
|
|
BWS
|
[NCBI]
|
4.46913e-05
|
|
|
SMA1
|
[NCBI]
|
4.45917e-05
|
|
|
PMP22
|
[NCBI]
|
4.45218e-05
|
|
|
ARH
|
[NCBI]
|
4.40776e-05
|
|
|
autoimmune disease
|
[NCBI]
|
4.40776e-05
|
|
|
FTNS
|
[NCBI]
|
4.40776e-05
|
|
|
SLC26A2
|
[NCBI]
|
4.39731e-05
|
|
|
TPH1
|
[NCBI]
|
4.39731e-05
|
|
|
SLC3A1
|
[NCBI]
|
4.37947e-05
|
|
|
FKRP
|
[NCBI]
|
4.37947e-05
|
|
|
noonan-like/multiple giant cell lesion syndrome
|
[NCBI]
|
4.35861e-05
|
|
|
CGL1
|
[NCBI]
|
4.35861e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
4.35861e-05
|
|
|
USH2C
|
[NCBI]
|
4.35861e-05
|
|
|
CMD1E
|
[NCBI]
|
4.35861e-05
|
|
|
EVR4
|
[NCBI]
|
4.35861e-05
|
|
|
GSTT1
|
[NCBI]
|
4.34703e-05
|
|
|
ATP8B1
|
[NCBI]
|
4.34703e-05
|
|
|
CYP2E
|
[NCBI]
|
4.34703e-05
|
|
|
TFPI
|
[NCBI]
|
4.33538e-05
|
|
|
BRCA2
|
[NCBI]
|
4.27976e-05
|
|
|
TSC1
|
[NCBI]
|
4.27905e-05
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
4.27761e-05
|
|
|
IDE
|
[NCBI]
|
4.27755e-05
|
|
|
JMML
|
[NCBI]
|
4.22409e-05
|
|
|
USH2A
|
[NCBI]
|
4.21601e-05
|
|
|
ROR2
|
[NCBI]
|
4.21601e-05
|
|
|
saitohin
|
[NCBI]
|
4.21375e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
4.20342e-05
|
|
|
COL7A1
|
[NCBI]
|
4.19313e-05
|
|
|
SLC26A4
|
[NCBI]
|
4.10322e-05
|
|
|
PRND
|
[NCBI]
|
4.08032e-05
|
|
|
IL6
|
[NCBI]
|
4.02661e-05
|
|
|
cri-du-chat syndrome
|
[NCBI]
|
4.01943e-05
|
|
|
MICA
|
[NCBI]
|
4.00612e-05
|
|
|
ADRB2
|
[NCBI]
|
4.00612e-05
|
|
|
EKV
|
[NCBI]
|
4.00081e-05
|
|
|
PGL1
|
[NCBI]
|
3.98506e-05
|
|
|
EEC1
|
[NCBI]
|
3.96339e-05
|
|
|
GCK
|
[NCBI]
|
3.93419e-05
|
|
|
RHCE
|
[NCBI]
|
3.91218e-05
|
|
|
ELN
|
[NCBI]
|
3.90858e-05
|
|
|
IRF5
|
[NCBI]
|
3.84473e-05
|
|
|
POMC
|
[NCBI]
|
3.81357e-05
|
|
|
GSTP1
|
[NCBI]
|
3.76879e-05
|
|
|
DLG5
|
[NCBI]
|
3.76044e-05
|
|
|
FUCA2
|
[NCBI]
|
3.76044e-05
|
|
|
KIR2DL2
|
[NCBI]
|
3.76044e-05
|
|
|
XDH
|
[NCBI]
|
3.75753e-05
|
|
|
GIP
|
[NCBI]
|
3.75484e-05
|
|
|
TSD
|
[NCBI]
|
3.74061e-05
|
|
|
FFI
|
[NCBI]
|
3.7366e-05
|
|
|
CLN6
|
[NCBI]
|
3.73521e-05
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
3.73521e-05
|
|
|
mental health wellness 2
|
[NCBI]
|
3.73521e-05
|
|
|
LGMD1C
|
[NCBI]
|
3.73521e-05
|
|
|
AOII
|
[NCBI]
|
3.73521e-05
|
|
|
IDDM5
|
[NCBI]
|
3.73521e-05
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
3.73521e-05
|
|
|
SHEP3
|
[NCBI]
|
3.73521e-05
|
|
|
PMD
|
[NCBI]
|
3.68304e-05
|
|
|
gilbert syndrome
|
[NCBI]
|
3.67025e-05
|
|
|
alpha-thalassemia/mental retardation syndrome, deletion-type
|
[NCBI]
|
3.67025e-05
|
|
|
HMS1
|
[NCBI]
|
3.67025e-05
|
|
|
IL1B
|
[NCBI]
|
3.66202e-05
|
|
|
LQT1
|
[NCBI]
|
3.65902e-05
|
|
|
RET
|
[NCBI]
|
3.63754e-05
|
|
|
NPC2
|
[NCBI]
|
3.63407e-05
|
|
|
FCGR2B
|
[NCBI]
|
3.63407e-05
|
|
|
ALB
|
[NCBI]
|
3.63314e-05
|
|
|
TPO
|
[NCBI]
|
3.58154e-05
|
|
|
SCA6
|
[NCBI]
|
3.58052e-05
|
|
|
MM
|
[NCBI]
|
3.57836e-05
|
|
|
REN
|
[NCBI]
|
3.51149e-05
|
|
|
PNKD1
|
[NCBI]
|
3.50065e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
3.47357e-05
|
|
|
MC4R
|
[NCBI]
|
3.47198e-05
|
|
|
CYP3A5
|
[NCBI]
|
3.44384e-05
|
|
|
CALCR
|
[NCBI]
|
3.44384e-05
|
|
|
KCNJ1
|
[NCBI]
|
3.44384e-05
|
|
|
CJD
|
[NCBI]
|
3.44285e-05
|
|
|
FA
|
[NCBI]
|
3.43539e-05
|
|
|
RASA1
|
[NCBI]
|
3.42496e-05
|
|
|
AT
|
[NCBI]
|
3.41295e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
3.40967e-05
|
|
|
ALDH5A1
|
[NCBI]
|
3.40967e-05
|
|
|
ATP2C1
|
[NCBI]
|
3.40967e-05
|
|
|
INS
|
[NCBI]
|
3.40839e-05
|
|
|
IH
|
[NCBI]
|
3.40796e-05
|
|
|
SPG5A
|
[NCBI]
|
3.40796e-05
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
3.40796e-05
|
|
|
BMND3
|
[NCBI]
|
3.40796e-05
|
|
|
acetabular dysplasia
|
[NCBI]
|
3.40796e-05
|
|
|
MCOP1
|
[NCBI]
|
3.40796e-05
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
3.40796e-05
|
|
|
inclusion body myositis
|
[NCBI]
|
3.40796e-05
|
|
|
cluster headache, familial
|
[NCBI]
|
3.40796e-05
|
|
|
PSORS4
|
[NCBI]
|
3.40796e-05
|
|
|
TAPVR1
|
[NCBI]
|
3.40796e-05
|
|
|
GAL
|
[NCBI]
|
3.39395e-05
|
|
|
GJA1
|
[NCBI]
|
3.39376e-05
|
|
|
WBS
|
[NCBI]
|
3.3915e-05
|
|
|
SMA3
|
[NCBI]
|
3.38964e-05
|
|
|
SAA1
|
[NCBI]
|
3.36638e-05
|
|
|
DLB
|
[NCBI]
|
3.35456e-05
|
|
|
RHD
|
[NCBI]
|
3.35018e-05
|
|
|
VLDLR
|
[NCBI]
|
3.3304e-05
|
|
|
CDK2
|
[NCBI]
|
3.32582e-05
|
|
|
MVP
|
[NCBI]
|
3.31119e-05
|
|
|
dubowitz syndrome
|
[NCBI]
|
3.31119e-05
|
|
|
PDCD8
|
[NCBI]
|
3.30899e-05
|
|
|
HDC
|
[NCBI]
|
3.29217e-05
|
|
|
PWS
|
[NCBI]
|
3.29175e-05
|
|
|
CBD
|
[NCBI]
|
3.27518e-05
|
|
|
FUT1
|
[NCBI]
|
3.27067e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.27067e-05
|
|
|
PKD2
|
[NCBI]
|
3.25264e-05
|
|
|
CDSN
|
[NCBI]
|
3.23332e-05
|
|
|
PMM2
|
[NCBI]
|
3.23332e-05
|
|
|
CDH23
|
[NCBI]
|
3.23332e-05
|
|
|
MFN2
|
[NCBI]
|
3.23332e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
3.22803e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
3.22803e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
3.22803e-05
|
|
|
MCOPS2
|
[NCBI]
|
3.22803e-05
|
|
|
char syndrome
|
[NCBI]
|
3.22803e-05
|
|
|
EPD
|
[NCBI]
|
3.22803e-05
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
3.22803e-05
|
|
|
MDC1C
|
[NCBI]
|
3.22803e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
3.22803e-05
|
|
|
SLEB1
|
[NCBI]
|
3.22803e-05
|
|
|
SPP1
|
[NCBI]
|
3.22232e-05
|
|
|
TYMS
|
[NCBI]
|
3.17745e-05
|
|
|
CDK5
|
[NCBI]
|
3.15793e-05
|
|
|
ALOX5AP
|
[NCBI]
|
3.11197e-05
|
|
|
MYBPC3
|
[NCBI]
|
3.11197e-05
|
|
|
NAGLU
|
[NCBI]
|
3.11197e-05
|
|
|
SGSH
|
[NCBI]
|
3.11197e-05
|
|
|
AGS2
|
[NCBI]
|
3.11193e-05
|
|
|
atrial standstill
|
[NCBI]
|
3.11193e-05
|
|
|
ARMD9
|
[NCBI]
|
3.11193e-05
|
|
|
STQTL9
|
[NCBI]
|
3.11193e-05
|
|
|
SHEP9
|
[NCBI]
|
3.11193e-05
|
|
|
cardiomyopathy, dilated, with quadriceps myopathy
|
[NCBI]
|
3.11193e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
3.11193e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
3.11193e-05
|
|
|
methylmalonyl-coa epimerase deficiency
|
[NCBI]
|
3.11193e-05
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
3.11193e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
3.11193e-05
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
3.11193e-05
|
|
|
epiphyseal dysplasia, multiple, with myopia and conductive deafness
|
[NCBI]
|
3.11193e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
3.11193e-05
|
|
|
ARMD3
|
[NCBI]
|
3.11193e-05
|
|
|
carney complex variant
|
[NCBI]
|
3.11193e-05
|
|
|
MCOP3
|
[NCBI]
|
3.11193e-05
|
|
|
ectrodactyly and ectodermal dysplasia without cleft lip/palate
|
[NCBI]
|
3.11193e-05
|
|
|
HMPS2
|
[NCBI]
|
3.11193e-05
|
|
|
bronchiectasis
|
[NCBI]
|
3.11193e-05
|
|
|
CMH8
|
[NCBI]
|
3.11193e-05
|
|
|
CLSD
|
[NCBI]
|
3.11193e-05
|
|
|
craniofacial dysmorphism with ocular coloboma, absent corpus callosum, and aortic dilatation
|
[NCBI]
|
3.11193e-05
|
|
|
CMH10
|
[NCBI]
|
3.11193e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
3.11193e-05
|
|
|
MCOPS5
|
[NCBI]
|
3.11193e-05
|
|
|
GS3
|
[NCBI]
|
3.11193e-05
|
|
|
protein-tyrosine kinase 2 deficiency
|
[NCBI]
|
3.11193e-05
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
3.11193e-05
|
|
|
xh antigen
|
[NCBI]
|
3.11193e-05
|
|
|
TCC
|
[NCBI]
|
3.11193e-05
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
3.11193e-05
|
|
|
PPCD2
|
[NCBI]
|
3.11193e-05
|
|
|
orofacial cleft 6
|
[NCBI]
|
3.11193e-05
|
|
|
ALGS2
|
[NCBI]
|
3.11193e-05
|
|
|
CCA3
|
[NCBI]
|
3.11193e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
3.11193e-05
|
|
|
HMN7B
|
[NCBI]
|
3.11193e-05
|
|
|
AVSD
|
[NCBI]
|
3.07386e-05
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
3.06784e-05
|
|
|
DHRD
|
[NCBI]
|
3.06784e-05
|
|
|
SPCH1
|
[NCBI]
|
3.06784e-05
|
|
|
FXTAS
|
[NCBI]
|
3.06784e-05
|
|
|
EEC3
|
[NCBI]
|
3.06784e-05
|
|
|
OPRM1
|
[NCBI]
|
3.04975e-05
|
|
|
ACPP
|
[NCBI]
|
3.04092e-05
|
|
|
FANCA
|
[NCBI]
|
3.02069e-05
|
|
|
CP
|
[NCBI]
|
2.9919e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
2.98149e-05
|
|
|
MHS1
|
[NCBI]
|
2.97143e-05
|
|
|
ALOX5
|
[NCBI]
|
2.96569e-05
|
|
|
SLC19A1
|
[NCBI]
|
2.96569e-05
|
|
|
PXE
|
[NCBI]
|
2.95911e-05
|
|
|
PTPN1
|
[NCBI]
|
2.91654e-05
|
|
|
FGF20
|
[NCBI]
|
2.88345e-05
|
|
|
hemojuvelin
|
[NCBI]
|
2.88345e-05
|
|
|
HHF1
|
[NCBI]
|
2.87535e-05
|
|
|
SPDA1
|
[NCBI]
|
2.8623e-05
|
|
|
neural tube defects
|
[NCBI]
|
2.8623e-05
|
|
|
FGB
|
[NCBI]
|
2.83021e-05
|
|
|
PSORS1
|
[NCBI]
|
2.81241e-05
|
|
|
OFD1
|
[NCBI]
|
2.80643e-05
|
|
|
SHEP2
|
[NCBI]
|
2.80643e-05
|
|
|
RMS1
|
[NCBI]
|
2.80523e-05
|
|
|
HFE3
|
[NCBI]
|
2.80523e-05
|
|
|
CMH4
|
[NCBI]
|
2.80523e-05
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
2.80523e-05
|
|
|
SBS
|
[NCBI]
|
2.80523e-05
|
|
|
NIDDM1
|
[NCBI]
|
2.80523e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
2.80523e-05
|
|
|
SPG11
|
[NCBI]
|
2.80523e-05
|
|
|
CMT4B2
|
[NCBI]
|
2.80523e-05
|
|
|
SPG10
|
[NCBI]
|
2.80523e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
2.80523e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
2.79125e-05
|
|
|
FY
|
[NCBI]
|
2.79125e-05
|
|
|
VHL
|
[NCBI]
|
2.75363e-05
|
|
|
MYH7
|
[NCBI]
|
2.73267e-05
|
|
|
IPF1
|
[NCBI]
|
2.72919e-05
|
|
|
ARX
|
[NCBI]
|
2.72919e-05
|
|
|
GAA
|
[NCBI]
|
2.71967e-05
|
|
|
POAG
|
[NCBI]
|
2.71963e-05
|
|
|
CDLS1
|
[NCBI]
|
2.71515e-05
|
|
|
NS1
|
[NCBI]
|
2.70653e-05
|
|
|
C5
|
[NCBI]
|
2.7042e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
2.70066e-05
|
|
|
PKD1
|
[NCBI]
|
2.69923e-05
|
|
|
TNFSF10
|
[NCBI]
|
2.68801e-05
|
|
|
ELOVL4
|
[NCBI]
|
2.67633e-05
|
|
|
EPHX2
|
[NCBI]
|
2.67633e-05
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
2.67474e-05
|
|
|
apert syndrome
|
[NCBI]
|
2.67474e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
2.65001e-05
|
|
|
TSC2
|
[NCBI]
|
2.6465e-05
|
|
|
DISC1
|
[NCBI]
|
2.64162e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
2.61546e-05
|
|
|
ATHS
|
[NCBI]
|
2.61546e-05
|
|
|
PTPN22
|
[NCBI]
|
2.58654e-05
|
|
|
IRDN
|
[NCBI]
|
2.58654e-05
|
|
|
CLN2
|
[NCBI]
|
2.56733e-05
|
|
|
KAL2
|
[NCBI]
|
2.56733e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
2.56733e-05
|
|
|
CBAVD
|
[NCBI]
|
2.56733e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
2.56733e-05
|
|
|
RPGR
|
[NCBI]
|
2.56204e-05
|
|
|
CYP11B2
|
[NCBI]
|
2.55775e-05
|
|
|
IRS2
|
[NCBI]
|
2.55775e-05
|
|
|
KSS
|
[NCBI]
|
2.54235e-05
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
2.53676e-05
|
|
|
CYP17A1
|
[NCBI]
|
2.51795e-05
|
|
|
CMT1A
|
[NCBI]
|
2.5146e-05
|
|
|
SLC6A14
|
[NCBI]
|
2.50689e-05
|
|
|
MAP3K3
|
[NCBI]
|
2.50689e-05
|
|
|
RRAD
|
[NCBI]
|
2.50689e-05
|
|
|
PLEKHG4
|
[NCBI]
|
2.50689e-05
|
|
|
SRR
|
[NCBI]
|
2.50689e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.50374e-05
|
|
|
homocysteinemia
|
[NCBI]
|
2.49824e-05
|
|
|
NEUROD1
|
[NCBI]
|
2.49491e-05
|
|
|
NPPB
|
[NCBI]
|
2.49491e-05
|
|
|
MTNR1A
|
[NCBI]
|
2.49491e-05
|
|
|
POMGNT1
|
[NCBI]
|
2.49491e-05
|
|
|
GALK1
|
[NCBI]
|
2.47634e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
2.47634e-05
|
|
|
CYP2C19
|
[NCBI]
|
2.47634e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.45492e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
2.44656e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
2.44656e-05
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
2.44656e-05
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
2.44656e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
2.44656e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
2.44656e-05
|
|
|
DFNB9
|
[NCBI]
|
2.44656e-05
|
|
|
LGMD2E
|
[NCBI]
|
2.44656e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
2.44656e-05
|
|
|
PSEN1
|
[NCBI]
|
2.43671e-05
|
|
|
MPZ
|
[NCBI]
|
2.415e-05
|
|
|
APOA1
|
[NCBI]
|
2.4126e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
2.40719e-05
|
|
|
WRN
|
[NCBI]
|
2.40668e-05
|
|
|
HLA-B
|
[NCBI]
|
2.40011e-05
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
2.39335e-05
|
|
|
SLOS
|
[NCBI]
|
2.39195e-05
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
2.35268e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.34803e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
2.34803e-05
|
|
|
ORW2
|
[NCBI]
|
2.34803e-05
|
|
|
KRT17
|
[NCBI]
|
2.33388e-05
|
|
|
CX3CR1
|
[NCBI]
|
2.33388e-05
|
|
|
ADH3
|
[NCBI]
|
2.33388e-05
|
|
|
loc387715 gene
|
[NCBI]
|
2.33388e-05
|
|
|
FUT3
|
[NCBI]
|
2.33388e-05
|
|
|
SLC7A9
|
[NCBI]
|
2.33388e-05
|
|
|
C10ORF2
|
[NCBI]
|
2.33388e-05
|
|
|
PON2
|
[NCBI]
|
2.33388e-05
|
|
|
PPR
|
[NCBI]
|
2.33308e-05
|
|
|
ALS1
|
[NCBI]
|
2.30328e-05
|
|
|
LI1
|
[NCBI]
|
2.29398e-05
|
|
|
AMH
|
[NCBI]
|
2.28619e-05
|
|
|
DBH
|
[NCBI]
|
2.2753e-05
|
|
|
ASIP
|
[NCBI]
|
2.2753e-05
|
|
|
AMPD1
|
[NCBI]
|
2.2753e-05
|
|
|
FOXC2
|
[NCBI]
|
2.2753e-05
|
|
|
GLB1
|
[NCBI]
|
2.25456e-05
|
|
|
SPG4
|
[NCBI]
|
2.25456e-05
|
|
|
MSTN
|
[NCBI]
|
2.21954e-05
|
|
|
TREX1
|
[NCBI]
|
2.18946e-05
|
|
|
iminoglycinuria
|
[NCBI]
|
2.18449e-05
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
2.18449e-05
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
2.18449e-05
|
|
|
ear, patella, short stature syndrome
|
[NCBI]
|
2.18449e-05
|
|
|
ANON1
|
[NCBI]
|
2.18449e-05
|
|
|
MCOPS1
|
[NCBI]
|
2.18449e-05
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
2.18449e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
2.18449e-05
|
|
|
MTACR1
|
[NCBI]
|
2.18449e-05
|
|
|
robinow syndrome, autosomal dominant
|
[NCBI]
|
2.18449e-05
|
|
|
IDDM7
|
[NCBI]
|
2.18449e-05
|
|
|
LTC4S
|
[NCBI]
|
2.18324e-05
|
|
|
CYP1B1
|
[NCBI]
|
2.18324e-05
|
|
|
pulmonary hypertension, familial persistent, of the newborn
|
[NCBI]
|
2.17912e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
2.17912e-05
|
|
|
proopiomelanocortin deficiency
|
[NCBI]
|
2.17912e-05
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
2.17912e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
2.17912e-05
|
|
|
PPROM
|
[NCBI]
|
2.17912e-05
|
|
|
DFNB31
|
[NCBI]
|
2.17912e-05
|
|
|
CELIAC3
|
[NCBI]
|
2.17912e-05
|
|
|
PEOA4
|
[NCBI]
|
2.17912e-05
|
|
|
MADB
|
[NCBI]
|
2.17912e-05
|
|
|
SRN1
|
[NCBI]
|
2.17912e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
2.17912e-05
|
|
|
stapes ankylosis with broad thumb and toes
|
[NCBI]
|
2.17912e-05
|
|
|
polydactyly
|
[NCBI]
|
2.17912e-05
|
|
|
FECD1
|
[NCBI]
|
2.17912e-05
|
|
|
FEB8
|
[NCBI]
|
2.17912e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
2.17912e-05
|
|
|
DDSH
|
[NCBI]
|
2.17912e-05
|
|
|
FEB4
|
[NCBI]
|
2.17912e-05
|
|
|
microduplication 22q11.2
|
[NCBI]
|
2.17912e-05
|
|
|
isovaleric acid, inability to smell
|
[NCBI]
|
2.17912e-05
|
|
|
lathosterolosis
|
[NCBI]
|
2.17912e-05
|
|
|
methylmalonic aciduria, cblb type
|
[NCBI]
|
2.17912e-05
|
|
|
mass syndrome
|
[NCBI]
|
2.17912e-05
|
|
|
SPS
|
[NCBI]
|
2.17912e-05
|
|
|
CMTX5
|
[NCBI]
|
2.17912e-05
|
|
|
sodium-potassium-atpase activity of red cell
|
[NCBI]
|
2.17912e-05
|
|
|
FEB3
|
[NCBI]
|
2.17912e-05
|
|
|
dermatitis herpetiformis, familial
|
[NCBI]
|
2.17912e-05
|
|
|
hypotonia-cystinuria syndrome
|
[NCBI]
|
2.17912e-05
|
|
|
amelogenesis imperfecta, hypoplastic, and openbite malocclusion, autosomal recessive
|
[NCBI]
|
2.17912e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
2.17912e-05
|
|
|
SLEB2
|
[NCBI]
|
2.17912e-05
|
|
|
TFCP2
|
[NCBI]
|
2.17338e-05
|
|
|
CDKAL1
|
[NCBI]
|
2.17338e-05
|
|
|
GBP1
|
[NCBI]
|
2.17338e-05
|
|
|
SLC25A12
|
[NCBI]
|
2.17338e-05
|
|
|
TOP3B
|
[NCBI]
|
2.17338e-05
|
|
|
CABP4
|
[NCBI]
|
2.17338e-05
|
|
|
CRKL
|
[NCBI]
|
2.17338e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
2.16479e-05
|
|
|
MKS1
|
[NCBI]
|
2.15862e-05
|
|
|
SMS
|
[NCBI]
|
2.15663e-05
|
|
|
CGL2
|
[NCBI]
|
2.14643e-05
|
|
|
ETM1
|
[NCBI]
|
2.14643e-05
|
|
|
SCA17
|
[NCBI]
|
2.14643e-05
|
|
|
SLC6A3
|
[NCBI]
|
2.14088e-05
|
|
|
RP11
|
[NCBI]
|
2.1383e-05
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
2.1383e-05
|
|
|
HNPCC2
|
[NCBI]
|
2.1383e-05
|
|
|
CMT2A2
|
[NCBI]
|
2.1383e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 1 deficiency
|
[NCBI]
|
2.1383e-05
|
|
|
SCZD2
|
[NCBI]
|
2.1383e-05
|
|
|
chiari malformation type i
|
[NCBI]
|
2.13595e-05
|
|
|
JBTS1
|
[NCBI]
|
2.13595e-05
|
|
|
GRP
|
[NCBI]
|
2.10717e-05
|
|
|
EPOR
|
[NCBI]
|
2.10717e-05
|
|
|
CYP11B1
|
[NCBI]
|
2.09615e-05
|
|
|
SST
|
[NCBI]
|
2.09115e-05
|
|
|
PEDF
|
[NCBI]
|
2.07515e-05
|
|
|
F13A1
|
[NCBI]
|
2.05977e-05
|
|
|
GSTA5
|
[NCBI]
|
2.0592e-05
|
|
|
OR7D4
|
[NCBI]
|
2.0592e-05
|
|
|
flj10986
|
[NCBI]
|
2.0592e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
2.0592e-05
|
|
|
ARPC1A
|
[NCBI]
|
2.0592e-05
|
|
|
FEA
|
[NCBI]
|
2.0592e-05
|
|
|
XGR
|
[NCBI]
|
2.0592e-05
|
|
|
tissue-specific extinguisher 3
|
[NCBI]
|
2.0592e-05
|
|
|
RTTN
|
[NCBI]
|
2.0592e-05
|
|
|
C2ORF34
|
[NCBI]
|
2.0592e-05
|
|
|
TCIRG1
|
[NCBI]
|
2.05883e-05
|
|
|
MTP
|
[NCBI]
|
2.05883e-05
|
|
|
HLA-C
|
[NCBI]
|
2.05883e-05
|
|
|
NAGA
|
[NCBI]
|
2.05883e-05
|
|
|
OLR1
|
[NCBI]
|
2.05883e-05
|
|
|
EN2
|
[NCBI]
|
2.05883e-05
|
|
|
BLMH
|
[NCBI]
|
2.05883e-05
|
|
|
CYP3A4
|
[NCBI]
|
2.0559e-05
|
|
|
MYH9
|
[NCBI]
|
2.01359e-05
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
1.99964e-05
|
|
|
RUNX2
|
[NCBI]
|
1.99434e-05
|
|
|
RECQL2
|
[NCBI]
|
1.99434e-05
|
|
|
PGR
|
[NCBI]
|
1.97769e-05
|
|
|
APRT
|
[NCBI]
|
1.97513e-05
|
|
|
long-chain 3-hydroxyacyl-coa dehydrogenase deficiency
|
[NCBI]
|
1.96076e-05
|
|
|
CNC1
|
[NCBI]
|
1.96076e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
1.96076e-05
|
|
|
GGH
|
[NCBI]
|
1.93982e-05
|
|
|
CD14
|
[NCBI]
|
1.93982e-05
|
|
|
HSPG2
|
[NCBI]
|
1.93982e-05
|
|
|
CDKN1C
|
[NCBI]
|
1.9352e-05
|
|
|
PDYN
|
[NCBI]
|
1.93491e-05
|
|
|
IHH
|
[NCBI]
|
1.93184e-05
|
|
|
IP
|
[NCBI]
|
1.93042e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.92367e-05
|
|
|
KIR2DL3
|
[NCBI]
|
1.92223e-05
|
|
|
HSN2
|
[NCBI]
|
1.92223e-05
|
|
|
COH1
|
[NCBI]
|
1.92223e-05
|
|
|
LSS
|
[NCBI]
|
1.92223e-05
|
|
|
PER3
|
[NCBI]
|
1.92223e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.92223e-05
|
|
|
LALBA
|
[NCBI]
|
1.92223e-05
|
|
|
ANK2
|
[NCBI]
|
1.92223e-05
|
|
|
NPHS2
|
[NCBI]
|
1.92223e-05
|
|
|
CALU
|
[NCBI]
|
1.92223e-05
|
|
|
GJB4
|
[NCBI]
|
1.92223e-05
|
|
|
CDKN2A
|
[NCBI]
|
1.8959e-05
|
|
|
CMD1A
|
[NCBI]
|
1.88839e-05
|
|
|
SPG4
|
[NCBI]
|
1.88839e-05
|
|
|
HCH
|
[NCBI]
|
1.88839e-05
|
|
|
STK11
|
[NCBI]
|
1.8775e-05
|
|
|
SMN2
|
[NCBI]
|
1.8775e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.87072e-05
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
1.87072e-05
|
|
|
DFNA6
|
[NCBI]
|
1.87072e-05
|
|
|
SMDP1
|
[NCBI]
|
1.87072e-05
|
|
|
LGMD2D
|
[NCBI]
|
1.87072e-05
|
|
|
HRPT2
|
[NCBI]
|
1.87072e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
1.87072e-05
|
|
|
CMT2B
|
[NCBI]
|
1.87072e-05
|
|
|
BCR
|
[NCBI]
|
1.86748e-05
|
|
|
IL4R
|
[NCBI]
|
1.86064e-05
|
|
|
GJA5
|
[NCBI]
|
1.86064e-05
|
|
|
OPA1
|
[NCBI]
|
1.86064e-05
|
|
|
ATXN8OS
|
[NCBI]
|
1.86064e-05
|
|
|
DMD
|
[NCBI]
|
1.85704e-05
|
|
|
NRG1
|
[NCBI]
|
1.85493e-05
|
|
|
MTM1
|
[NCBI]
|
1.84337e-05
|
|
|
RCC1
|
[NCBI]
|
1.84337e-05
|
|
|
DRD5
|
[NCBI]
|
1.83076e-05
|
|
|
PDCD1
|
[NCBI]
|
1.83076e-05
|
|
|
GGCX
|
[NCBI]
|
1.83076e-05
|
|
|
PKHD1
|
[NCBI]
|
1.83076e-05
|
|
|
POMT1
|
[NCBI]
|
1.83076e-05
|
|
|
ENAM
|
[NCBI]
|
1.83076e-05
|
|
|
PSEN2
|
[NCBI]
|
1.8204e-05
|
|
|
FRDA
|
[NCBI]
|
1.81423e-05
|
|
|
NPS
|
[NCBI]
|
1.8112e-05
|
|
|
BLM
|
[NCBI]
|
1.75806e-05
|
|
|
LS
|
[NCBI]
|
1.75806e-05
|
|
|
CMH
|
[NCBI]
|
1.75697e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.75695e-05
|
|
|
PCTT
|
[NCBI]
|
1.75695e-05
|
|
|
PARK2
|
[NCBI]
|
1.75052e-05
|
|
|
SLC18A3
|
[NCBI]
|
1.74289e-05
|
|
|
SGCA
|
[NCBI]
|
1.7303e-05
|
|
|
MC3R
|
[NCBI]
|
1.7303e-05
|
|
|
ADRB1
|
[NCBI]
|
1.7303e-05
|
|
|
IRF6
|
[NCBI]
|
1.7303e-05
|
|
|
RAPSN
|
[NCBI]
|
1.7303e-05
|
|
|
CPS1
|
[NCBI]
|
1.7303e-05
|
|
|
ARSB
|
[NCBI]
|
1.72189e-05
|
|
|
NOG
|
[NCBI]
|
1.72189e-05
|
|
|
LAMA1
|
[NCBI]
|
1.72179e-05
|
|
|
NHS
|
[NCBI]
|
1.72179e-05
|
|
|
CTNNA2
|
[NCBI]
|
1.72179e-05
|
|
|
TLR10
|
[NCBI]
|
1.72179e-05
|
|
|
SLC30A8
|
[NCBI]
|
1.72179e-05
|
|
|
IGF2BP2
|
[NCBI]
|
1.72179e-05
|
|
|
WHRN
|
[NCBI]
|
1.72179e-05
|
|
|
NHLRC1
|
[NCBI]
|
1.72179e-05
|
|
|
SUMO4
|
[NCBI]
|
1.72179e-05
|
|
|
CHMP4B
|
[NCBI]
|
1.72179e-05
|
|
|
IL23R
|
[NCBI]
|
1.72179e-05
|
|
|
TF
|
[NCBI]
|
1.70481e-05
|
|
|
CLS
|
[NCBI]
|
1.69001e-05
|
|
|
KITLG
|
[NCBI]
|
1.68049e-05
|
|
|
PLG
|
[NCBI]
|
1.67103e-05
|
|
|
PMCH
|
[NCBI]
|
1.66474e-05
|
|
|
TP73L
|
[NCBI]
|
1.65722e-05
|
|
|
TBX1
|
[NCBI]
|
1.63735e-05
|
|
|
TAZ
|
[NCBI]
|
1.63735e-05
|
|
|
CBR1
|
[NCBI]
|
1.63735e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.63735e-05
|
|
|
IL7R
|
[NCBI]
|
1.63735e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.63735e-05
|
|
|
THC2
|
[NCBI]
|
1.63668e-05
|
|
|
pick disease of brain
|
[NCBI]
|
1.63668e-05
|
|
|
ALS2
|
[NCBI]
|
1.63668e-05
|
|
|
ED2
|
[NCBI]
|
1.63668e-05
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
1.63668e-05
|
|
|
LDS
|
[NCBI]
|
1.63668e-05
|
|
|
RENS1
|
[NCBI]
|
1.63668e-05
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
1.63668e-05
|
|
|
pearson marrow-pancreas syndrome
|
[NCBI]
|
1.63668e-05
|
|
|
MEB
|
[NCBI]
|
1.6329e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.6313e-05
|
|
|
RMD
|
[NCBI]
|
1.6313e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
1.62186e-05
|
|
|
NF1
|
[NCBI]
|
1.62129e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.62127e-05
|
|
|
porphyria variegata
|
[NCBI]
|
1.62038e-05
|
|
|
C4A
|
[NCBI]
|
1.61736e-05
|
|
|
PRTS
|
[NCBI]
|
1.61386e-05
|
|
|
CAMT
|
[NCBI]
|
1.61386e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
1.61386e-05
|
|
|
bartter syndrome, antenatal, type 1
|
[NCBI]
|
1.61386e-05
|
|
|
CORD6
|
[NCBI]
|
1.61386e-05
|
|
|
ARMD2
|
[NCBI]
|
1.61386e-05
|
|
|
pancreatic agenesis, congenital
|
[NCBI]
|
1.61386e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
1.61386e-05
|
|
|
papilloma of choroid plexus
|
[NCBI]
|
1.61386e-05
|
|
|
SCA15
|
[NCBI]
|
1.61386e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
1.61386e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
1.61386e-05
|
|
|
CHBL
|
[NCBI]
|
1.61386e-05
|
|
|
USH1G
|
[NCBI]
|
1.61386e-05
|
|
|
CMD1C
|
[NCBI]
|
1.61386e-05
|
|
|
XS
|
[NCBI]
|
1.61386e-05
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
1.61386e-05
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
1.61386e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
1.61386e-05
|
|
|
MRT2
|
[NCBI]
|
1.61386e-05
|
|
|
PTLS
|
[NCBI]
|
1.61386e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
1.61386e-05
|
|
|
LCA5
|
[NCBI]
|
1.61386e-05
|
|
|
EEG
|
[NCBI]
|
1.61386e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
1.61386e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
1.61386e-05
|
|
|
SPG7
|
[NCBI]
|
1.61386e-05
|
|
|
CCL
|
[NCBI]
|
1.61386e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
1.61386e-05
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
1.61386e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
1.61386e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
1.61386e-05
|
|
|
FHL4
|
[NCBI]
|
1.61386e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
1.61386e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 2
|
[NCBI]
|
1.61386e-05
|
|
|
syndactyly, type iii
|
[NCBI]
|
1.61386e-05
|
|
|
SCA13
|
[NCBI]
|
1.61386e-05
|
|
|
EBN2
|
[NCBI]
|
1.61386e-05
|
|
|
resting heart rate
|
[NCBI]
|
1.61386e-05
|
|
|
kanzaki disease
|
[NCBI]
|
1.61386e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
1.61386e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
1.61386e-05
|
|
|
SW
|
[NCBI]
|
1.61386e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
1.61386e-05
|
|
|
USH1F
|
[NCBI]
|
1.61386e-05
|
|
|
MCOP2
|
[NCBI]
|
1.61386e-05
|
|
|
CLN7
|
[NCBI]
|
1.61386e-05
|
|
|
oculopalatoskeletal syndrome
|
[NCBI]
|
1.61386e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
1.61386e-05
|
|
|
IDUA
|
[NCBI]
|
1.60843e-05
|
|
|
HHT
|
[NCBI]
|
1.60129e-05
|
|
|
HNPP
|
[NCBI]
|
1.60129e-05
|
|
|
NF2
|
[NCBI]
|
1.60129e-05
|
|
|
RBP4
|
[NCBI]
|
1.59538e-05
|
|
|
HLXB9
|
[NCBI]
|
1.55586e-05
|
|
|
TMPRSS3
|
[NCBI]
|
1.55586e-05
|
|
|
INHBB
|
[NCBI]
|
1.55586e-05
|
|
|
CYP4A11
|
[NCBI]
|
1.55586e-05
|
|
|
TARDBP
|
[NCBI]
|
1.55586e-05
|
|
|
GPR154
|
[NCBI]
|
1.55586e-05
|
|
|
FUT6
|
[NCBI]
|
1.55586e-05
|
|
|
AGRP
|
[NCBI]
|
1.55586e-05
|
|
|
LOXL1
|
[NCBI]
|
1.55586e-05
|
|
|
CHIT1
|
[NCBI]
|
1.55586e-05
|
|
|
SLC25A13
|
[NCBI]
|
1.55586e-05
|
|
|
ME1
|
[NCBI]
|
1.55586e-05
|
|
|
SLC22A4
|
[NCBI]
|
1.55586e-05
|
|
|
HBA1
|
[NCBI]
|
1.55339e-05
|
|
|
UCHL1
|
[NCBI]
|
1.55103e-05
|
|
|
IL6R
|
[NCBI]
|
1.55103e-05
|
|
|
BHMT
|
[NCBI]
|
1.55103e-05
|
|
|
PTS
|
[NCBI]
|
1.55103e-05
|
|
|
FOXC1
|
[NCBI]
|
1.55103e-05
|
|
|
ATM
|
[NCBI]
|
1.54161e-05
|
|
|
IGF1R
|
[NCBI]
|
1.53621e-05
|
|
|
PTPN11
|
[NCBI]
|
1.53621e-05
|
|
|
UGT1A1
|
[NCBI]
|
1.53236e-05
|
|
|
IFNG
|
[NCBI]
|
1.52439e-05
|
|
|
UCP2
|
[NCBI]
|
1.51556e-05
|
|
|
ADM
|
[NCBI]
|
1.51393e-05
|
|
|
TERT
|
[NCBI]
|
1.49528e-05
|
|
|
FGFR2
|
[NCBI]
|
1.48739e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
1.48504e-05
|
|
|
SLC2A4
|
[NCBI]
|
1.47998e-05
|
|
|
ALPS
|
[NCBI]
|
1.47953e-05
|
|
|
ENPP1
|
[NCBI]
|
1.47952e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.47059e-05
|
|
|
RETN
|
[NCBI]
|
1.47059e-05
|
|
|
SGCE
|
[NCBI]
|
1.47059e-05
|
|
|
PRKCG
|
[NCBI]
|
1.47059e-05
|
|
|
HADHA
|
[NCBI]
|
1.47059e-05
|
|
|
LNS
|
[NCBI]
|
1.46597e-05
|
|
|
PCD
|
[NCBI]
|
1.45876e-05
|
|
|
CORDX1
|
[NCBI]
|
1.43076e-05
|
|
|
LGMD1B
|
[NCBI]
|
1.43076e-05
|
|
|
LQT3
|
[NCBI]
|
1.43076e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
1.43076e-05
|
|
|
AGS1
|
[NCBI]
|
1.43076e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
1.43076e-05
|
|
|
STGD3
|
[NCBI]
|
1.43076e-05
|
|
|
PAFAH1B1
|
[NCBI]
|
1.42517e-05
|
|
|
FGF2
|
[NCBI]
|
1.41905e-05
|
|
|
TBCE
|
[NCBI]
|
1.41499e-05
|
|
|
CRLF1
|
[NCBI]
|
1.41499e-05
|
|
|
NTS
|
[NCBI]
|
1.41499e-05
|
|
|
MKKS
|
[NCBI]
|
1.41499e-05
|
|
|
OPHN1
|
[NCBI]
|
1.41499e-05
|
|
|
GPD2
|
[NCBI]
|
1.41499e-05
|
|
|
HTR2C
|
[NCBI]
|
1.41499e-05
|
|
|
HEY2
|
[NCBI]
|
1.41499e-05
|
|
|
MTRR
|
[NCBI]
|
1.41499e-05
|
|
|
F2RL3
|
[NCBI]
|
1.41499e-05
|
|
|
FCAR
|
[NCBI]
|
1.41499e-05
|
|
|
HYPP
|
[NCBI]
|
1.40528e-05
|
|
|
NEB
|
[NCBI]
|
1.3954e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
1.39515e-05
|
|
|
RP2
|
[NCBI]
|
1.39515e-05
|
|
|
small cell cancer of the lung
|
[NCBI]
|
1.39248e-05
|
|
|
FTD
|
[NCBI]
|
1.3857e-05
|
|
|
PPOX
|
[NCBI]
|
1.37301e-05
|
|
|
DYX1
|
[NCBI]
|
1.34973e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
1.34973e-05
|
|
|
lung cancer
|
[NCBI]
|
1.34973e-05
|
|
|
CLN3
|
[NCBI]
|
1.32495e-05
|
|
|
HR
|
[NCBI]
|
1.32495e-05
|
|
|
CPT2
|
[NCBI]
|
1.32495e-05
|
|
|
ICAM1
|
[NCBI]
|
1.32292e-05
|
|
|
IL13
|
[NCBI]
|
1.32292e-05
|
|
|
GHRL
|
[NCBI]
|
1.32292e-05
|
|
|
ALK
|
[NCBI]
|
1.31808e-05
|
|
|
SCN5A
|
[NCBI]
|
1.31517e-05
|
|
|
CDB2
|
[NCBI]
|
1.30596e-05
|
|
|
HBA2
|
[NCBI]
|
1.29727e-05
|
|
|
MLPH
|
[NCBI]
|
1.29316e-05
|
|
|
KRTHB6
|
[NCBI]
|
1.29316e-05
|
|
|
MORF4
|
[NCBI]
|
1.29316e-05
|
|
|
CLDN16
|
[NCBI]
|
1.29316e-05
|
|
|
PEX12
|
[NCBI]
|
1.29316e-05
|
|
|
HTRA1
|
[NCBI]
|
1.29316e-05
|
|
|
GBE1
|
[NCBI]
|
1.29316e-05
|
|
|
IL9R
|
[NCBI]
|
1.29316e-05
|
|
|
APOA5
|
[NCBI]
|
1.29316e-05
|
|
|
ASPN
|
[NCBI]
|
1.29316e-05
|
|
|
ALMS1
|
[NCBI]
|
1.29316e-05
|
|
|
ABCC6
|
[NCBI]
|
1.27478e-05
|
|
|
DBI
|
[NCBI]
|
1.26846e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.25877e-05
|
|
|
ATP2A2
|
[NCBI]
|
1.25877e-05
|
|
|
CBX5
|
[NCBI]
|
1.25355e-05
|
|
|
OR13G1
|
[NCBI]
|
1.25341e-05
|
|
|
DACH2
|
[NCBI]
|
1.25341e-05
|
|
|
FCGR3B
|
[NCBI]
|
1.25341e-05
|
|
|
g-substrate
|
[NCBI]
|
1.25341e-05
|
|
|
UNC13A
|
[NCBI]
|
1.25341e-05
|
|
|
C6ORF15
|
[NCBI]
|
1.25341e-05
|
|
|
LIX1
|
[NCBI]
|
1.25341e-05
|
|
|
CKMTS
|
[NCBI]
|
1.25341e-05
|
|
|
PGLYRP3
|
[NCBI]
|
1.25341e-05
|
|
|
SOX8
|
[NCBI]
|
1.25341e-05
|
|
|
TBCD
|
[NCBI]
|
1.25341e-05
|
|
|
PGA3
|
[NCBI]
|
1.25341e-05
|
|
|
MASTL
|
[NCBI]
|
1.25341e-05
|
|
|
ZC3H12D
|
[NCBI]
|
1.25341e-05
|
|
|
MTNR1B
|
[NCBI]
|
1.25341e-05
|
|
|
KRTHB3
|
[NCBI]
|
1.25341e-05
|
|
|
HYLS1
|
[NCBI]
|
1.25341e-05
|
|
|
CARKL
|
[NCBI]
|
1.25341e-05
|
|
|
FBXL20
|
[NCBI]
|
1.25341e-05
|
|
|
MYO3A
|
[NCBI]
|
1.25341e-05
|
|
|
ste20-related adaptor protein
|
[NCBI]
|
1.25341e-05
|
|
|
THBS4
|
[NCBI]
|
1.25341e-05
|
|
|
ORAOV1
|
[NCBI]
|
1.25341e-05
|
|
|
TMPRSS11A
|
[NCBI]
|
1.25341e-05
|
|
|
OTOA
|
[NCBI]
|
1.25341e-05
|
|
|
ichthyin
|
[NCBI]
|
1.25341e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.25341e-05
|
|
|
SLC12A8
|
[NCBI]
|
1.25341e-05
|
|
|
mapbp-interacting protein
|
[NCBI]
|
1.25341e-05
|
|
|
CDX4
|
[NCBI]
|
1.25341e-05
|
|
|
SPG11
|
[NCBI]
|
1.25341e-05
|
|
|
TAS2R50
|
[NCBI]
|
1.25341e-05
|
|
|
dendritic cell nuclear protein 1
|
[NCBI]
|
1.25341e-05
|
|
|
ADAMTS2
|
[NCBI]
|
1.25341e-05
|
|
|
abl interactor 2
|
[NCBI]
|
1.25341e-05
|
|
|
CTTNBP2
|
[NCBI]
|
1.25341e-05
|
|
|
PGLYRP4
|
[NCBI]
|
1.25341e-05
|
|
|
FVT1
|
[NCBI]
|
1.25341e-05
|
|
|
TOR1B
|
[NCBI]
|
1.25341e-05
|
|
|
GMIP
|
[NCBI]
|
1.25341e-05
|
|
|
XYLT2
|
[NCBI]
|
1.25341e-05
|
|
|
SCS
|
[NCBI]
|
1.24995e-05
|
|
|
BHC
|
[NCBI]
|
1.24876e-05
|
|
|
SCZD4
|
[NCBI]
|
1.24876e-05
|
|
|
GAN1
|
[NCBI]
|
1.24876e-05
|
|
|
mowat-wilson syndrome
|
[NCBI]
|
1.24876e-05
|
|
|
propionic acidemia
|
[NCBI]
|
1.24876e-05
|
|
|
LGMD2B
|
[NCBI]
|
1.24876e-05
|
|
|
UMS
|
[NCBI]
|
1.24876e-05
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
1.24876e-05
|
|
|
JH
|
[NCBI]
|
1.24876e-05
|
|
|
SOST
|
[NCBI]
|
1.24876e-05
|
|
|
LHCGR
|
[NCBI]
|
1.23968e-05
|
|
|
PROCR
|
[NCBI]
|
1.23968e-05
|
|
|
HBFQTL1
|
[NCBI]
|
1.22448e-05
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
1.22314e-05
|
|
|
CACP
|
[NCBI]
|
1.22314e-05
|
|
|
PFIC2
|
[NCBI]
|
1.22314e-05
|
|
|
anderson disease
|
[NCBI]
|
1.22314e-05
|
|
|
CSCD
|
[NCBI]
|
1.22314e-05
|
|
|
RTADR
|
[NCBI]
|
1.22314e-05
|
|
|
LISX2
|
[NCBI]
|
1.22314e-05
|
|
|
TINU
|
[NCBI]
|
1.22314e-05
|
|
|
gtp cyclohydrolase i deficiency
|
[NCBI]
|
1.22314e-05
|
|
|
DFNB2
|
[NCBI]
|
1.22314e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
1.22314e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
1.22314e-05
|
|
|
HCHOLA3
|
[NCBI]
|
1.22314e-05
|
|
|
LCA2
|
[NCBI]
|
1.22314e-05
|
|
|
3-@methylcrotonyl-coa carboxylase 2 deficiency
|
[NCBI]
|
1.22314e-05
|
|
|
anemia, microcytic
|
[NCBI]
|
1.22314e-05
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
1.22314e-05
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
1.22314e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
1.22314e-05
|
|
|
DFNB12
|
[NCBI]
|
1.22314e-05
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
1.22314e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
1.22314e-05
|
|
|
KRS
|
[NCBI]
|
1.22314e-05
|
|
|
EBDSC
|
[NCBI]
|
1.22314e-05
|
|
|
MRX59
|
[NCBI]
|
1.22314e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
1.22314e-05
|
|
|
CMD1D
|
[NCBI]
|
1.22314e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
1.22314e-05
|
|
|
epidermolysis bullosa pruriginosa
|
[NCBI]
|
1.22314e-05
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
1.22314e-05
|
|
|
AIHHT
|
[NCBI]
|
1.22314e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
1.22314e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
1.22314e-05
|
|
|
CDHS
|
[NCBI]
|
1.22314e-05
|
|
|
TRPS3
|
[NCBI]
|
1.22314e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.21906e-05
|
|
|
FOP
|
[NCBI]
|
1.20252e-05
|
|
|
INSR
|
[NCBI]
|
1.18762e-05
|
|
|
PEPC
|
[NCBI]
|
1.1863e-05
|
|
|
FACL4
|
[NCBI]
|
1.1863e-05
|
|
|
T
|
[NCBI]
|
1.1863e-05
|
|
|
HMGCR
|
[NCBI]
|
1.1863e-05
|
|
|
HOXA1
|
[NCBI]
|
1.1863e-05
|
|
|
CCL5
|
[NCBI]
|
1.1863e-05
|
|
|
PLA2G4A
|
[NCBI]
|
1.1863e-05
|
|
|
ATP2B2
|
[NCBI]
|
1.1863e-05
|
|
|
GSS
|
[NCBI]
|
1.1863e-05
|
|
|
KRT16
|
[NCBI]
|
1.1863e-05
|
|
|
SEMA3B
|
[NCBI]
|
1.1863e-05
|
|
|
NR2E3
|
[NCBI]
|
1.1863e-05
|
|
|
SHOX
|
[NCBI]
|
1.18393e-05
|
|
|
JAG1
|
[NCBI]
|
1.18393e-05
|
|
|
PEMT
|
[NCBI]
|
1.18393e-05
|
|
|
LAD
|
[NCBI]
|
1.17991e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.17364e-05
|
|
|
EV
|
[NCBI]
|
1.16888e-05
|
|
|
VWS
|
[NCBI]
|
1.15467e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.15467e-05
|
|
|
PPT1
|
[NCBI]
|
1.14103e-05
|
|
|
C4B
|
[NCBI]
|
1.14103e-05
|
|
|
HSR
|
[NCBI]
|
1.13772e-05
|
|
|
EMD
|
[NCBI]
|
1.13772e-05
|
|
|
MLH1
|
[NCBI]
|
1.1372e-05
|
|
|
RTS
|
[NCBI]
|
1.11094e-05
|
|
|
DAR
|
[NCBI]
|
1.10851e-05
|
|
|
SLPI
|
[NCBI]
|
1.10605e-05
|
|
|
MLC1
|
[NCBI]
|
1.09152e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.09152e-05
|
|
|
ASPM
|
[NCBI]
|
1.09152e-05
|
|
|
HPS1
|
[NCBI]
|
1.09152e-05
|
|
|
SOST
|
[NCBI]
|
1.09152e-05
|
|
|
MCM6
|
[NCBI]
|
1.09152e-05
|
|
|
CDKN2B
|
[NCBI]
|
1.09152e-05
|
|
|
SOAT1
|
[NCBI]
|
1.09152e-05
|
|
|
ORM2
|
[NCBI]
|
1.09152e-05
|
|
|
KIR2DL1
|
[NCBI]
|
1.09152e-05
|
|
|
DGAT1
|
[NCBI]
|
1.09152e-05
|
|
|
TFAP2A
|
[NCBI]
|
1.09152e-05
|
|
|
KCNQ4
|
[NCBI]
|
1.09152e-05
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.08737e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
1.08737e-05
|
|
|
FED
|
[NCBI]
|
1.08737e-05
|
|
|
HSAN2
|
[NCBI]
|
1.08737e-05
|
|
|
PARK6
|
[NCBI]
|
1.08737e-05
|
|
|
alexander disease
|
[NCBI]
|
1.08737e-05
|
|
|
SRD5A2
|
[NCBI]
|
1.08221e-05
|
|
|
CLOCK
|
[NCBI]
|
1.08221e-05
|
|
|
TGM1
|
[NCBI]
|
1.08221e-05
|
|
|
LRP5
|
[NCBI]
|
1.08221e-05
|
|
|
GPI
|
[NCBI]
|
1.05676e-05
|
|
|
CDK4
|
[NCBI]
|
1.04661e-05
|
|
|
HAE
|
[NCBI]
|
1.04307e-05
|
|
|
AIRE
|
[NCBI]
|
1.04208e-05
|
|
|
SCN1A
|
[NCBI]
|
1.0297e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.0297e-05
|
|
|
GALC
|
[NCBI]
|
1.0297e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.02144e-05
|
|
|
PSACH
|
[NCBI]
|
1.01441e-05
|
|
|
SPINK5
|
[NCBI]
|
1.00669e-05
|
|
|
LGI1
|
[NCBI]
|
1.00669e-05
|
|
|
SULT1A1
|
[NCBI]
|
1.00669e-05
|
|
|
OLIG2
|
[NCBI]
|
1.00669e-05
|
|
|
HHEX
|
[NCBI]
|
1.00669e-05
|
|
|
MTND4
|
[NCBI]
|
1.00646e-05
|
|
|
RB1
|
[NCBI]
|
9.92587e-06
|
|
|
SCN4A
|
[NCBI]
|
9.8437e-06
|
|
|
ADIPOQ
|
[NCBI]
|
9.8437e-06
|
|
|
AHSG
|
[NCBI]
|
9.79938e-06
|
|
|
MVK
|
[NCBI]
|
9.79938e-06
|
|
|
NF2
|
[NCBI]
|
9.76634e-06
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
9.76376e-06
|
|
|
TS
|
[NCBI]
|
9.71819e-06
|
|
|
ATP13A2
|
[NCBI]
|
9.61084e-06
|
|
|
HS1BP3
|
[NCBI]
|
9.61084e-06
|
|
|
STOX1
|
[NCBI]
|
9.61084e-06
|
|
|
MDFI
|
[NCBI]
|
9.61084e-06
|
|
|
HOXA11
|
[NCBI]
|
9.61084e-06
|
|
|
CTH
|
[NCBI]
|
9.61084e-06
|
|
|
PDLIM4
|
[NCBI]
|
9.61084e-06
|
|
|
E2F5
|
[NCBI]
|
9.61084e-06
|
|
|
FCRL3
|
[NCBI]
|
9.61084e-06
|
|
|
GSTA3
|
[NCBI]
|
9.61084e-06
|
|
|
ACCN4
|
[NCBI]
|
9.61084e-06
|
|
|
PPM1B
|
[NCBI]
|
9.61084e-06
|
|
|
RRH
|
[NCBI]
|
9.61084e-06
|
|
|
DDX25
|
[NCBI]
|
9.61084e-06
|
|
|
RBM17
|
[NCBI]
|
9.61084e-06
|
|
|
WTAP
|
[NCBI]
|
9.61084e-06
|
|
|
HS3ST1
|
[NCBI]
|
9.61084e-06
|
|
|
DPP10
|
[NCBI]
|
9.61084e-06
|
|
|
locus control region, alpha
|
[NCBI]
|
9.61084e-06
|
|
|
PEX10
|
[NCBI]
|
9.61084e-06
|
|
|
RRN3
|
[NCBI]
|
9.61084e-06
|
|
|
TAAR2
|
[NCBI]
|
9.61084e-06
|
|
|
CHL1
|
[NCBI]
|
9.61084e-06
|
|
|
ATP6V0A4
|
[NCBI]
|
9.61084e-06
|
|
|
ZNF365
|
[NCBI]
|
9.61084e-06
|
|
|
BARHL1
|
[NCBI]
|
9.61084e-06
|
|
|
KRT6B
|
[NCBI]
|
9.61084e-06
|
|
|
CRBN
|
[NCBI]
|
9.61084e-06
|
|
|
WNT5B
|
[NCBI]
|
9.61084e-06
|
|
|
CCL26
|
[NCBI]
|
9.61084e-06
|
|
|
RPS6KB2
|
[NCBI]
|
9.61084e-06
|
|
|
PTGES2
|
[NCBI]
|
9.61084e-06
|
|
|
P2RX5
|
[NCBI]
|
9.61084e-06
|
|
|
PCDH21
|
[NCBI]
|
9.61084e-06
|
|
|
EPHB4
|
[NCBI]
|
9.61084e-06
|
|
|
AKAP10
|
[NCBI]
|
9.61084e-06
|
|
|
LETM1
|
[NCBI]
|
9.61084e-06
|
|
|
ETFDH
|
[NCBI]
|
9.61084e-06
|
|
|
SACP
|
[NCBI]
|
9.61084e-06
|
|
|
GRM3
|
[NCBI]
|
9.61084e-06
|
|
|
SPAG6
|
[NCBI]
|
9.61084e-06
|
|
|
GSTA1
|
[NCBI]
|
9.61084e-06
|
|
|
CHK
|
[NCBI]
|
9.61084e-06
|
|
|
POMT2
|
[NCBI]
|
9.61084e-06
|
|
|
ANKS1A
|
[NCBI]
|
9.61084e-06
|
|
|
LCA5
|
[NCBI]
|
9.61084e-06
|
|
|
MTHFD1L
|
[NCBI]
|
9.61084e-06
|
|
|
FOXL1
|
[NCBI]
|
9.61084e-06
|
|
|
RNASE1
|
[NCBI]
|
9.61084e-06
|
|
|
MPST
|
[NCBI]
|
9.61084e-06
|
|
|
GMDS
|
[NCBI]
|
9.61084e-06
|
|
|
CACNA2D4
|
[NCBI]
|
9.61084e-06
|
|
|
HSF2
|
[NCBI]
|
9.61084e-06
|
|
|
FBN3
|
[NCBI]
|
9.61084e-06
|
|
|
USP24
|
[NCBI]
|
9.61084e-06
|
|
|
MAEA
|
[NCBI]
|
9.61084e-06
|
|
|
COX17
|
[NCBI]
|
9.61084e-06
|
|
|
DNMT1
|
[NCBI]
|
9.5935e-06
|
|
|
CPI
|
[NCBI]
|
9.53849e-06
|
|
|
IAPP
|
[NCBI]
|
9.50483e-06
|
|
|
POLG
|
[NCBI]
|
9.48593e-06
|
|
|
ENG
|
[NCBI]
|
9.48593e-06
|
|
|
CYP19A1
|
[NCBI]
|
9.47598e-06
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
9.4706e-06
|
|
|
MKKS
|
[NCBI]
|
9.43907e-06
|
|
|
ICP
|
[NCBI]
|
9.43907e-06
|
|
|
hydatidiform mole
|
[NCBI]
|
9.43907e-06
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
9.43907e-06
|
|
|
SCZD1
|
[NCBI]
|
9.43907e-06
|
|
|
TMAU
|
[NCBI]
|
9.43907e-06
|
|
|
OPTB3
|
[NCBI]
|
9.43907e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
9.43907e-06
|
|
|
EVR1
|
[NCBI]
|
9.43907e-06
|
|
|
EDC
|
[NCBI]
|
9.43907e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
9.43907e-06
|
|
|
JPS
|
[NCBI]
|
9.39503e-06
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
9.35246e-06
|
|
|
ADCC
|
[NCBI]
|
9.35246e-06
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
9.35246e-06
|
|
|
paget disease, juvenile
|
[NCBI]
|
9.35246e-06
|
|
|
OCA1B
|
[NCBI]
|
9.35246e-06
|
|
|
LGMD2F
|
[NCBI]
|
9.35246e-06
|
|
|
HDL1
|
[NCBI]
|
9.35246e-06
|
|
|
adenylosuccinase deficiency
|
[NCBI]
|
9.35246e-06
|
|
|
SHFM4
|
[NCBI]
|
9.35246e-06
|
|
|
UL
|
[NCBI]
|
9.35246e-06
|
|
|
ATCAY
|
[NCBI]
|
9.35246e-06
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
9.35246e-06
|
|
|
optic atrophy 1 and deafness
|
[NCBI]
|
9.35246e-06
|
|
|
elejalde disease
|
[NCBI]
|
9.35246e-06
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
9.35246e-06
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
9.35246e-06
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
9.35246e-06
|
|
|
HDL2
|
[NCBI]
|
9.35246e-06
|
|
|
amyloidosis vii
|
[NCBI]
|
9.35246e-06
|
|
|
HOMG2
|
[NCBI]
|
9.35246e-06
|
|
|
FANCD1
|
[NCBI]
|
9.35246e-06
|
|
|
cherubism
|
[NCBI]
|
9.35246e-06
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
9.35246e-06
|
|
|
gamma-glutamylcysteine synthetase deficiency, hemolytic anemia due to
|
[NCBI]
|
9.35246e-06
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
9.35246e-06
|
|
|
thrombophilia
|
[NCBI]
|
9.35246e-06
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
9.35246e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
9.35246e-06
|
|
|
RCDP2
|
[NCBI]
|
9.35246e-06
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
9.35246e-06
|
|
|
ectodermal dysplasia/skin fragility syndrome
|
[NCBI]
|
9.35246e-06
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
9.35246e-06
|
|
|
PVOD
|
[NCBI]
|
9.35246e-06
|
|
|
CMRD
|
[NCBI]
|
9.35246e-06
|
|
|
CHRNE
|
[NCBI]
|
9.3273e-06
|
|
|
GJA8
|
[NCBI]
|
9.3273e-06
|
|
|
PRKAR1A
|
[NCBI]
|
9.3273e-06
|
|
|
C5R1
|
[NCBI]
|
9.3022e-06
|
|
|
MTHFD1
|
[NCBI]
|
9.3022e-06
|
|
|
ATP1A1
|
[NCBI]
|
9.3022e-06
|
|
|
EIF2B5
|
[NCBI]
|
9.3022e-06
|
|
|
ODC1
|
[NCBI]
|
9.3022e-06
|
|
|
RAI1
|
[NCBI]
|
9.3022e-06
|
|
|
SFTPA1
|
[NCBI]
|
9.3022e-06
|
|
|
MSR1
|
[NCBI]
|
9.3022e-06
|
|
|
HLCS
|
[NCBI]
|
9.3022e-06
|
|
|
NQO1
|
[NCBI]
|
9.3022e-06
|
|
|
tyrosinemia, type i
|
[NCBI]
|
9.14048e-06
|
|
|
MTS
|
[NCBI]
|
9.109e-06
|
|
|
STL1
|
[NCBI]
|
9.01741e-06
|
|
|
TTR
|
[NCBI]
|
8.99634e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
8.91541e-06
|
|
|
SCA2
|
[NCBI]
|
8.91541e-06
|
|
|
PITX2
|
[NCBI]
|
8.8789e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
8.8789e-06
|
|
|
SLC25A4
|
[NCBI]
|
8.8789e-06
|
|
|
TNFRSF10A
|
[NCBI]
|
8.8789e-06
|
|
|
AHR
|
[NCBI]
|
8.82737e-06
|
|
|
ATRX
|
[NCBI]
|
8.80681e-06
|
|
|
LPI
|
[NCBI]
|
8.80057e-06
|
|
|
ND
|
[NCBI]
|
8.80057e-06
|
|
|
RNASE2
|
[NCBI]
|
8.77051e-06
|
|
|
HOS
|
[NCBI]
|
8.66714e-06
|
|
|
TGFB1
|
[NCBI]
|
8.64972e-06
|
|
|
CD36
|
[NCBI]
|
8.64972e-06
|
|
|
TBXA2R
|
[NCBI]
|
8.60852e-06
|
|
|
ADAR
|
[NCBI]
|
8.60852e-06
|
|
|
SLC27A1
|
[NCBI]
|
8.60852e-06
|
|
|
PCCA
|
[NCBI]
|
8.60852e-06
|
|
|
EPM2A
|
[NCBI]
|
8.60852e-06
|
|
|
OGG1
|
[NCBI]
|
8.60852e-06
|
|
|
P2RX7
|
[NCBI]
|
8.60852e-06
|
|
|
L1CAM
|
[NCBI]
|
8.4844e-06
|
|
|
CTSC
|
[NCBI]
|
8.4844e-06
|
|
|
TRPS2
|
[NCBI]
|
8.46711e-06
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
8.46711e-06
|
|
|
MEN2A
|
[NCBI]
|
8.28599e-06
|
|
|
camurati-engelmann disease
|
[NCBI]
|
8.16189e-06
|
|
|
glycogen storage disease iv
|
[NCBI]
|
8.16189e-06
|
|
|
EA2
|
[NCBI]
|
8.16189e-06
|
|
|
GABEB
|
[NCBI]
|
8.16189e-06
|
|
|
AIS
|
[NCBI]
|
8.08783e-06
|
|
|
CAV3
|
[NCBI]
|
8.04679e-06
|
|
|
PRODH
|
[NCBI]
|
8.04679e-06
|
|
|
KCNJ11
|
[NCBI]
|
8.04679e-06
|
|
|
TWIST1
|
[NCBI]
|
8.04679e-06
|
|
|
DTNBP1
|
[NCBI]
|
7.97601e-06
|
|
|
CTNS
|
[NCBI]
|
7.97601e-06
|
|
|
CRB1
|
[NCBI]
|
7.97601e-06
|
|
|
PLAU
|
[NCBI]
|
7.97601e-06
|
|
|
SIX5
|
[NCBI]
|
7.97601e-06
|
|
|
OTOF
|
[NCBI]
|
7.97601e-06
|
|
|
ME2
|
[NCBI]
|
7.97601e-06
|
|
|
PGK2
|
[NCBI]
|
7.97601e-06
|
|
|
FOXP2
|
[NCBI]
|
7.97601e-06
|
|
|
IFNA1
|
[NCBI]
|
7.93794e-06
|
|
|
HLA-A
|
[NCBI]
|
7.91553e-06
|
|
|
PLTP
|
[NCBI]
|
7.9045e-06
|
|
|
sotos syndrome
|
[NCBI]
|
7.88498e-06
|
|
|
ALGS1
|
[NCBI]
|
7.88498e-06
|
|
|
AKT1
|
[NCBI]
|
7.87154e-06
|
|
|
WAS
|
[NCBI]
|
7.87154e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
7.83876e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
7.83876e-06
|
|
|
HDAC1
|
[NCBI]
|
7.80075e-06
|
|
|
PC
|
[NCBI]
|
7.80075e-06
|
|
|
TD1
|
[NCBI]
|
7.78185e-06
|
|
|
RNASEH1
|
[NCBI]
|
7.77899e-06
|
|
|
DNMBP
|
[NCBI]
|
7.77899e-06
|
|
|
IGLV
|
[NCBI]
|
7.77899e-06
|
|
|
scribble, drosophila, homolog of
|
[NCBI]
|
7.77899e-06
|
|
|
DND1
|
[NCBI]
|
7.77899e-06
|
|
|
FDFT1
|
[NCBI]
|
7.77899e-06
|
|
|
GULP1
|
[NCBI]
|
7.77899e-06
|
|
|
PLEKHA1
|
[NCBI]
|
7.77899e-06
|
|
|
EDN2
|
[NCBI]
|
7.77899e-06
|
|
|
CTNND2
|
[NCBI]
|
7.77899e-06
|
|
|
IGHG3
|
[NCBI]
|
7.77899e-06
|
|
|
GUCY2F
|
[NCBI]
|
7.77899e-06
|
|
|
UGT1A9
|
[NCBI]
|
7.77899e-06
|
|
|
SLC5A3
|
[NCBI]
|
7.77899e-06
|
|
|
BTBD9
|
[NCBI]
|
7.77899e-06
|
|
|
UBR1
|
[NCBI]
|
7.77899e-06
|
|
|
COL8A2
|
[NCBI]
|
7.77899e-06
|
|
|
TSNAX
|
[NCBI]
|
7.77899e-06
|
|
|
SCARB2
|
[NCBI]
|
7.77899e-06
|
|
|
NELF
|
[NCBI]
|
7.77899e-06
|
|
|
NT5E
|
[NCBI]
|
7.77899e-06
|
|
|
H1FT
|
[NCBI]
|
7.77899e-06
|
|
|
IFNA17
|
[NCBI]
|
7.77899e-06
|
|
|
CYP46A1
|
[NCBI]
|
7.77899e-06
|
|
|
MUC7
|
[NCBI]
|
7.77899e-06
|
|
|
CTDP1
|
[NCBI]
|
7.77899e-06
|
|
|
HOXB8
|
[NCBI]
|
7.77899e-06
|
|
|
FGL2
|
[NCBI]
|
7.77899e-06
|
|
|
POU6F2
|
[NCBI]
|
7.77899e-06
|
|
|
ALOXE3
|
[NCBI]
|
7.77899e-06
|
|
|
GAPDHS
|
[NCBI]
|
7.77899e-06
|
|
|
KIR2DL5
|
[NCBI]
|
7.77899e-06
|
|
|
SLC12A1
|
[NCBI]
|
7.77899e-06
|
|
|
LRP1B
|
[NCBI]
|
7.77899e-06
|
|
|
JRK
|
[NCBI]
|
7.77899e-06
|
|
|
ITPKC
|
[NCBI]
|
7.77899e-06
|
|
|
PEX26
|
[NCBI]
|
7.77899e-06
|
|
|
COLEC12
|
[NCBI]
|
7.77899e-06
|
|
|
BAAT
|
[NCBI]
|
7.77899e-06
|
|
|
MKL2
|
[NCBI]
|
7.77899e-06
|
|
|
ITGA1
|
[NCBI]
|
7.77899e-06
|
|
|
PIK3CB
|
[NCBI]
|
7.77899e-06
|
|
|
SNAP29
|
[NCBI]
|
7.77899e-06
|
|
|
IL1R2
|
[NCBI]
|
7.77899e-06
|
|
|
FKBP6
|
[NCBI]
|
7.77899e-06
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
7.77899e-06
|
|
|
PRKACG
|
[NCBI]
|
7.77899e-06
|
|
|
deleted in split-hand/split-foot 1 region
|
[NCBI]
|
7.77899e-06
|
|
|
CHGB
|
[NCBI]
|
7.77899e-06
|
|
|
ADAMTS5
|
[NCBI]
|
7.77899e-06
|
|
|
XYLT1
|
[NCBI]
|
7.77899e-06
|
|
|
CD109
|
[NCBI]
|
7.77899e-06
|
|
|
WWC1
|
[NCBI]
|
7.77899e-06
|
|
|
CD72
|
[NCBI]
|
7.77899e-06
|
|
|
ANXA9
|
[NCBI]
|
7.77899e-06
|
|
|
CACNA2D2
|
[NCBI]
|
7.77899e-06
|
|
|
LSP1
|
[NCBI]
|
7.77899e-06
|
|
|
MKRN1
|
[NCBI]
|
7.77899e-06
|
|
|
HSPE1
|
[NCBI]
|
7.77899e-06
|
|
|
HPS3
|
[NCBI]
|
7.77899e-06
|
|
|
GSTA4
|
[NCBI]
|
7.77899e-06
|
|
|
MTTY
|
[NCBI]
|
7.77899e-06
|
|
|
VAMP4
|
[NCBI]
|
7.77899e-06
|
|
|
PAXIP1
|
[NCBI]
|
7.77899e-06
|
|
|
TAF10
|
[NCBI]
|
7.77899e-06
|
|
|
ETFB
|
[NCBI]
|
7.77899e-06
|
|
|
UGT1A8
|
[NCBI]
|
7.77899e-06
|
|
|
CH25H
|
[NCBI]
|
7.77899e-06
|
|
|
CACNG4
|
[NCBI]
|
7.77899e-06
|
|
|
B4GALNT1
|
[NCBI]
|
7.77899e-06
|
|
|
SC5DL
|
[NCBI]
|
7.77899e-06
|
|
|
PREPL
|
[NCBI]
|
7.77899e-06
|
|
|
GAN
|
[NCBI]
|
7.77899e-06
|
|
|
GABRB1
|
[NCBI]
|
7.77899e-06
|
|
|
MAG
|
[NCBI]
|
7.73255e-06
|
|
|
APS1
|
[NCBI]
|
7.72068e-06
|
|
|
CAPN3
|
[NCBI]
|
7.66027e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
7.66027e-06
|
|
|
GCH1
|
[NCBI]
|
7.66027e-06
|
|
|
CETP
|
[NCBI]
|
7.66027e-06
|
|
|
CACNA1A
|
[NCBI]
|
7.58022e-06
|
|
|
DDC
|
[NCBI]
|
7.51406e-06
|
|
|
COL2A1
|
[NCBI]
|
7.50135e-06
|
|
|
BMPR1A
|
[NCBI]
|
7.39675e-06
|
|
|
CYBA
|
[NCBI]
|
7.39675e-06
|
|
|
PLIN
|
[NCBI]
|
7.39675e-06
|
|
|
NCF1
|
[NCBI]
|
7.39675e-06
|
|
|
NPHS1
|
[NCBI]
|
7.39675e-06
|
|
|
LYST
|
[NCBI]
|
7.39675e-06
|
|
|
ATP1A2
|
[NCBI]
|
7.39675e-06
|
|
|
ADIPOR1
|
[NCBI]
|
7.39675e-06
|
|
|
SI
|
[NCBI]
|
7.39205e-06
|
|
|
PIGR
|
[NCBI]
|
7.39205e-06
|
|
|
IL12B
|
[NCBI]
|
7.29178e-06
|
|
|
MN
|
[NCBI]
|
7.29178e-06
|
|
|
DJS
|
[NCBI]
|
7.24733e-06
|
|
|
LFS1
|
[NCBI]
|
7.22468e-06
|
|
|
COH1
|
[NCBI]
|
7.22468e-06
|
|
|
OCA1A
|
[NCBI]
|
7.22468e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
7.19138e-06
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
7.15283e-06
|
|
|
pancreatic cancer, susceptibility to, 1
|
[NCBI]
|
7.15283e-06
|
|
|
asthma, nasal polyps, and aspirin intolerance
|
[NCBI]
|
7.15283e-06
|
|
|
STHAG3
|
[NCBI]
|
7.15283e-06
|
|
|
TD2
|
[NCBI]
|
7.15283e-06
|
|
|
SCA5
|
[NCBI]
|
7.15283e-06
|
|
|
MCOPS9
|
[NCBI]
|
7.15283e-06
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
7.15283e-06
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
7.15283e-06
|
|
|
CDG1C
|
[NCBI]
|
7.15283e-06
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
7.15283e-06
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
7.15283e-06
|
|
|
twinning, monozygotic
|
[NCBI]
|
7.15283e-06
|
|
|
FSGS1
|
[NCBI]
|
7.15283e-06
|
|
|
thyrotoxic periodic paralysis
|
[NCBI]
|
7.15283e-06
|
|
|
AN1
|
[NCBI]
|
7.15283e-06
|
|
|
cerebral palsy, spastic, symmetric, autosomal recessive
|
[NCBI]
|
7.15283e-06
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
7.15283e-06
|
|
|
PC1
|
[NCBI]
|
7.15283e-06
|
|
|
CCM3
|
[NCBI]
|
7.15283e-06
|
|
|
polymicrogyria, bilateral frontoparietal
|
[NCBI]
|
7.15283e-06
|
|
|
SPMM
|
[NCBI]
|
7.15283e-06
|
|
|
STL2
|
[NCBI]
|
7.15283e-06
|
|
|
GBS
|
[NCBI]
|
7.15283e-06
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
7.15283e-06
|
|
|
WT5
|
[NCBI]
|
7.15283e-06
|
|
|
CZP3
|
[NCBI]
|
7.15283e-06
|
|
|
pemphigus vulgaris, familial
|
[NCBI]
|
7.15283e-06
|
|
|
HRPT1
|
[NCBI]
|
7.02411e-06
|
|
|
HNA
|
[NCBI]
|
7.02411e-06
|
|
|
VWM
|
[NCBI]
|
7.02411e-06
|
|
|
ABCC8
|
[NCBI]
|
7.01245e-06
|
|
|
corneal dystrophy, crystalline, of schnyder
|
[NCBI]
|
6.95232e-06
|
|
|
SHFLD1
|
[NCBI]
|
6.95232e-06
|
|
|
dermatitis, atopic
|
[NCBI]
|
6.95232e-06
|
|
|
stiff skin syndrome
|
[NCBI]
|
6.95232e-06
|
|
|
BULN1
|
[NCBI]
|
6.95232e-06
|
|
|
TOC
|
[NCBI]
|
6.95232e-06
|
|
|
MODY
|
[NCBI]
|
6.88502e-06
|
|
|
orotic aciduria i
|
[NCBI]
|
6.86424e-06
|
|
|
KEL
|
[NCBI]
|
6.86424e-06
|
|
|
GJA4
|
[NCBI]
|
6.86424e-06
|
|
|
GABRG2
|
[NCBI]
|
6.86424e-06
|
|
|
CCR2
|
[NCBI]
|
6.86424e-06
|
|
|
VASP
|
[NCBI]
|
6.74992e-06
|
|
|
PNMT
|
[NCBI]
|
6.68896e-06
|
|
|
HD
|
[NCBI]
|
6.68633e-06
|
|
|
PI
|
[NCBI]
|
6.66981e-06
|
|
|
MPO
|
[NCBI]
|
6.6588e-06
|
|
|
FIH
|
[NCBI]
|
6.62566e-06
|
|
|
GCPS
|
[NCBI]
|
6.62566e-06
|
|
|
MDLS
|
[NCBI]
|
6.62566e-06
|
|
|
complement component 2 deficiency
|
[NCBI]
|
6.60463e-06
|
|
|
CMT1B
|
[NCBI]
|
6.54894e-06
|
|
|
PTGDR
|
[NCBI]
|
6.4655e-06
|
|
|
KLF9
|
[NCBI]
|
6.4655e-06
|
|
|
DNAJB1
|
[NCBI]
|
6.4655e-06
|
|
|
RNF128
|
[NCBI]
|
6.4655e-06
|
|
|
IL10RA
|
[NCBI]
|
6.4655e-06
|
|
|
CPT1B
|
[NCBI]
|
6.4655e-06
|
|
|
NDUFV2
|
[NCBI]
|
6.4655e-06
|
|
|
GLMN
|
[NCBI]
|
6.4655e-06
|
|
|
MALL
|
[NCBI]
|
6.4655e-06
|
|
|
STK19
|
[NCBI]
|
6.4655e-06
|
|
|
CCM2
|
[NCBI]
|
6.4655e-06
|
|
|
ABCC11
|
[NCBI]
|
6.4655e-06
|
|
|
g30 gene
|
[NCBI]
|
6.4655e-06
|
|
|
TGM5
|
[NCBI]
|
6.4655e-06
|
|
|
DCDC2
|
[NCBI]
|
6.4655e-06
|
|
|
TSTA3
|
[NCBI]
|
6.4655e-06
|
|
|
ETFA
|
[NCBI]
|
6.4655e-06
|
|
|
B4GALNT2
|
[NCBI]
|
6.4655e-06
|
|
|
lipin 1
|
[NCBI]
|
6.4655e-06
|
|
|
ACLY
|
[NCBI]
|
6.4655e-06
|
|
|
KCNC3
|
[NCBI]
|
6.4655e-06
|
|
|
CD63
|
[NCBI]
|
6.4655e-06
|
|
|
PLOD2
|
[NCBI]
|
6.4655e-06
|
|
|
GANC
|
[NCBI]
|
6.4655e-06
|
|
|
EIF2B2
|
[NCBI]
|
6.4655e-06
|
|
|
AP1S2
|
[NCBI]
|
6.4655e-06
|
|
|
MTX1
|
[NCBI]
|
6.4655e-06
|
|
|
FADS1
|
[NCBI]
|
6.4655e-06
|
|
|
MYH3
|
[NCBI]
|
6.4655e-06
|
|
|
CPA4
|
[NCBI]
|
6.4655e-06
|
|
|
TTDN1
|
[NCBI]
|
6.4655e-06
|
|
|
FKBP4
|
[NCBI]
|
6.4655e-06
|
|
|
TJP2
|
[NCBI]
|
6.4655e-06
|
|
|
NPR2
|
[NCBI]
|
6.4655e-06
|
|
|
MGLL
|
[NCBI]
|
6.4655e-06
|
|
|
MMP20
|
[NCBI]
|
6.4655e-06
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
6.4655e-06
|
|
|
RDH12
|
[NCBI]
|
6.4655e-06
|
|
|
CXCR6
|
[NCBI]
|
6.4655e-06
|
|
|
GABRA5
|
[NCBI]
|
6.4655e-06
|
|
|
RPL9
|
[NCBI]
|
6.4655e-06
|
|
|
CATSPER2
|
[NCBI]
|
6.4655e-06
|
|
|
GPD1
|
[NCBI]
|
6.4655e-06
|
|
|
VPS33B
|
[NCBI]
|
6.4655e-06
|
|
|
PLXNA2
|
[NCBI]
|
6.4655e-06
|
|
|
GABRA6
|
[NCBI]
|
6.4655e-06
|
|
|
NCR3
|
[NCBI]
|
6.4655e-06
|
|
|
CCT
|
[NCBI]
|
6.4655e-06
|
|
|
ROCK2
|
[NCBI]
|
6.4655e-06
|
|
|
CHI3L1
|
[NCBI]
|
6.4655e-06
|
|
|
CRK
|
[NCBI]
|
6.4655e-06
|
|
|
POSTN
|
[NCBI]
|
6.4655e-06
|
|
|
CYSLTR2
|
[NCBI]
|
6.4655e-06
|
|
|
NPR1
|
[NCBI]
|
6.4655e-06
|
|
|
ABCD3
|
[NCBI]
|
6.4655e-06
|
|
|
DMTF1
|
[NCBI]
|
6.4655e-06
|
|
|
NLRP1
|
[NCBI]
|
6.4655e-06
|
|
|
INSRR
|
[NCBI]
|
6.4655e-06
|
|
|
DMC1
|
[NCBI]
|
6.4655e-06
|
|
|
GFRA3
|
[NCBI]
|
6.4655e-06
|
|
|
PLA2G6
|
[NCBI]
|
6.4655e-06
|
|
|
ITGA6
|
[NCBI]
|
6.4655e-06
|
|
|
SLC26A5
|
[NCBI]
|
6.4655e-06
|
|
|
SEL1L
|
[NCBI]
|
6.4655e-06
|
|
|
PARK2
|
[NCBI]
|
6.46176e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
6.46176e-06
|
|
|
STAT5A
|
[NCBI]
|
6.41294e-06
|
|
|
GJA3
|
[NCBI]
|
6.37312e-06
|
|
|
TSHB
|
[NCBI]
|
6.37312e-06
|
|
|
MAPK8IP1
|
[NCBI]
|
6.37312e-06
|
|
|
ACADVL
|
[NCBI]
|
6.37312e-06
|
|
|
ADSL
|
[NCBI]
|
6.37312e-06
|
|
|
ITGB4
|
[NCBI]
|
6.37312e-06
|
|
|
SPG7
|
[NCBI]
|
6.37312e-06
|
|
|
SQSTM1
|
[NCBI]
|
6.37312e-06
|
|
|
UCP1
|
[NCBI]
|
6.29073e-06
|
|
|
IGKC
|
[NCBI]
|
6.28406e-06
|
|
|
KIT
|
[NCBI]
|
6.25954e-06
|
|
|
MSH2
|
[NCBI]
|
6.25954e-06
|
|
|
GJB1
|
[NCBI]
|
6.19548e-06
|
|
|
ABCB11
|
[NCBI]
|
6.19382e-06
|
|
|
FPGS
|
[NCBI]
|
6.06349e-06
|
|
|
CDPX2
|
[NCBI]
|
6.04257e-06
|
|
|
OCA2
|
[NCBI]
|
6.04257e-06
|
|
|
CLL
|
[NCBI]
|
6.04257e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
6.04257e-06
|
|
|
meningioma, familial
|
[NCBI]
|
6.04257e-06
|
|
|
TBS
|
[NCBI]
|
6.04257e-06
|
|
|
CADASIL
|
[NCBI]
|
6.04257e-06
|
|
|
C3
|
[NCBI]
|
6.02028e-06
|
|
|
PGM1
|
[NCBI]
|
6.02028e-06
|
|
|
PLP1
|
[NCBI]
|
6.02028e-06
|
|
|
canavan disease
|
[NCBI]
|
6.01059e-06
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
6.01059e-06
|
|
|
autonomic control, congenital failure of
|
[NCBI]
|
6.01059e-06
|
|
|
AAA
|
[NCBI]
|
6.01059e-06
|
|
|
ST3
|
[NCBI]
|
5.9787e-06
|
|
|
MYO7A
|
[NCBI]
|
5.97769e-06
|
|
|
BRRS
|
[NCBI]
|
5.94135e-06
|
|
|
PQBP1
|
[NCBI]
|
5.91889e-06
|
|
|
KCNJ2
|
[NCBI]
|
5.91889e-06
|
|
|
IL9
|
[NCBI]
|
5.91889e-06
|
|
|
FOXL2
|
[NCBI]
|
5.91889e-06
|
|
|
PCDH15
|
[NCBI]
|
5.91889e-06
|
|
|
GUCY2D
|
[NCBI]
|
5.91889e-06
|
|
|
PCCB
|
[NCBI]
|
5.91889e-06
|
|
|
PRLR
|
[NCBI]
|
5.84098e-06
|
|
|
AS
|
[NCBI]
|
5.78545e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
5.78545e-06
|
|
|
TSHR
|
[NCBI]
|
5.72806e-06
|
|
|
glycogen storage disease i
|
[NCBI]
|
5.68474e-06
|
|
|
GK
|
[NCBI]
|
5.68474e-06
|
|
|
CA2
|
[NCBI]
|
5.49776e-06
|
|
|
PHOX2B
|
[NCBI]
|
5.49776e-06
|
|
|
CACNA1S
|
[NCBI]
|
5.49776e-06
|
|
|
MME
|
[NCBI]
|
5.49776e-06
|
|
|
DBT
|
[NCBI]
|
5.49776e-06
|
|
|
HSD11B1
|
[NCBI]
|
5.49776e-06
|
|
|
SFTPB
|
[NCBI]
|
5.49776e-06
|
|
|
DLL4
|
[NCBI]
|
5.49776e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
5.49776e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
5.47634e-06
|
|
|
SLC22A12
|
[NCBI]
|
5.45731e-06
|
|
|
MYH8
|
[NCBI]
|
5.45731e-06
|
|
|
PLOD3
|
[NCBI]
|
5.45731e-06
|
|
|
GCM1
|
[NCBI]
|
5.45731e-06
|
|
|
PCDH8
|
[NCBI]
|
5.45731e-06
|
|
|
SYN2
|
[NCBI]
|
5.45731e-06
|
|
|
SOAT2
|
[NCBI]
|
5.45731e-06
|
|
|
MYL3
|
[NCBI]
|
5.45731e-06
|
|
|
CHRNB4
|
[NCBI]
|
5.45731e-06
|
|
|
SLC4A3
|
[NCBI]
|
5.45731e-06
|
|
|
PHB2
|
[NCBI]
|
5.45731e-06
|
|
|
KCNN3
|
[NCBI]
|
5.45731e-06
|
|
|
MOCS1
|
[NCBI]
|
5.45731e-06
|
|
|
NPHP3
|
[NCBI]
|
5.45731e-06
|
|
|
IGHA2
|
[NCBI]
|
5.45731e-06
|
|
|
ADRA2C
|
[NCBI]
|
5.45731e-06
|
|
|
NPY5R
|
[NCBI]
|
5.45731e-06
|
|
|
NHEJ1
|
[NCBI]
|
5.45731e-06
|
|
|
FOXF2
|
[NCBI]
|
5.45731e-06
|
|
|
CES2
|
[NCBI]
|
5.45731e-06
|
|
|
HTR7
|
[NCBI]
|
5.45731e-06
|
|
|
VAMP8
|
[NCBI]
|
5.45731e-06
|
|
|
ALPPL2
|
[NCBI]
|
5.45731e-06
|
|
|
CD24
|
[NCBI]
|
5.45731e-06
|
|
|
GATM
|
[NCBI]
|
5.45731e-06
|
|
|
TACR2
|
[NCBI]
|
5.45731e-06
|
|
|
P2RX4
|
[NCBI]
|
5.45731e-06
|
|
|
CMA1
|
[NCBI]
|
5.45731e-06
|
|
|
E2F2
|
[NCBI]
|
5.45731e-06
|
|
|
STX11
|
[NCBI]
|
5.45731e-06
|
|
|
GRK1
|
[NCBI]
|
5.45731e-06
|
|
|
GABRA4
|
[NCBI]
|
5.45731e-06
|
|
|
PRB3
|
[NCBI]
|
5.45731e-06
|
|
|
NIPA1
|
[NCBI]
|
5.45731e-06
|
|
|
CDAN1
|
[NCBI]
|
5.45731e-06
|
|
|
KCNE2
|
[NCBI]
|
5.45731e-06
|
|
|
CAMTA1
|
[NCBI]
|
5.45731e-06
|
|
|
GRIK2
|
[NCBI]
|
5.45731e-06
|
|
|
bsnd gene
|
[NCBI]
|
5.45731e-06
|
|
|
ALG6
|
[NCBI]
|
5.45731e-06
|
|
|
GPRK2L
|
[NCBI]
|
5.45731e-06
|
|
|
CHST6
|
[NCBI]
|
5.45731e-06
|
|
|
PREP
|
[NCBI]
|
5.45731e-06
|
|
|
MLX
|
[NCBI]
|
5.45731e-06
|
|
|
SBF2
|
[NCBI]
|
5.45731e-06
|
|
|
BTNL2
|
[NCBI]
|
5.45731e-06
|
|
|
MPV17
|
[NCBI]
|
5.45731e-06
|
|
|
SYNJ1
|
[NCBI]
|
5.45731e-06
|
|
|
VAV3
|
[NCBI]
|
5.45731e-06
|
|
|
IGSF1
|
[NCBI]
|
5.45731e-06
|
|
|
MCCC1
|
[NCBI]
|
5.45731e-06
|
|
|
SEPS1
|
[NCBI]
|
5.45731e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
5.45731e-06
|
|
|
CFC1
|
[NCBI]
|
5.45731e-06
|
|
|
PTGIS
|
[NCBI]
|
5.45731e-06
|
|
|
MYL2
|
[NCBI]
|
5.45731e-06
|
|
|
HMCN1
|
[NCBI]
|
5.45731e-06
|
|
|
NDST2
|
[NCBI]
|
5.45731e-06
|
|
|
DACH1
|
[NCBI]
|
5.45731e-06
|
|
|
PVRL2
|
[NCBI]
|
5.45731e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
5.45731e-06
|
|
|
MTTN
|
[NCBI]
|
5.45731e-06
|
|
|
CASP12
|
[NCBI]
|
5.45731e-06
|
|
|
FKBP5
|
[NCBI]
|
5.45731e-06
|
|
|
CRYBB3
|
[NCBI]
|
5.45731e-06
|
|
|
ATP6V1B1
|
[NCBI]
|
5.45731e-06
|
|
|
SLC35C1
|
[NCBI]
|
5.45731e-06
|
|
|
MTF1
|
[NCBI]
|
5.45731e-06
|
|
|
ARL6
|
[NCBI]
|
5.45731e-06
|
|
|
ALOX12B
|
[NCBI]
|
5.45731e-06
|
|
|
HK3
|
[NCBI]
|
5.45731e-06
|
|
|
TCP1
|
[NCBI]
|
5.45731e-06
|
|
|
FDXR
|
[NCBI]
|
5.45731e-06
|
|
|
ANKK1
|
[NCBI]
|
5.45731e-06
|
|
|
SEC23A
|
[NCBI]
|
5.45731e-06
|
|
|
EEF1A2
|
[NCBI]
|
5.45731e-06
|
|
|
SBDS
|
[NCBI]
|
5.45731e-06
|
|
|
EPPK
|
[NCBI]
|
5.43605e-06
|
|
|
TRMA
|
[NCBI]
|
5.43605e-06
|
|
|
PARK7
|
[NCBI]
|
5.43605e-06
|
|
|
kuru, susceptibility to
|
[NCBI]
|
5.43605e-06
|
|
|
IDD
|
[NCBI]
|
5.43605e-06
|
|
|
IBMPFD
|
[NCBI]
|
5.43605e-06
|
|
|
JBTS3
|
[NCBI]
|
5.43605e-06
|
|
|
GS1
|
[NCBI]
|
5.43605e-06
|
|
|
aceruloplasminemia
|
[NCBI]
|
5.43605e-06
|
|
|
SCA8
|
[NCBI]
|
5.43605e-06
|
|
|
GLYS1
|
[NCBI]
|
5.43605e-06
|
|
|
AITD3
|
[NCBI]
|
5.43605e-06
|
|
|
cystathioninuria
|
[NCBI]
|
5.43605e-06
|
|
|
OPLL
|
[NCBI]
|
5.43605e-06
|
|
|
myopathy, myosin storage
|
[NCBI]
|
5.43605e-06
|
|
|
colorectal adenomatous polyposis, autosomal recessive
|
[NCBI]
|
5.43605e-06
|
|
|
ear wax, wet/dry
|
[NCBI]
|
5.43605e-06
|
|
|
ODG2
|
[NCBI]
|
5.43605e-06
|
|
|
AMDM
|
[NCBI]
|
5.43605e-06
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
5.43605e-06
|
|
|
ehlers-danlos syndrome, type vii, autosomal recessive
|
[NCBI]
|
5.43605e-06
|
|
|
LADD
|
[NCBI]
|
5.43605e-06
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
5.43605e-06
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
5.43605e-06
|
|
|
GRA
|
[NCBI]
|
5.37172e-06
|
|
|
factor v deficiency
|
[NCBI]
|
5.18119e-06
|
|
|
DSG1
|
[NCBI]
|
5.13634e-06
|
|
|
KDR
|
[NCBI]
|
5.11341e-06
|
|
|
EDMD2
|
[NCBI]
|
5.10854e-06
|
|
|
UCMD
|
[NCBI]
|
5.10854e-06
|
|
|
NHS
|
[NCBI]
|
5.10854e-06
|
|
|
APL
|
[NCBI]
|
5.10854e-06
|
|
|
DCX
|
[NCBI]
|
5.1065e-06
|
|
|
PEX7
|
[NCBI]
|
5.1065e-06
|
|
|
SLC2A1
|
[NCBI]
|
5.1065e-06
|
|
|
HLA-G
|
[NCBI]
|
5.1065e-06
|
|
|
SJS1
|
[NCBI]
|
5.0692e-06
|
|
|
HRAS
|
[NCBI]
|
4.93286e-06
|
|
|
costello syndrome
|
[NCBI]
|
4.92798e-06
|
|
|
SPG3A
|
[NCBI]
|
4.92798e-06
|
|
|
PKS
|
[NCBI]
|
4.92798e-06
|
|
|
AR
|
[NCBI]
|
4.90416e-06
|
|
|
EDN1
|
[NCBI]
|
4.87963e-06
|
|
|
CCM
|
[NCBI]
|
4.83847e-06
|
|
|
HHF2
|
[NCBI]
|
4.83847e-06
|
|
|
GHSR
|
[NCBI]
|
4.74231e-06
|
|
|
HOXD13
|
[NCBI]
|
4.74231e-06
|
|
|
MPL
|
[NCBI]
|
4.74231e-06
|
|
|
PLOD1
|
[NCBI]
|
4.74231e-06
|
|
|
NMB
|
[NCBI]
|
4.67243e-06
|
|
|
VNN1
|
[NCBI]
|
4.65086e-06
|
|
|
CAPN1
|
[NCBI]
|
4.65086e-06
|
|
|
RABGGTA
|
[NCBI]
|
4.65086e-06
|
|
|
MYH10
|
[NCBI]
|
4.65086e-06
|
|
|
WHSC2
|
[NCBI]
|
4.65086e-06
|
|
|
XRCC3
|
[NCBI]
|
4.65086e-06
|
|
|
VAMP1
|
[NCBI]
|
4.65086e-06
|
|
|
PTBP1
|
[NCBI]
|
4.65086e-06
|
|
|
RYK
|
[NCBI]
|
4.65086e-06
|
|
|
CHD7
|
[NCBI]
|
4.65086e-06
|
|
|
SP110
|
[NCBI]
|
4.65086e-06
|
|
|
CLN2
|
[NCBI]
|
4.65086e-06
|
|
|
CCL7
|
[NCBI]
|
4.65086e-06
|
|
|
PTPRZ1
|
[NCBI]
|
4.65086e-06
|
|
|
MUC3A
|
[NCBI]
|
4.65086e-06
|
|
|
TTID
|
[NCBI]
|
4.65086e-06
|
|
|
FCER1G
|
[NCBI]
|
4.65086e-06
|
|
|
TRMU
|
[NCBI]
|
4.65086e-06
|
|
|
AKR1C3
|
[NCBI]
|
4.65086e-06
|
|
|
AKAP13
|
[NCBI]
|
4.65086e-06
|
|
|
HRPT2
|
[NCBI]
|
4.65086e-06
|
|
|
ACTN4
|
[NCBI]
|
4.65086e-06
|
|
|
DPYSL2
|
[NCBI]
|
4.65086e-06
|
|
|
DYX1C1
|
[NCBI]
|
4.65086e-06
|
|
|
PCK1
|
[NCBI]
|
4.65086e-06
|
|
|
SORL1
|
[NCBI]
|
4.65086e-06
|
|
|
KIR2DL4
|
[NCBI]
|
4.65086e-06
|
|
|
VPS13A
|
[NCBI]
|
4.65086e-06
|
|
|
LMNB2
|
[NCBI]
|
4.65086e-06
|
|
|
KCNQ3
|
[NCBI]
|
4.65086e-06
|
|
|
SATB2
|
[NCBI]
|
4.65086e-06
|
|
|
UCHL3
|
[NCBI]
|
4.65086e-06
|
|
|
FTO
|
[NCBI]
|
4.65086e-06
|
|
|
BRD2
|
[NCBI]
|
4.65086e-06
|
|
|
TRPV5
|
[NCBI]
|
4.65086e-06
|
|
|
LIPE
|
[NCBI]
|
4.65086e-06
|
|
|
SLURP1
|
[NCBI]
|
4.65086e-06
|
|
|
SGNE1
|
[NCBI]
|
4.65086e-06
|
|
|
RNF2
|
[NCBI]
|
4.65086e-06
|
|
|
MMP8
|
[NCBI]
|
4.65086e-06
|
|
|
CDKN2C
|
[NCBI]
|
4.65086e-06
|
|
|
IL24
|
[NCBI]
|
4.65086e-06
|
|
|
PPARGC1B
|
[NCBI]
|
4.65086e-06
|
|
|
FBLN5
|
[NCBI]
|
4.65086e-06
|
|
|
ADIPOR2
|
[NCBI]
|
4.65086e-06
|
|
|
ESCO2
|
[NCBI]
|
4.65086e-06
|
|
|
FABP4
|
[NCBI]
|
4.65086e-06
|
|
|
NCOA4
|
[NCBI]
|
4.65086e-06
|
|
|
AIF1
|
[NCBI]
|
4.65086e-06
|
|
|
PNOC
|
[NCBI]
|
4.65086e-06
|
|
|
DLAT
|
[NCBI]
|
4.65086e-06
|
|
|
KRT6A
|
[NCBI]
|
4.65086e-06
|
|
|
GLP1R
|
[NCBI]
|
4.65086e-06
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
4.65086e-06
|
|
|
PPP1R3A
|
[NCBI]
|
4.65086e-06
|
|
|
TNNT1
|
[NCBI]
|
4.65086e-06
|
|
|
PALLD
|
[NCBI]
|
4.65086e-06
|
|
|
EPHB3
|
[NCBI]
|
4.65086e-06
|
|
|
IL1RAPL1
|
[NCBI]
|
4.65086e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
4.63383e-06
|
|
|
SLS
|
[NCBI]
|
4.57666e-06
|
|
|
PLN
|
[NCBI]
|
4.55022e-06
|
|
|
SERPINA6
|
[NCBI]
|
4.50706e-06
|
|
|
CMTX1
|
[NCBI]
|
4.45516e-06
|
|
|
WFS1
|
[NCBI]
|
4.45516e-06
|
|
|
IGAD1
|
[NCBI]
|
4.44617e-06
|
|
|
ASS
|
[NCBI]
|
4.42879e-06
|
|
|
giant platelet syndrome
|
[NCBI]
|
4.41317e-06
|
|
|
DLD
|
[NCBI]
|
4.40278e-06
|
|
|
ATR
|
[NCBI]
|
4.40278e-06
|
|
|
CASP8
|
[NCBI]
|
4.40278e-06
|
|
|
GATA3
|
[NCBI]
|
4.40278e-06
|
|
|
LAMB3
|
[NCBI]
|
4.40278e-06
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
4.39863e-06
|
|
|
SGBS1
|
[NCBI]
|
4.39863e-06
|
|
|
HLA-DRA
|
[NCBI]
|
4.3984e-06
|
|
|
thrombocythemia, essential
|
[NCBI]
|
4.30706e-06
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
4.30706e-06
|
|
|
CHAC
|
[NCBI]
|
4.30706e-06
|
|
|
mucolipidosis iv
|
[NCBI]
|
4.30706e-06
|
|
|
epidermolysis bullosa with pyloric atresia
|
[NCBI]
|
4.30706e-06
|
|
|
EIF4E
|
[NCBI]
|
4.17978e-06
|
|
|
BRAF
|
[NCBI]
|
4.17287e-06
|
|
|
MTCYB
|
[NCBI]
|
4.17287e-06
|
|
|
IGFALS
|
[NCBI]
|
4.09691e-06
|
|
|
UROS
|
[NCBI]
|
4.0858e-06
|
|
|
TGFBI
|
[NCBI]
|
4.0858e-06
|
|
|
LDHA
|
[NCBI]
|
4.0858e-06
|
|
|
CRYAA
|
[NCBI]
|
4.0858e-06
|
|
|
MTND3
|
[NCBI]
|
4.0858e-06
|
|
|
EDA
|
[NCBI]
|
4.0858e-06
|
|
|
OSBP
|
[NCBI]
|
4.0858e-06
|
|
|
PLSJ
|
[NCBI]
|
4.0803e-06
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
4.0803e-06
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
4.0803e-06
|
|
|
SYNS1
|
[NCBI]
|
4.0803e-06
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
4.0803e-06
|
|
|
GS2
|
[NCBI]
|
4.0803e-06
|
|
|
CLPED1
|
[NCBI]
|
4.0803e-06
|
|
|
growth hormone insensitivity with immunodeficiency
|
[NCBI]
|
4.0803e-06
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
4.0803e-06
|
|
|
morquio syndrome b
|
[NCBI]
|
4.0803e-06
|
|
|
currarino syndrome
|
[NCBI]
|
4.0803e-06
|
|
|
HMN2A
|
[NCBI]
|
4.0803e-06
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
4.0803e-06
|
|
|
INAD1
|
[NCBI]
|
4.0803e-06
|
|
|
FTC
|
[NCBI]
|
4.0803e-06
|
|
|
RP12
|
[NCBI]
|
4.0803e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
4.0803e-06
|
|
|
emanuel syndrome
|
[NCBI]
|
4.0803e-06
|
|
|
RHN
|
[NCBI]
|
4.0803e-06
|
|
|
sc phocomelia syndrome
|
[NCBI]
|
4.0803e-06
|
|
|
CMT2D
|
[NCBI]
|
4.0803e-06
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
4.0803e-06
|
|
|
MAFD2
|
[NCBI]
|
4.00644e-06
|
|
|
LIPC
|
[NCBI]
|
4.00606e-06
|
|
|
MITF
|
[NCBI]
|
3.99897e-06
|
|
|
ABCG5
|
[NCBI]
|
3.98778e-06
|
|
|
NDUFS4
|
[NCBI]
|
3.98778e-06
|
|
|
NIPBL
|
[NCBI]
|
3.98778e-06
|
|
|
DVL2
|
[NCBI]
|
3.98778e-06
|
|
|
PBX1
|
[NCBI]
|
3.98778e-06
|
|
|
HADHB
|
[NCBI]
|
3.98778e-06
|
|
|
CENPE
|
[NCBI]
|
3.98778e-06
|
|
|
TRIM32
|
[NCBI]
|
3.98778e-06
|
|
|
BECN1
|
[NCBI]
|
3.98778e-06
|
|
|
ROS1
|
[NCBI]
|
3.98778e-06
|
|
|
FKBP1B
|
[NCBI]
|
3.98778e-06
|
|
|
CAMK2G
|
[NCBI]
|
3.98778e-06
|
|
|
ADRA2A
|
[NCBI]
|
3.98778e-06
|
|
|
PAI2
|
[NCBI]
|
3.98778e-06
|
|
|
IL10RB
|
[NCBI]
|
3.98778e-06
|
|
|
SRD5A1
|
[NCBI]
|
3.98778e-06
|
|
|
PEX6
|
[NCBI]
|
3.98778e-06
|
|
|
USH3A
|
[NCBI]
|
3.98778e-06
|
|
|
PTGFR
|
[NCBI]
|
3.98778e-06
|
|
|
CTF1
|
[NCBI]
|
3.98778e-06
|
|
|
HSD17B1
|
[NCBI]
|
3.98778e-06
|
|
|
NASP
|
[NCBI]
|
3.98778e-06
|
|
|
VKORC1
|
[NCBI]
|
3.98778e-06
|
|
|
ADCY8
|
[NCBI]
|
3.98778e-06
|
|
|
TLX3
|
[NCBI]
|
3.98778e-06
|
|
|
TAS2R16
|
[NCBI]
|
3.98778e-06
|
|
|
ADORA1
|
[NCBI]
|
3.98778e-06
|
|
|
NNT
|
[NCBI]
|
3.98778e-06
|
|
|
GLRA2
|
[NCBI]
|
3.98778e-06
|
|
|
TM4SF2
|
[NCBI]
|
3.98778e-06
|
|
|
YWHAE
|
[NCBI]
|
3.98778e-06
|
|
|
IFNAR2
|
[NCBI]
|
3.98778e-06
|
|
|
MOCS2
|
[NCBI]
|
3.98778e-06
|
|
|
PSTPIP1
|
[NCBI]
|
3.98778e-06
|
|
|
TDP1
|
[NCBI]
|
3.98778e-06
|
|
|
TPSAB1
|
[NCBI]
|
3.98778e-06
|
|
|
E2F4
|
[NCBI]
|
3.98778e-06
|
|
|
CCHCR1
|
[NCBI]
|
3.98778e-06
|
|
|
AVPR1A
|
[NCBI]
|
3.98778e-06
|
|
|
GNB1
|
[NCBI]
|
3.98778e-06
|
|
|
EPB72
|
[NCBI]
|
3.98778e-06
|
|
|
PPP1R2
|
[NCBI]
|
3.98778e-06
|
|
|
GATA6
|
[NCBI]
|
3.98778e-06
|
|
|
BCYRN1
|
[NCBI]
|
3.98778e-06
|
|
|
CLCN2
|
[NCBI]
|
3.98778e-06
|
|
|
RXRG
|
[NCBI]
|
3.98778e-06
|
|
|
PRPF31
|
[NCBI]
|
3.98778e-06
|
|
|
IL11
|
[NCBI]
|
3.98778e-06
|
|
|
NOVA1
|
[NCBI]
|
3.98778e-06
|
|
|
PODXL
|
[NCBI]
|
3.98778e-06
|
|
|
GSTA2
|
[NCBI]
|
3.98778e-06
|
|
|
NEUROG1
|
[NCBI]
|
3.98778e-06
|
|
|
tl antigen
|
[NCBI]
|
3.98778e-06
|
|
|
ANPEP
|
[NCBI]
|
3.98778e-06
|
|
|
BHLHB2
|
[NCBI]
|
3.98778e-06
|
|
|
ATP10A
|
[NCBI]
|
3.98778e-06
|
|
|
TRPV1
|
[NCBI]
|
3.95121e-06
|
|
|
ARNT
|
[NCBI]
|
3.95121e-06
|
|
|
lactase persistence
|
[NCBI]
|
3.89175e-06
|
|
|
CDG1A
|
[NCBI]
|
3.89175e-06
|
|
|
BCPM
|
[NCBI]
|
3.88949e-06
|
|
|
LGMD2C
|
[NCBI]
|
3.88949e-06
|
|
|
FPLD2
|
[NCBI]
|
3.88949e-06
|
|
|
RBS
|
[NCBI]
|
3.88949e-06
|
|
|
ARPKD
|
[NCBI]
|
3.87516e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
3.87516e-06
|
|
|
MYO5A
|
[NCBI]
|
3.78954e-06
|
|
|
FGFR4
|
[NCBI]
|
3.78954e-06
|
|
|
NKX2E
|
[NCBI]
|
3.78954e-06
|
|
|
SLC12A3
|
[NCBI]
|
3.78954e-06
|
|
|
ED1
|
[NCBI]
|
3.77786e-06
|
|
|
SPINK1
|
[NCBI]
|
3.70948e-06
|
|
|
GTS
|
[NCBI]
|
3.70146e-06
|
|
|
FGF8
|
[NCBI]
|
3.60215e-06
|
|
|
MLC
|
[NCBI]
|
3.59677e-06
|
|
|
CLN1
|
[NCBI]
|
3.59677e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.59677e-06
|
|
|
hodgkin lymphoma
|
[NCBI]
|
3.59677e-06
|
|
|
MADA
|
[NCBI]
|
3.59677e-06
|
|
|
niemann-pick disease, type a
|
[NCBI]
|
3.59677e-06
|
|
|
ALD
|
[NCBI]
|
3.58072e-06
|
|
|
COL1A1
|
[NCBI]
|
3.5769e-06
|
|
|
RELN
|
[NCBI]
|
3.55131e-06
|
|
|
GHR
|
[NCBI]
|
3.53429e-06
|
|
|
PMS2
|
[NCBI]
|
3.51237e-06
|
|
|
MTND2
|
[NCBI]
|
3.51237e-06
|
|
|
HNF1A
|
[NCBI]
|
3.50091e-06
|
|
|
GCKR
|
[NCBI]
|
3.43191e-06
|
|
|
CYP3A7
|
[NCBI]
|
3.43191e-06
|
|
|
GCLM
|
[NCBI]
|
3.43191e-06
|
|
|
NOTCH2
|
[NCBI]
|
3.43191e-06
|
|
|
ACR
|
[NCBI]
|
3.43191e-06
|
|
|
SACS
|
[NCBI]
|
3.43191e-06
|
|
|
EDNRA
|
[NCBI]
|
3.43191e-06
|
|
|
DYNC1H1
|
[NCBI]
|
3.43191e-06
|
|
|
PDE11A
|
[NCBI]
|
3.43191e-06
|
|
|
DDB2
|
[NCBI]
|
3.43191e-06
|
|
|
SIP1
|
[NCBI]
|
3.43191e-06
|
|
|
TDGF1
|
[NCBI]
|
3.43191e-06
|
|
|
RPS6KB1
|
[NCBI]
|
3.43191e-06
|
|
|
SOD3
|
[NCBI]
|
3.43191e-06
|
|
|
ST8SIA2
|
[NCBI]
|
3.43191e-06
|
|
|
ARHGEF6
|
[NCBI]
|
3.43191e-06
|
|
|
BTG2
|
[NCBI]
|
3.43191e-06
|
|
|
CLCNKB
|
[NCBI]
|
3.43191e-06
|
|
|
ABCA2
|
[NCBI]
|
3.43191e-06
|
|
|
SIM2
|
[NCBI]
|
3.43191e-06
|
|
|
DFNA5
|
[NCBI]
|
3.43191e-06
|
|
|
TRPC3
|
[NCBI]
|
3.43191e-06
|
|
|
PTF1A
|
[NCBI]
|
3.43191e-06
|
|
|
SDC3
|
[NCBI]
|
3.43191e-06
|
|
|
SIRT3
|
[NCBI]
|
3.43191e-06
|
|
|
CD34
|
[NCBI]
|
3.43191e-06
|
|
|
BSCL2
|
[NCBI]
|
3.43191e-06
|
|
|
FRZB
|
[NCBI]
|
3.43191e-06
|
|
|
RABAC1
|
[NCBI]
|
3.43191e-06
|
|
|
KRT12
|
[NCBI]
|
3.43191e-06
|
|
|
TOP3A
|
[NCBI]
|
3.43191e-06
|
|
|
GPR98
|
[NCBI]
|
3.43191e-06
|
|
|
CYSLTR1
|
[NCBI]
|
3.43191e-06
|
|
|
GRIK1
|
[NCBI]
|
3.43191e-06
|
|
|
GNAL
|
[NCBI]
|
3.43191e-06
|
|
|
PRLHR
|
[NCBI]
|
3.43191e-06
|
|
|
SCGB3A2
|
[NCBI]
|
3.43191e-06
|
|
|
HOXC8
|
[NCBI]
|
3.43191e-06
|
|
|
MTTE
|
[NCBI]
|
3.43191e-06
|
|
|
CITED2
|
[NCBI]
|
3.43191e-06
|
|
|
CYR61
|
[NCBI]
|
3.43191e-06
|
|
|
TIAM1
|
[NCBI]
|
3.43191e-06
|
|
|
MPG
|
[NCBI]
|
3.43191e-06
|
|
|
NEUROG2
|
[NCBI]
|
3.43191e-06
|
|
|
ACTN3
|
[NCBI]
|
3.43191e-06
|
|
|
NFE2L2
|
[NCBI]
|
3.43191e-06
|
|
|
PECAM1
|
[NCBI]
|
3.43191e-06
|
|
|
CCL3L1
|
[NCBI]
|
3.43191e-06
|
|
|
DNASE1
|
[NCBI]
|
3.43191e-06
|
|
|
TFAP2C
|
[NCBI]
|
3.43191e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.40193e-06
|
|
|
MCOPS7
|
[NCBI]
|
3.40193e-06
|
|
|
LSA
|
[NCBI]
|
3.40193e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
3.38721e-06
|
|
|
aHUS
|
[NCBI]
|
3.37616e-06
|
|
|
CTNS
|
[NCBI]
|
3.37616e-06
|
|
|
MEN1
|
[NCBI]
|
3.37069e-06
|
|
|
PAX3
|
[NCBI]
|
3.36431e-06
|
|
|
ABCD1
|
[NCBI]
|
3.36431e-06
|
|
|
ABCA1
|
[NCBI]
|
3.36116e-06
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
3.35951e-06
|
|
|
CD
|
[NCBI]
|
3.2817e-06
|
|
|
LRP8
|
[NCBI]
|
3.25284e-06
|
|
|
CRYAB
|
[NCBI]
|
3.25284e-06
|
|
|
WHS
|
[NCBI]
|
3.2383e-06
|
|
|
WAS
|
[NCBI]
|
3.17745e-06
|
|
|
MCP
|
[NCBI]
|
3.15141e-06
|
|
|
TLR9
|
[NCBI]
|
3.15111e-06
|
|
|
SLC4A1
|
[NCBI]
|
3.15004e-06
|
|
|
SDS
|
[NCBI]
|
3.07827e-06
|
|
|
H6PD
|
[NCBI]
|
3.07319e-06
|
|
|
VCP
|
[NCBI]
|
3.03956e-06
|
|
|
AICDA
|
[NCBI]
|
3.00966e-06
|
|
|
CES1
|
[NCBI]
|
3.00966e-06
|
|
|
PROP1
|
[NCBI]
|
3.00966e-06
|
|
|
PTCH1
|
[NCBI]
|
3.00966e-06
|
|
|
GPX1
|
[NCBI]
|
3.00966e-06
|
|
|
MUT
|
[NCBI]
|
3.00966e-06
|
|
|
DYT1
|
[NCBI]
|
3.00966e-06
|
|
|
NETH
|
[NCBI]
|
3.00478e-06
|
|
|
XPG
|
[NCBI]
|
3.00478e-06
|
|
|
LISX1
|
[NCBI]
|
3.00478e-06
|
|
|
HCHWAD
|
[NCBI]
|
3.00478e-06
|
|
|
CDB1
|
[NCBI]
|
3.00478e-06
|
|
|
HFE4
|
[NCBI]
|
3.00478e-06
|
|
|
afibrinogenemia, congenital
|
[NCBI]
|
3.00478e-06
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
3.00478e-06
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
3.00478e-06
|
|
|
argininemia
|
[NCBI]
|
3.00478e-06
|
|
|
epstein syndrome
|
[NCBI]
|
3.00478e-06
|
|
|
CTLN2
|
[NCBI]
|
3.00478e-06
|
|
|
CSNB2A
|
[NCBI]
|
3.00478e-06
|
|
|
CLN8
|
[NCBI]
|
3.00478e-06
|
|
|
CZP1
|
[NCBI]
|
3.00478e-06
|
|
|
MCPH5
|
[NCBI]
|
3.00478e-06
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
3.00478e-06
|
|
|
hydrocephalus
|
[NCBI]
|
3.00478e-06
|
|
|
ankyloblepharon-ectodermal defects-cleft lip/palate
|
[NCBI]
|
3.00478e-06
|
|
|
NYS1
|
[NCBI]
|
3.00478e-06
|
|
|
CMT4C
|
[NCBI]
|
3.00478e-06
|
|
|
DFNA2
|
[NCBI]
|
3.00478e-06
|
|
|
FMD
|
[NCBI]
|
3.00478e-06
|
|
|
pygmy
|
[NCBI]
|
2.98474e-06
|
|
|
sjogren syndrome
|
[NCBI]
|
2.98474e-06
|
|
|
LCAT
|
[NCBI]
|
2.97012e-06
|
|
|
CEBPE
|
[NCBI]
|
2.95926e-06
|
|
|
srebp cleavage-activating protein
|
[NCBI]
|
2.95926e-06
|
|
|
NRP2
|
[NCBI]
|
2.95926e-06
|
|
|
FZD4
|
[NCBI]
|
2.95926e-06
|
|
|
SYN1
|
[NCBI]
|
2.95926e-06
|
|
|
SCN1B
|
[NCBI]
|
2.95926e-06
|
|
|
CCL11
|
[NCBI]
|
2.95926e-06
|
|
|
HAS1
|
[NCBI]
|
2.95926e-06
|
|
|
SETX
|
[NCBI]
|
2.95926e-06
|
|
|
BBS4
|
[NCBI]
|
2.95926e-06
|
|
|
DSCAM
|
[NCBI]
|
2.95926e-06
|
|
|
LITAF
|
[NCBI]
|
2.95926e-06
|
|
|
PRKG1
|
[NCBI]
|
2.95926e-06
|
|
|
MYCBP2
|
[NCBI]
|
2.95926e-06
|
|
|
ACVR1
|
[NCBI]
|
2.95926e-06
|
|
|
SLC30A3
|
[NCBI]
|
2.95926e-06
|
|
|
CD3E
|
[NCBI]
|
2.95926e-06
|
|
|
TRPS1
|
[NCBI]
|
2.95926e-06
|
|
|
ANXA7
|
[NCBI]
|
2.95926e-06
|
|
|
GRHL3
|
[NCBI]
|
2.95926e-06
|
|
|
WHSC1
|
[NCBI]
|
2.95926e-06
|
|
|
TSPY
|
[NCBI]
|
2.95926e-06
|
|
|
TUB
|
[NCBI]
|
2.95926e-06
|
|
|
FCER1A
|
[NCBI]
|
2.95926e-06
|
|
|
HAL
|
[NCBI]
|
2.95926e-06
|
|
|
CNGB3
|
[NCBI]
|
2.95926e-06
|
|
|
CTSG
|
[NCBI]
|
2.95926e-06
|
|
|
ITGA5
|
[NCBI]
|
2.95926e-06
|
|
|
AKT2
|
[NCBI]
|
2.95926e-06
|
|
|
ZIC2
|
[NCBI]
|
2.95926e-06
|
|
|
ACACB
|
[NCBI]
|
2.95926e-06
|
|
|
MBD4
|
[NCBI]
|
2.95926e-06
|
|
|
RAMP2
|
[NCBI]
|
2.95926e-06
|
|
|
EYA4
|
[NCBI]
|
2.95926e-06
|
|
|
MAP3K1
|
[NCBI]
|
2.95926e-06
|
|
|
TRPC1
|
[NCBI]
|
2.95926e-06
|
|
|
CHEK1
|
[NCBI]
|
2.95926e-06
|
|
|
LMAN1
|
[NCBI]
|
2.95926e-06
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
2.93743e-06
|
|
|
PENK
|
[NCBI]
|
2.93015e-06
|
|
|
DHFR
|
[NCBI]
|
2.91167e-06
|
|
|
BTHS
|
[NCBI]
|
2.90579e-06
|
|
|
ADA
|
[NCBI]
|
2.86762e-06
|
|
|
TBG
|
[NCBI]
|
2.83694e-06
|
|
|
TCRB
|
[NCBI]
|
2.78169e-06
|
|
|
SMPD1
|
[NCBI]
|
2.78169e-06
|
|
|
THRA
|
[NCBI]
|
2.78169e-06
|
|
|
PRSS1
|
[NCBI]
|
2.78169e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
2.78145e-06
|
|
|
ACH
|
[NCBI]
|
2.71592e-06
|
|
|
ANG
|
[NCBI]
|
2.71468e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
2.69255e-06
|
|
|
FGA
|
[NCBI]
|
2.67068e-06
|
|
|
CHS
|
[NCBI]
|
2.64068e-06
|
|
|
DSPP
|
[NCBI]
|
2.60867e-06
|
|
|
TTN
|
[NCBI]
|
2.56789e-06
|
|
|
GP1BA
|
[NCBI]
|
2.56789e-06
|
|
|
HPS
|
[NCBI]
|
2.55367e-06
|
|
|
SLC1A5
|
[NCBI]
|
2.55308e-06
|
|
|
FOXF1
|
[NCBI]
|
2.55308e-06
|
|
|
GUCA2B
|
[NCBI]
|
2.55308e-06
|
|
|
MAP3K7IP1
|
[NCBI]
|
2.55308e-06
|
|
|
SLC17A5
|
[NCBI]
|
2.55308e-06
|
|
|
GYS1
|
[NCBI]
|
2.55308e-06
|
|
|
NPHP1
|
[NCBI]
|
2.55308e-06
|
|
|
DAP3
|
[NCBI]
|
2.55308e-06
|
|
|
SGCG
|
[NCBI]
|
2.55308e-06
|
|
|
PRKAA2
|
[NCBI]
|
2.55308e-06
|
|
|
TBPL1
|
[NCBI]
|
2.55308e-06
|
|
|
CYLD1
|
[NCBI]
|
2.55308e-06
|
|
|
HESX1
|
[NCBI]
|
2.55308e-06
|
|
|
ZFX
|
[NCBI]
|
2.55308e-06
|
|
|
NRXN1
|
[NCBI]
|
2.55308e-06
|
|
|
LIM2
|
[NCBI]
|
2.55308e-06
|
|
|
CSPG2
|
[NCBI]
|
2.55308e-06
|
|
|
TRAF1
|
[NCBI]
|
2.55308e-06
|
|
|
CD38
|
[NCBI]
|
2.55308e-06
|
|
|
HOXA13
|
[NCBI]
|
2.55308e-06
|
|
|
OAS1
|
[NCBI]
|
2.55308e-06
|
|
|
HTR1A
|
[NCBI]
|
2.55308e-06
|
|
|
TOP2A
|
[NCBI]
|
2.55308e-06
|
|
|
CYP27A1
|
[NCBI]
|
2.55308e-06
|
|
|
DEFB1
|
[NCBI]
|
2.55308e-06
|
|
|
EIF5
|
[NCBI]
|
2.55308e-06
|
|
|
CENPA
|
[NCBI]
|
2.55308e-06
|
|
|
PTPRO
|
[NCBI]
|
2.55308e-06
|
|
|
SMAD7
|
[NCBI]
|
2.55308e-06
|
|
|
AAAS
|
[NCBI]
|
2.55308e-06
|
|
|
IQGAP1
|
[NCBI]
|
2.55308e-06
|
|
|
VANGL2
|
[NCBI]
|
2.55308e-06
|
|
|
PDCD2
|
[NCBI]
|
2.55308e-06
|
|
|
SGKL
|
[NCBI]
|
2.55308e-06
|
|
|
HTR1B
|
[NCBI]
|
2.55308e-06
|
|
|
EPHA4
|
[NCBI]
|
2.55308e-06
|
|
|
BUB1B
|
[NCBI]
|
2.55308e-06
|
|
|
IFIH1
|
[NCBI]
|
2.55308e-06
|
|
|
IL4
|
[NCBI]
|
2.55067e-06
|
|
|
CFB
|
[NCBI]
|
2.523e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
2.50386e-06
|
|
|
PHS
|
[NCBI]
|
2.49763e-06
|
|
|
POF1
|
[NCBI]
|
2.49763e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.47825e-06
|
|
|
von willebrand disease
|
[NCBI]
|
2.42919e-06
|
|
|
SEDC
|
[NCBI]
|
2.41829e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
2.41829e-06
|
|
|
CCL17
|
[NCBI]
|
2.40028e-06
|
|
|
GPT
|
[NCBI]
|
2.40028e-06
|
|
|
COL4A5
|
[NCBI]
|
2.36734e-06
|
|
|
APOH
|
[NCBI]
|
2.36734e-06
|
|
|
AQP3
|
[NCBI]
|
2.36734e-06
|
|
|
STAT4
|
[NCBI]
|
2.36734e-06
|
|
|
ATXN1
|
[NCBI]
|
2.36734e-06
|
|
|
MSH6
|
[NCBI]
|
2.36734e-06
|
|
|
GCDH
|
[NCBI]
|
2.36734e-06
|
|
|
SRY
|
[NCBI]
|
2.34385e-06
|
|
|
TYR
|
[NCBI]
|
2.34385e-06
|
|
|
BPES
|
[NCBI]
|
2.3246e-06
|
|
|
behcet syndrome
|
[NCBI]
|
2.30692e-06
|
|
|
NOTCH1
|
[NCBI]
|
2.29797e-06
|
|
|
FAAH
|
[NCBI]
|
2.2922e-06
|
|
|
SRC
|
[NCBI]
|
2.28831e-06
|
|
|
holoprosencephaly
|
[NCBI]
|
2.23901e-06
|
|
|
CRHR2
|
[NCBI]
|
2.20123e-06
|
|
|
GAD1
|
[NCBI]
|
2.20123e-06
|
|
|
ARG1
|
[NCBI]
|
2.20123e-06
|
|
|
SUZ12
|
[NCBI]
|
2.20123e-06
|
|
|
BRIP1
|
[NCBI]
|
2.20123e-06
|
|
|
GNPAT
|
[NCBI]
|
2.20123e-06
|
|
|
MCPH1
|
[NCBI]
|
2.20123e-06
|
|
|
tritanopia
|
[NCBI]
|
2.20123e-06
|
|
|
BMI1
|
[NCBI]
|
2.20123e-06
|
|
|
AKR1A1
|
[NCBI]
|
2.20123e-06
|
|
|
SCN8A
|
[NCBI]
|
2.20123e-06
|
|
|
CILP
|
[NCBI]
|
2.20123e-06
|
|
|
CX3CL1
|
[NCBI]
|
2.20123e-06
|
|
|
COL4A4
|
[NCBI]
|
2.20123e-06
|
|
|
PAX9
|
[NCBI]
|
2.20123e-06
|
|
|
ITPA
|
[NCBI]
|
2.20123e-06
|
|
|
IL12RB1
|
[NCBI]
|
2.20123e-06
|
|
|
ITPR1
|
[NCBI]
|
2.20123e-06
|
|
|
BFSP2
|
[NCBI]
|
2.20123e-06
|
|
|
CXORF5
|
[NCBI]
|
2.20123e-06
|
|
|
EIF2AK3
|
[NCBI]
|
2.20123e-06
|
|
|
FMN
|
[NCBI]
|
2.20123e-06
|
|
|
TBX3
|
[NCBI]
|
2.20123e-06
|
|
|
DGUOK
|
[NCBI]
|
2.20123e-06
|
|
|
CCR3
|
[NCBI]
|
2.20123e-06
|
|
|
RAB7
|
[NCBI]
|
2.20123e-06
|
|
|
PEA15
|
[NCBI]
|
2.20123e-06
|
|
|
MS4A2
|
[NCBI]
|
2.20123e-06
|
|
|
JAK3
|
[NCBI]
|
2.19697e-06
|
|
|
PRLH
|
[NCBI]
|
2.19697e-06
|
|
|
ERCC2
|
[NCBI]
|
2.17919e-06
|
|
|
GLI3
|
[NCBI]
|
2.17919e-06
|
|
|
COL6A1
|
[NCBI]
|
2.17919e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
2.17919e-06
|
|
|
SLC40A1
|
[NCBI]
|
2.17919e-06
|
|
|
metachromatic leukodystrophy due to saposin b deficiency
|
[NCBI]
|
2.15314e-06
|
|
|
MODY3
|
[NCBI]
|
2.15314e-06
|
|
|
kawasaki disease
|
[NCBI]
|
2.15314e-06
|
|
|
MCOPS3
|
[NCBI]
|
2.15314e-06
|
|
|
IRID2
|
[NCBI]
|
2.15314e-06
|
|
|
DGI1
|
[NCBI]
|
2.15314e-06
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
2.15314e-06
|
|
|
DFNA12
|
[NCBI]
|
2.15314e-06
|
|
|
BDC
|
[NCBI]
|
2.15314e-06
|
|
|
SPG6
|
[NCBI]
|
2.15314e-06
|
|
|
PFHB1A
|
[NCBI]
|
2.15314e-06
|
|
|
SCAR1
|
[NCBI]
|
2.15314e-06
|
|
|
BDB1
|
[NCBI]
|
2.15314e-06
|
|
|
GVM
|
[NCBI]
|
2.15314e-06
|
|
|
GINGF
|
[NCBI]
|
2.15314e-06
|
|
|
hydrolethalus syndrome 1
|
[NCBI]
|
2.15314e-06
|
|
|
scheie syndrome
|
[NCBI]
|
2.15314e-06
|
|
|
marshall syndrome
|
[NCBI]
|
2.15314e-06
|
|
|
DRRS
|
[NCBI]
|
2.15314e-06
|
|
|
IRS1
|
[NCBI]
|
2.09731e-06
|
|
|
FHM1
|
[NCBI]
|
2.08437e-06
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
2.08437e-06
|
|
|
EVC
|
[NCBI]
|
2.08437e-06
|
|
|
SNCA
|
[NCBI]
|
2.08316e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
2.05155e-06
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
2.00357e-06
|
|
|
alopecia areata 1
|
[NCBI]
|
2.00357e-06
|
|
|
DYSF
|
[NCBI]
|
2.00268e-06
|
|
|
CXCL12
|
[NCBI]
|
2.00268e-06
|
|
|
RECQL3
|
[NCBI]
|
2.00268e-06
|
|
|
LCN2
|
[NCBI]
|
1.99905e-06
|
|
|
HNFJ
|
[NCBI]
|
1.9368e-06
|
|
|
LCA1
|
[NCBI]
|
1.9368e-06
|
|
|
ALMS
|
[NCBI]
|
1.9368e-06
|
|
|
FGFR1
|
[NCBI]
|
1.91944e-06
|
|
|
F13B
|
[NCBI]
|
1.89463e-06
|
|
|
IL8RB
|
[NCBI]
|
1.89463e-06
|
|
|
COL6A2
|
[NCBI]
|
1.89463e-06
|
|
|
KIR3DL1
|
[NCBI]
|
1.89463e-06
|
|
|
APOC1
|
[NCBI]
|
1.89463e-06
|
|
|
XRN1
|
[NCBI]
|
1.89463e-06
|
|
|
ADD1
|
[NCBI]
|
1.89463e-06
|
|
|
RPGRIP1
|
[NCBI]
|
1.89463e-06
|
|
|
KLK1
|
[NCBI]
|
1.89463e-06
|
|
|
NDRG1
|
[NCBI]
|
1.89463e-06
|
|
|
CLCN7
|
[NCBI]
|
1.89463e-06
|
|
|
ATP2A1
|
[NCBI]
|
1.89463e-06
|
|
|
RBPSUH
|
[NCBI]
|
1.89463e-06
|
|
|
SALL4
|
[NCBI]
|
1.89463e-06
|
|
|
NRF1
|
[NCBI]
|
1.89463e-06
|
|
|
FKTN
|
[NCBI]
|
1.89463e-06
|
|
|
NCOA6
|
[NCBI]
|
1.89463e-06
|
|
|
OCRL
|
[NCBI]
|
1.89463e-06
|
|
|
DYRK1A
|
[NCBI]
|
1.89463e-06
|
|
|
SIX3
|
[NCBI]
|
1.89463e-06
|
|
|
ATP5O
|
[NCBI]
|
1.89463e-06
|
|
|
ICOS
|
[NCBI]
|
1.89463e-06
|
|
|
PRDX5
|
[NCBI]
|
1.89463e-06
|
|
|
PKM2
|
[NCBI]
|
1.89463e-06
|
|
|
SILV
|
[NCBI]
|
1.89463e-06
|
|
|
MEG3
|
[NCBI]
|
1.89463e-06
|
|
|
GNRHR
|
[NCBI]
|
1.84763e-06
|
|
|
SOX10
|
[NCBI]
|
1.83711e-06
|
|
|
fabry disease
|
[NCBI]
|
1.82457e-06
|
|
|
SCD
|
[NCBI]
|
1.81687e-06
|
|
|
KLF1
|
[NCBI]
|
1.80685e-06
|
|
|
GSC
|
[NCBI]
|
1.80685e-06
|
|
|
TBP
|
[NCBI]
|
1.77884e-06
|
|
|
STAT6
|
[NCBI]
|
1.77611e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
1.77172e-06
|
|
|
neuroblastoma
|
[NCBI]
|
1.75793e-06
|
|
|
PPARA
|
[NCBI]
|
1.75675e-06
|
|
|
IGF2
|
[NCBI]
|
1.72957e-06
|
|
|
menkes disease
|
[NCBI]
|
1.72258e-06
|
|
|
hepatocellular carcinoma
|
[NCBI]
|
1.69968e-06
|
|
|
SOD1
|
[NCBI]
|
1.68364e-06
|
|
|
PEPD
|
[NCBI]
|
1.68185e-06
|
|
|
CREM
|
[NCBI]
|
1.68185e-06
|
|
|
RARA
|
[NCBI]
|
1.68185e-06
|
|
|
GH1
|
[NCBI]
|
1.66832e-06
|
|
|
HMGA1
|
[NCBI]
|
1.62629e-06
|
|
|
XRCC2
|
[NCBI]
|
1.62629e-06
|
|
|
GARS
|
[NCBI]
|
1.62629e-06
|
|
|
MPI
|
[NCBI]
|
1.62629e-06
|
|
|
MCOLN1
|
[NCBI]
|
1.62629e-06
|
|
|
FEN1
|
[NCBI]
|
1.62629e-06
|
|
|
ITGA2
|
[NCBI]
|
1.62629e-06
|
|
|
HCRTR2
|
[NCBI]
|
1.62629e-06
|
|
|
PVRL1
|
[NCBI]
|
1.62629e-06
|
|
|
PXMP3
|
[NCBI]
|
1.62629e-06
|
|
|
ADH1
|
[NCBI]
|
1.62629e-06
|
|
|
FCGR2A
|
[NCBI]
|
1.62629e-06
|
|
|
GRIN2B
|
[NCBI]
|
1.62629e-06
|
|
|
MED12
|
[NCBI]
|
1.62629e-06
|
|
|
CPT1A
|
[NCBI]
|
1.62629e-06
|
|
|
MSX2
|
[NCBI]
|
1.62629e-06
|
|
|
LDLRAP1
|
[NCBI]
|
1.62629e-06
|
|
|
alsin
|
[NCBI]
|
1.62629e-06
|
|
|
PEPA
|
[NCBI]
|
1.62629e-06
|
|
|
AQP7
|
[NCBI]
|
1.62629e-06
|
|
|
PLAG1
|
[NCBI]
|
1.62629e-06
|
|
|
NPAS2
|
[NCBI]
|
1.62629e-06
|
|
|
UBB
|
[NCBI]
|
1.62629e-06
|
|
|
KRT9
|
[NCBI]
|
1.62629e-06
|
|
|
HBD
|
[NCBI]
|
1.61673e-06
|
|
|
CLU
|
[NCBI]
|
1.58885e-06
|
|
|
TYRP1
|
[NCBI]
|
1.53631e-06
|
|
|
OA1
|
[NCBI]
|
1.53631e-06
|
|
|
CEL
|
[NCBI]
|
1.53012e-06
|
|
|
RCDP1
|
[NCBI]
|
1.51959e-06
|
|
|
OPTB1
|
[NCBI]
|
1.51959e-06
|
|
|
IGF1
|
[NCBI]
|
1.50894e-06
|
|
|
TP53
|
[NCBI]
|
1.48873e-06
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
1.48449e-06
|
|
|
MTC
|
[NCBI]
|
1.48449e-06
|
|
|
CLN5
|
[NCBI]
|
1.48449e-06
|
|
|
CYLD
|
[NCBI]
|
1.48449e-06
|
|
|
RHS
|
[NCBI]
|
1.48449e-06
|
|
|
CDA
|
[NCBI]
|
1.48449e-06
|
|
|
SACS
|
[NCBI]
|
1.48449e-06
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
1.48449e-06
|
|
|
glutathione synthetase deficiency
|
[NCBI]
|
1.48449e-06
|
|
|
SEDT
|
[NCBI]
|
1.48449e-06
|
|
|
IHPS1
|
[NCBI]
|
1.48449e-06
|
|
|
DA2B
|
[NCBI]
|
1.48449e-06
|
|
|
MERRF
|
[NCBI]
|
1.48449e-06
|
|
|
PPD2
|
[NCBI]
|
1.48449e-06
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
1.48449e-06
|
|
|
pycnodysostosis
|
[NCBI]
|
1.48449e-06
|
|
|
LWD
|
[NCBI]
|
1.48328e-06
|
|
|
temporal arteritis
|
[NCBI]
|
1.47985e-06
|
|
|
TCOF
|
[NCBI]
|
1.45506e-06
|
|
|
DCC
|
[NCBI]
|
1.44116e-06
|
|
|
VMD
|
[NCBI]
|
1.43152e-06
|
|
|
RHO
|
[NCBI]
|
1.41629e-06
|
|
|
LCT
|
[NCBI]
|
1.41478e-06
|
|
|
MDM2
|
[NCBI]
|
1.39997e-06
|
|
|
PHEX
|
[NCBI]
|
1.39997e-06
|
|
|
RPS6KA3
|
[NCBI]
|
1.39997e-06
|
|
|
PTHR1
|
[NCBI]
|
1.39997e-06
|
|
|
AURKA
|
[NCBI]
|
1.39073e-06
|
|
|
PCSK9
|
[NCBI]
|
1.39073e-06
|
|
|
SPAM1
|
[NCBI]
|
1.39073e-06
|
|
|
PRPH
|
[NCBI]
|
1.39073e-06
|
|
|
RHAG
|
[NCBI]
|
1.39073e-06
|
|
|
AGXT
|
[NCBI]
|
1.39073e-06
|
|
|
APOC3
|
[NCBI]
|
1.39073e-06
|
|
|
HABP2
|
[NCBI]
|
1.39073e-06
|
|
|
NDN
|
[NCBI]
|
1.39073e-06
|
|
|
TECTA
|
[NCBI]
|
1.39073e-06
|
|
|
TNNI3
|
[NCBI]
|
1.39073e-06
|
|
|
JUP
|
[NCBI]
|
1.39073e-06
|
|
|
CSF3R
|
[NCBI]
|
1.39073e-06
|
|
|
DCTN1
|
[NCBI]
|
1.39073e-06
|
|
|
KRT10
|
[NCBI]
|
1.39073e-06
|
|
|
FOLR1
|
[NCBI]
|
1.39073e-06
|
|
|
NOTCH3
|
[NCBI]
|
1.39073e-06
|
|
|
HSPD1
|
[NCBI]
|
1.39073e-06
|
|
|
CRYGD
|
[NCBI]
|
1.39073e-06
|
|
|
SMARCB1
|
[NCBI]
|
1.39073e-06
|
|
|
NEFH
|
[NCBI]
|
1.39073e-06
|
|
|
CACNA1F
|
[NCBI]
|
1.39073e-06
|
|
|
FOXE1
|
[NCBI]
|
1.39073e-06
|
|
|
BTD
|
[NCBI]
|
1.39073e-06
|
|
|
LBR
|
[NCBI]
|
1.35395e-06
|
|
|
PARG
|
[NCBI]
|
1.35395e-06
|
|
|
PDB
|
[NCBI]
|
1.34585e-06
|
|
|
charge syndrome
|
[NCBI]
|
1.34585e-06
|
|
|
ODDD
|
[NCBI]
|
1.34585e-06
|
|
|
OCRL
|
[NCBI]
|
1.34585e-06
|
|
|
thiourea tasting
|
[NCBI]
|
1.34585e-06
|
|
|
MELAS
|
[NCBI]
|
1.34585e-06
|
|
|
MRXHF1
|
[NCBI]
|
1.34585e-06
|
|
|
NEM3
|
[NCBI]
|
1.34585e-06
|
|
|
CPX
|
[NCBI]
|
1.34585e-06
|
|
|
PNPLA6
|
[NCBI]
|
1.29164e-06
|
|
|
ASPA
|
[NCBI]
|
1.27233e-06
|
|
|
RAG1
|
[NCBI]
|
1.27233e-06
|
|
|
TFRC
|
[NCBI]
|
1.26853e-06
|
|
|
OTC
|
[NCBI]
|
1.26853e-06
|
|
|
SCIDX1
|
[NCBI]
|
1.22844e-06
|
|
|
aortic valve disease
|
[NCBI]
|
1.22844e-06
|
|
|
CD
|
[NCBI]
|
1.2129e-06
|
|
|
HBB
|
[NCBI]
|
1.19811e-06
|
|
|
FSHMD1A
|
[NCBI]
|
1.19304e-06
|
|
|
ITGB2
|
[NCBI]
|
1.18499e-06
|
|
|
ABL1
|
[NCBI]
|
1.18499e-06
|
|
|
IGFBP3
|
[NCBI]
|
1.18357e-06
|
|
|
THBS1
|
[NCBI]
|
1.18357e-06
|
|
|
SOCS2
|
[NCBI]
|
1.18357e-06
|
|
|
HPSE
|
[NCBI]
|
1.18357e-06
|
|
|
BMPR2
|
[NCBI]
|
1.18357e-06
|
|
|
ECE1
|
[NCBI]
|
1.18357e-06
|
|
|
EPAS1
|
[NCBI]
|
1.18357e-06
|
|
|
AGL
|
[NCBI]
|
1.18357e-06
|
|
|
SDHB
|
[NCBI]
|
1.18357e-06
|
|
|
oncogene dj1
|
[NCBI]
|
1.18357e-06
|
|
|
LDHC
|
[NCBI]
|
1.18357e-06
|
|
|
ATRN
|
[NCBI]
|
1.18357e-06
|
|
|
LIG4
|
[NCBI]
|
1.18357e-06
|
|
|
MMP13
|
[NCBI]
|
1.18357e-06
|
|
|
LOR
|
[NCBI]
|
1.18357e-06
|
|
|
TULP1
|
[NCBI]
|
1.18357e-06
|
|
|
MHC2TA
|
[NCBI]
|
1.18357e-06
|
|
|
CCKAR
|
[NCBI]
|
1.18357e-06
|
|
|
NTRK3
|
[NCBI]
|
1.18357e-06
|
|
|
MGMT
|
[NCBI]
|
1.18357e-06
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.16181e-06
|
|
|
PPSH
|
[NCBI]
|
1.16181e-06
|
|
|
BOR1
|
[NCBI]
|
1.16181e-06
|
|
|
ABL
|
[NCBI]
|
1.15493e-06
|
|
|
EDMD
|
[NCBI]
|
1.15493e-06
|
|
|
RS1
|
[NCBI]
|
1.15293e-06
|
|
|
CHEK2
|
[NCBI]
|
1.15293e-06
|
|
|
UNG
|
[NCBI]
|
1.10337e-06
|
|
|
PKLR
|
[NCBI]
|
1.04137e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.04137e-06
|
|
|
BIRC1
|
[NCBI]
|
1.04015e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
1.02546e-06
|
|
|
acyl-coa dehydrogenase, medium-chain, deficiency of
|
[NCBI]
|
1.02546e-06
|
|
|
CMM2
|
[NCBI]
|
1.02546e-06
|
|
|
SCDO1
|
[NCBI]
|
1.02546e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
1.02546e-06
|
|
|
HOKPP
|
[NCBI]
|
1.02546e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
1.02546e-06
|
|
|
CSF3
|
[NCBI]
|
1.02376e-06
|
|
|
AGER
|
[NCBI]
|
1.00257e-06
|
|
|
NFKBIA
|
[NCBI]
|
1.00125e-06
|
|
|
JARID2
|
[NCBI]
|
1.00125e-06
|
|
|
PANK2
|
[NCBI]
|
1.00125e-06
|
|
|
PRKCA
|
[NCBI]
|
1.00125e-06
|
|
|
FLG
|
[NCBI]
|
1.00125e-06
|
|
|
LRAT
|
[NCBI]
|
1.00125e-06
|
|
|
CRYBB2
|
[NCBI]
|
1.00125e-06
|
|
|
SCARB1
|
[NCBI]
|
1.00125e-06
|
|
|
LAMA2
|
[NCBI]
|
1.00125e-06
|
|
|
GJD2
|
[NCBI]
|
1.00125e-06
|
|
|
UTRN
|
[NCBI]
|
1.00125e-06
|
|
|
ZEB2
|
[NCBI]
|
1.00125e-06
|
|
|
THBD
|
[NCBI]
|
1.00125e-06
|
|
|
PLA2G2A
|
[NCBI]
|
1.00125e-06
|
|
|
PPARBP
|
[NCBI]
|
1.00125e-06
|
|
|
FST
|
[NCBI]
|
1.00125e-06
|
|
|
CNR1
|
[NCBI]
|
1.00125e-06
|
|
|
COL5A1
|
[NCBI]
|
1.00125e-06
|
|
|
SCN9A
|
[NCBI]
|
1.00125e-06
|
|
|
POLD1
|
[NCBI]
|
1.00125e-06
|
|
|
GRIN2A
|
[NCBI]
|
1.00125e-06
|
|
|
GPR24
|
[NCBI]
|
1.00125e-06
|
|
|
LBP
|
[NCBI]
|
9.9812e-07
|
|
|
COL1A2
|
[NCBI]
|
9.9812e-07
|
|
|
HEXA
|
[NCBI]
|
9.9812e-07
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
9.9812e-07
|
|
|
TNFRSF1A
|
[NCBI]
|
9.9812e-07
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
9.9657e-07
|
|
|
leber optic atrophy
|
[NCBI]
|
9.69037e-07
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
9.68207e-07
|
|
|
chromosome 18q deletion syndrome
|
[NCBI]
|
9.68207e-07
|
|
|
acyl-coa dehydrogenase, short-chain, deficiency of
|
[NCBI]
|
9.68207e-07
|
|
|
chromosome 22q13.3 deletion syndrome
|
[NCBI]
|
9.68207e-07
|
|
|
ACCPN
|
[NCBI]
|
9.68207e-07
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
9.68207e-07
|
|
|
EDM1
|
[NCBI]
|
9.68207e-07
|
|
|
monilethrix
|
[NCBI]
|
9.68207e-07
|
|
|
CMT2A1
|
[NCBI]
|
9.68207e-07
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
9.68207e-07
|
|
|
argininosuccinic aciduria
|
[NCBI]
|
9.68207e-07
|
|
|
XPD
|
[NCBI]
|
9.68207e-07
|
|
|
NM
|
[NCBI]
|
9.68207e-07
|
|
|
OPD1
|
[NCBI]
|
9.68207e-07
|
|
|
USH3
|
[NCBI]
|
9.68207e-07
|
|
|
CMD3B
|
[NCBI]
|
9.68207e-07
|
|
|
XFS
|
[NCBI]
|
9.68207e-07
|
|
|
denys-drash syndrome
|
[NCBI]
|
9.68207e-07
|
|
|
DSMA1
|
[NCBI]
|
9.68207e-07
|
|
|
GRTH
|
[NCBI]
|
9.68207e-07
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
9.68207e-07
|
|
|
septooptic dysplasia
|
[NCBI]
|
9.68207e-07
|
|
|
NCIE1
|
[NCBI]
|
9.68207e-07
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
9.68207e-07
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
9.68207e-07
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
9.68207e-07
|
|
|
GC
|
[NCBI]
|
9.50266e-07
|
|
|
MAP1B
|
[NCBI]
|
9.46227e-07
|
|
|
SH2D1A
|
[NCBI]
|
9.46227e-07
|
|
|
HS
|
[NCBI]
|
9.46227e-07
|
|
|
fucosidosis
|
[NCBI]
|
9.37257e-07
|
|
|
SNRPN
|
[NCBI]
|
9.37257e-07
|
|
|
LIF
|
[NCBI]
|
9.37257e-07
|
|
|
GRN
|
[NCBI]
|
9.37257e-07
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
9.22223e-07
|
|
|
DYT1
|
[NCBI]
|
9.11682e-07
|
|
|
GCCR
|
[NCBI]
|
8.8273e-07
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
8.59121e-07
|
|
|
ATRX
|
[NCBI]
|
8.59121e-07
|
|
|
testicular tumors
|
[NCBI]
|
8.59121e-07
|
|
|
alzheimer disease 3
|
[NCBI]
|
8.59121e-07
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
8.59121e-07
|
|
|
SLC45A2
|
[NCBI]
|
8.40848e-07
|
|
|
CRX
|
[NCBI]
|
8.40848e-07
|
|
|
MEF2A
|
[NCBI]
|
8.40848e-07
|
|
|
MIF
|
[NCBI]
|
8.40848e-07
|
|
|
RNASEL
|
[NCBI]
|
8.40848e-07
|
|
|
WNT1
|
[NCBI]
|
8.40848e-07
|
|
|
MYOD1
|
[NCBI]
|
8.40848e-07
|
|
|
CBFA2T1
|
[NCBI]
|
8.40848e-07
|
|
|
ANKRD1
|
[NCBI]
|
8.40848e-07
|
|
|
COL11A1
|
[NCBI]
|
8.40848e-07
|
|
|
SCNN1B
|
[NCBI]
|
8.40848e-07
|
|
|
GNB3
|
[NCBI]
|
8.40848e-07
|
|
|
BTRC
|
[NCBI]
|
8.40848e-07
|
|
|
NSD1
|
[NCBI]
|
8.40848e-07
|
|
|
SIRT1
|
[NCBI]
|
8.40226e-07
|
|
|
AANAT
|
[NCBI]
|
7.97728e-07
|
|
|
NTRK1
|
[NCBI]
|
7.97728e-07
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
7.81929e-07
|
|
|
PSORS2
|
[NCBI]
|
7.66456e-07
|
|
|
ETL2
|
[NCBI]
|
7.66456e-07
|
|
|
marden-walker syndrome
|
[NCBI]
|
7.66456e-07
|
|
|
TFR2
|
[NCBI]
|
7.49948e-07
|
|
|
MSD
|
[NCBI]
|
7.41419e-07
|
|
|
CSNB1A
|
[NCBI]
|
7.41419e-07
|
|
|
DRD
|
[NCBI]
|
7.41419e-07
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
7.41419e-07
|
|
|
MADD
|
[NCBI]
|
7.41419e-07
|
|
|
sudden infant death syndrome
|
[NCBI]
|
7.41419e-07
|
|
|
APOD
|
[NCBI]
|
7.41001e-07
|
|
|
CCL2
|
[NCBI]
|
7.41001e-07
|
|
|
HBG2
|
[NCBI]
|
7.26936e-07
|
|
|
ADAM17
|
[NCBI]
|
7.26936e-07
|
|
|
CD47
|
[NCBI]
|
7.26936e-07
|
|
|
SVAS
|
[NCBI]
|
7.18748e-07
|
|
|
PFKM
|
[NCBI]
|
6.99918e-07
|
|
|
GDI1
|
[NCBI]
|
6.99918e-07
|
|
|
TRHR
|
[NCBI]
|
6.99918e-07
|
|
|
JK
|
[NCBI]
|
6.99918e-07
|
|
|
SURF1
|
[NCBI]
|
6.99918e-07
|
|
|
NEFL
|
[NCBI]
|
6.99918e-07
|
|
|
VCAM1
|
[NCBI]
|
6.99918e-07
|
|
|
GLRA1
|
[NCBI]
|
6.99918e-07
|
|
|
HSD17B4
|
[NCBI]
|
6.99918e-07
|
|
|
TAL1
|
[NCBI]
|
6.99918e-07
|
|
|
GLDC
|
[NCBI]
|
6.99918e-07
|
|
|
Ge
|
[NCBI]
|
6.99918e-07
|
|
|
TCF3
|
[NCBI]
|
6.99918e-07
|
|
|
HEXB
|
[NCBI]
|
6.6611e-07
|
|
|
CREBBP
|
[NCBI]
|
6.58573e-07
|
|
|
TPT1
|
[NCBI]
|
6.58573e-07
|
|
|
APCS
|
[NCBI]
|
6.58573e-07
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
6.58573e-07
|
|
|
ESD
|
[NCBI]
|
6.38435e-07
|
|
|
DGS
|
[NCBI]
|
6.28905e-07
|
|
|
NRCLP1
|
[NCBI]
|
6.07654e-07
|
|
|
RP3
|
[NCBI]
|
6.07654e-07
|
|
|
HHC1
|
[NCBI]
|
6.07654e-07
|
|
|
MTATP6
|
[NCBI]
|
5.9274e-07
|
|
|
OPMD
|
[NCBI]
|
5.92575e-07
|
|
|
USF1
|
[NCBI]
|
5.88424e-07
|
|
|
MODY1
|
[NCBI]
|
5.80783e-07
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
5.80783e-07
|
|
|
SPD1
|
[NCBI]
|
5.80783e-07
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
5.80783e-07
|
|
|
NFNS
|
[NCBI]
|
5.80783e-07
|
|
|
USH1C
|
[NCBI]
|
5.80783e-07
|
|
|
FRA16A
|
[NCBI]
|
5.80783e-07
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
5.80783e-07
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
5.80783e-07
|
|
|
complement component 7 deficiency
|
[NCBI]
|
5.80783e-07
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
5.80783e-07
|
|
|
JME
|
[NCBI]
|
5.80783e-07
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
5.80783e-07
|
|
|
HFTC
|
[NCBI]
|
5.80783e-07
|
|
|
sitosterolemia
|
[NCBI]
|
5.80783e-07
|
|
|
trichodentoosseous syndrome
|
[NCBI]
|
5.80783e-07
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
5.80783e-07
|
|
|
tetralogy of fallot
|
[NCBI]
|
5.80783e-07
|
|
|
OPD2
|
[NCBI]
|
5.80783e-07
|
|
|
HMN5
|
[NCBI]
|
5.80783e-07
|
|
|
kaposi sarcoma
|
[NCBI]
|
5.80783e-07
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
5.80783e-07
|
|
|
HSCR2
|
[NCBI]
|
5.80783e-07
|
|
|
ACTC1
|
[NCBI]
|
5.76411e-07
|
|
|
NR4A2
|
[NCBI]
|
5.76411e-07
|
|
|
BMP7
|
[NCBI]
|
5.76411e-07
|
|
|
CSF1R
|
[NCBI]
|
5.76411e-07
|
|
|
CEBPB
|
[NCBI]
|
5.76411e-07
|
|
|
FRAXE
|
[NCBI]
|
5.76411e-07
|
|
|
LMX1B
|
[NCBI]
|
5.76411e-07
|
|
|
SPR
|
[NCBI]
|
5.76411e-07
|
|
|
PGM3
|
[NCBI]
|
5.76411e-07
|
|
|
FGF3
|
[NCBI]
|
5.76411e-07
|
|
|
FLT4
|
[NCBI]
|
5.76411e-07
|
|
|
ACACA
|
[NCBI]
|
5.76411e-07
|
|
|
SLC6A8
|
[NCBI]
|
5.76411e-07
|
|
|
FUT2
|
[NCBI]
|
5.76411e-07
|
|
|
MUTYH
|
[NCBI]
|
5.76411e-07
|
|
|
PER2
|
[NCBI]
|
5.76411e-07
|
|
|
TNFRSF13B
|
[NCBI]
|
5.76411e-07
|
|
|
KCNE1
|
[NCBI]
|
5.76411e-07
|
|
|
ECM1
|
[NCBI]
|
5.76411e-07
|
|
|
PTEN
|
[NCBI]
|
5.742e-07
|
|
|
PTGS2
|
[NCBI]
|
5.66894e-07
|
|
|
IL2RA
|
[NCBI]
|
5.29547e-07
|
|
|
RUNX1
|
[NCBI]
|
5.29547e-07
|
|
|
ZNF145
|
[NCBI]
|
5.29547e-07
|
|
|
NR1I2
|
[NCBI]
|
5.27216e-07
|
|
|
KAL1
|
[NCBI]
|
5.1662e-07
|
|
|
TCRA
|
[NCBI]
|
5.1662e-07
|
|
|
BSG
|
[NCBI]
|
5.14989e-07
|
|
|
THRB
|
[NCBI]
|
5.01116e-07
|
|
|
FSHR
|
[NCBI]
|
5.01116e-07
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
4.97023e-07
|
|
|
MDC1A
|
[NCBI]
|
4.97023e-07
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
4.97023e-07
|
|
|
sialuria, finnish type
|
[NCBI]
|
4.97023e-07
|
|
|
PPH1
|
[NCBI]
|
4.97023e-07
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
4.97023e-07
|
|
|
UOX
|
[NCBI]
|
4.97023e-07
|
|
|
SOX9
|
[NCBI]
|
4.69106e-07
|
|
|
SN
|
[NCBI]
|
4.68582e-07
|
|
|
PPARD
|
[NCBI]
|
4.68582e-07
|
|
|
C9
|
[NCBI]
|
4.68582e-07
|
|
|
SMAD2
|
[NCBI]
|
4.68582e-07
|
|
|
DMBT1
|
[NCBI]
|
4.68582e-07
|
|
|
RAG2
|
[NCBI]
|
4.68582e-07
|
|
|
IGHV
|
[NCBI]
|
4.68582e-07
|
|
|
AMELX
|
[NCBI]
|
4.68582e-07
|
|
|
CSF1
|
[NCBI]
|
4.68582e-07
|
|
|
GAD2
|
[NCBI]
|
4.68582e-07
|
|
|
PGD
|
[NCBI]
|
4.68582e-07
|
|
|
BMD
|
[NCBI]
|
4.265e-07
|
|
|
CDSP
|
[NCBI]
|
4.265e-07
|
|
|
FMR1
|
[NCBI]
|
4.19378e-07
|
|
|
SLC6A6
|
[NCBI]
|
4.11541e-07
|
|
|
AMACR
|
[NCBI]
|
4.11541e-07
|
|
|
HMBS
|
[NCBI]
|
4.05587e-07
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
4.03934e-07
|
|
|
PAX6
|
[NCBI]
|
4.01393e-07
|
|
|
ERBB2
|
[NCBI]
|
3.89657e-07
|
|
|
TNFRSF6
|
[NCBI]
|
3.89657e-07
|
|
|
factor x deficiency
|
[NCBI]
|
3.89657e-07
|
|
|
DMPK
|
[NCBI]
|
3.89657e-07
|
|
|
DCT
|
[NCBI]
|
3.89657e-07
|
|
|
PD
|
[NCBI]
|
3.86098e-07
|
|
|
MTTL1
|
[NCBI]
|
3.83687e-07
|
|
|
SLC11A2
|
[NCBI]
|
3.83687e-07
|
|
|
ADHD
|
[NCBI]
|
3.82849e-07
|
|
|
HSPCA
|
[NCBI]
|
3.74935e-07
|
|
|
ABCC3
|
[NCBI]
|
3.74935e-07
|
|
|
TNXB
|
[NCBI]
|
3.74935e-07
|
|
|
CR1
|
[NCBI]
|
3.74935e-07
|
|
|
TBX5
|
[NCBI]
|
3.74935e-07
|
|
|
EPHB2
|
[NCBI]
|
3.74935e-07
|
|
|
GJB6
|
[NCBI]
|
3.74935e-07
|
|
|
GPR54
|
[NCBI]
|
3.74935e-07
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
3.67325e-07
|
|
|
RP
|
[NCBI]
|
3.61426e-07
|
|
|
TRAF2
|
[NCBI]
|
3.56983e-07
|
|
|
ARF6
|
[NCBI]
|
3.56983e-07
|
|
|
ACADM
|
[NCBI]
|
3.49997e-07
|
|
|
BMP2
|
[NCBI]
|
3.4358e-07
|
|
|
SHFM1
|
[NCBI]
|
3.37266e-07
|
|
|
AKR1B1
|
[NCBI]
|
3.35534e-07
|
|
|
ALAD
|
[NCBI]
|
3.3404e-07
|
|
|
TLR5
|
[NCBI]
|
3.3404e-07
|
|
|
PARP1
|
[NCBI]
|
3.14206e-07
|
|
|
CDA
|
[NCBI]
|
3.0557e-07
|
|
|
HIF1A
|
[NCBI]
|
3.0557e-07
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
3.0376e-07
|
|
|
CDG2C
|
[NCBI]
|
3.0376e-07
|
|
|
esophageal cancer
|
[NCBI]
|
3.0376e-07
|
|
|
CTHM
|
[NCBI]
|
3.0376e-07
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
3.0376e-07
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
3.0376e-07
|
|
|
CFTD
|
[NCBI]
|
3.0376e-07
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
3.0376e-07
|
|
|
omenn syndrome
|
[NCBI]
|
3.0376e-07
|
|
|
complement factor h deficiency
|
[NCBI]
|
3.0376e-07
|
|
|
danon disease
|
[NCBI]
|
3.0376e-07
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
3.0376e-07
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
2.96057e-07
|
|
|
GLC3A
|
[NCBI]
|
2.96057e-07
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
2.96057e-07
|
|
|
CCAL2
|
[NCBI]
|
2.96057e-07
|
|
|
histidinemia
|
[NCBI]
|
2.96057e-07
|
|
|
EBR1
|
[NCBI]
|
2.96057e-07
|
|
|
TRPS1
|
[NCBI]
|
2.96057e-07
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
2.96057e-07
|
|
|
ERCC1
|
[NCBI]
|
2.94181e-07
|
|
|
MYB
|
[NCBI]
|
2.94181e-07
|
|
|
JUN
|
[NCBI]
|
2.94181e-07
|
|
|
DKC1
|
[NCBI]
|
2.94181e-07
|
|
|
FUS
|
[NCBI]
|
2.94181e-07
|
|
|
KRT1
|
[NCBI]
|
2.94181e-07
|
|
|
PDGFRA
|
[NCBI]
|
2.94181e-07
|
|
|
CPM
|
[NCBI]
|
2.94181e-07
|
|
|
CYCS
|
[NCBI]
|
2.94181e-07
|
|
|
EBF
|
[NCBI]
|
2.94181e-07
|
|
|
SELP
|
[NCBI]
|
2.94181e-07
|
|
|
ADAMTS13
|
[NCBI]
|
2.94181e-07
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
2.94181e-07
|
|
|
LRE1
|
[NCBI]
|
2.94181e-07
|
|
|
F12
|
[NCBI]
|
2.94181e-07
|
|
|
PDGFRB
|
[NCBI]
|
2.94181e-07
|
|
|
EBP
|
[NCBI]
|
2.94181e-07
|
|
|
COL3A1
|
[NCBI]
|
2.83383e-07
|
|
|
CTSL
|
[NCBI]
|
2.83383e-07
|
|
|
PRF1
|
[NCBI]
|
2.83383e-07
|
|
|
XIST
|
[NCBI]
|
2.69139e-07
|
|
|
GNMT
|
[NCBI]
|
2.57454e-07
|
|
|
UMOD
|
[NCBI]
|
2.57454e-07
|
|
|
DES
|
[NCBI]
|
2.57454e-07
|
|
|
MYH11
|
[NCBI]
|
2.57454e-07
|
|
|
PG
|
[NCBI]
|
2.53233e-07
|
|
|
gastric cancer
|
[NCBI]
|
2.44827e-07
|
|
|
down syndrome
|
[NCBI]
|
2.43249e-07
|
|
|
sickle cell anemia
|
[NCBI]
|
2.43249e-07
|
|
|
CNTF
|
[NCBI]
|
2.36654e-07
|
|
|
UBE3A
|
[NCBI]
|
2.25197e-07
|
|
|
CTSB
|
[NCBI]
|
2.25197e-07
|
|
|
SDHD
|
[NCBI]
|
2.25197e-07
|
|
|
NRP1
|
[NCBI]
|
2.25197e-07
|
|
|
FOS
|
[NCBI]
|
2.25197e-07
|
|
|
NKX2-1
|
[NCBI]
|
2.25197e-07
|
|
|
VAMP2
|
[NCBI]
|
2.25197e-07
|
|
|
TCOF1
|
[NCBI]
|
2.25197e-07
|
|
|
NR3C2
|
[NCBI]
|
2.25197e-07
|
|
|
APTX
|
[NCBI]
|
2.25197e-07
|
|
|
GJB3
|
[NCBI]
|
2.25197e-07
|
|
|
WFS1
|
[NCBI]
|
2.25197e-07
|
|
|
CA1
|
[NCBI]
|
2.25197e-07
|
|
|
COMP
|
[NCBI]
|
2.24557e-07
|
|
|
GAMT
|
[NCBI]
|
2.12794e-07
|
|
|
AGTR1
|
[NCBI]
|
2.12794e-07
|
|
|
NR0B1
|
[NCBI]
|
2.12794e-07
|
|
|
EDNRB
|
[NCBI]
|
2.12794e-07
|
|
|
krabbe disease
|
[NCBI]
|
2.1263e-07
|
|
|
IL3
|
[NCBI]
|
2.02733e-07
|
|
|
ABCG2
|
[NCBI]
|
1.97122e-07
|
|
|
DSG3
|
[NCBI]
|
1.96172e-07
|
|
|
HRG
|
[NCBI]
|
1.74936e-07
|
|
|
PTPRC
|
[NCBI]
|
1.71764e-07
|
|
|
wolman disease
|
[NCBI]
|
1.71764e-07
|
|
|
HNF1B
|
[NCBI]
|
1.67001e-07
|
|
|
IRF1
|
[NCBI]
|
1.67001e-07
|
|
|
PINK1
|
[NCBI]
|
1.67001e-07
|
|
|
TK1
|
[NCBI]
|
1.67001e-07
|
|
|
SLC25A20
|
[NCBI]
|
1.67001e-07
|
|
|
COL4A1
|
[NCBI]
|
1.67001e-07
|
|
|
ACOX1
|
[NCBI]
|
1.67001e-07
|
|
|
FGFR3
|
[NCBI]
|
1.66764e-07
|
|
|
FH
|
[NCBI]
|
1.5926e-07
|
|
|
PSAP
|
[NCBI]
|
1.5926e-07
|
|
|
IGHG1
|
[NCBI]
|
1.5926e-07
|
|
|
DRPLA
|
[NCBI]
|
1.57252e-07
|
|
|
AN2
|
[NCBI]
|
1.45862e-07
|
|
|
GUSB
|
[NCBI]
|
1.43718e-07
|
|
|
porphyria, congenital erythropoietic
|
[NCBI]
|
1.42865e-07
|
|
|
stroke, ischemic
|
[NCBI]
|
1.42865e-07
|
|
|
DA2A
|
[NCBI]
|
1.42865e-07
|
|
|
masa syndrome
|
[NCBI]
|
1.42865e-07
|
|
|
HEPOD
|
[NCBI]
|
1.42865e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
1.42865e-07
|
|
|
EL1
|
[NCBI]
|
1.42865e-07
|
|
|
PMC
|
[NCBI]
|
1.42865e-07
|
|
|
MSS
|
[NCBI]
|
1.42865e-07
|
|
|
MEN2B
|
[NCBI]
|
1.42865e-07
|
|
|
G6PD
|
[NCBI]
|
1.41929e-07
|
|
|
ACADS
|
[NCBI]
|
1.34549e-07
|
|
|
APOC2
|
[NCBI]
|
1.34549e-07
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.34549e-07
|
|
|
BAX
|
[NCBI]
|
1.34549e-07
|
|
|
FGG
|
[NCBI]
|
1.34549e-07
|
|
|
FOXO1A
|
[NCBI]
|
1.34549e-07
|
|
|
MTCO1
|
[NCBI]
|
1.34549e-07
|
|
|
ATP7A
|
[NCBI]
|
1.34549e-07
|
|
|
B2M
|
[NCBI]
|
1.26586e-07
|
|
|
FXN
|
[NCBI]
|
1.26586e-07
|
|
|
FLNA
|
[NCBI]
|
1.26586e-07
|
|
|
hemophilia a
|
[NCBI]
|
1.23862e-07
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
1.22385e-07
|
|
|
PFIC1
|
[NCBI]
|
1.22385e-07
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
1.22385e-07
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
1.22385e-07
|
|
|
CMDD
|
[NCBI]
|
1.22385e-07
|
|
|
seckel syndrome 1
|
[NCBI]
|
1.22385e-07
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
1.22385e-07
|
|
|
coumarin resistance
|
[NCBI]
|
1.22385e-07
|
|
|
PPAC
|
[NCBI]
|
1.22385e-07
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
1.22385e-07
|
|
|
CSID
|
[NCBI]
|
1.22385e-07
|
|
|
IVA
|
[NCBI]
|
1.22385e-07
|
|
|
GNAS
|
[NCBI]
|
1.22327e-07
|
|
|
MMP1
|
[NCBI]
|
1.1873e-07
|
|
|
RPS19
|
[NCBI]
|
1.1873e-07
|
|
|
CRP
|
[NCBI]
|
1.1873e-07
|
|
|
GZMB
|
[NCBI]
|
1.1873e-07
|
|
|
MTCO3
|
[NCBI]
|
1.1873e-07
|
|
|
DMD
|
[NCBI]
|
1.16024e-07
|
|
|
FGF10
|
[NCBI]
|
1.01352e-07
|
|
|
AVPR2
|
[NCBI]
|
1.01352e-07
|
|
|
ACP1
|
[NCBI]
|
1.01352e-07
|
|
|
CTCF
|
[NCBI]
|
1.01352e-07
|
|
|
PRPH2
|
[NCBI]
|
1.01352e-07
|
|
|
INHBA
|
[NCBI]
|
1.01352e-07
|
|
|
NDP
|
[NCBI]
|
1.01352e-07
|
|
|
NR6A1
|
[NCBI]
|
1.01352e-07
|
|
|
coproporphyria
|
[NCBI]
|
1.01352e-07
|
|
|
NTRK2
|
[NCBI]
|
1.01352e-07
|
|
|
GATA1
|
[NCBI]
|
1.01352e-07
|
|
|
BCL6
|
[NCBI]
|
1.01352e-07
|
|
|
OMP
|
[NCBI]
|
9.58371e-08
|
|
|
GLC1A
|
[NCBI]
|
8.49858e-08
|
|
|
IL2RG
|
[NCBI]
|
7.96204e-08
|
|
|
KLK7
|
[NCBI]
|
7.96204e-08
|
|
|
SLN
|
[NCBI]
|
7.96204e-08
|
|
|
BMP15
|
[NCBI]
|
7.96204e-08
|
|
|
MAPK7
|
[NCBI]
|
7.96204e-08
|
|
|
WS1
|
[NCBI]
|
7.40729e-08
|
|
|
SCA7
|
[NCBI]
|
7.40729e-08
|
|
|
PSIP1
|
[NCBI]
|
7.23875e-08
|
|
|
CXCR4
|
[NCBI]
|
7.23875e-08
|
|
|
GDF5
|
[NCBI]
|
7.23875e-08
|
|
|
FHIT
|
[NCBI]
|
7.23875e-08
|
|
|
APP
|
[NCBI]
|
6.49545e-08
|
|
|
CCD
|
[NCBI]
|
5.5609e-08
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
5.37542e-08
|
|
|
NFKB1
|
[NCBI]
|
5.24854e-08
|
|
|
CHM
|
[NCBI]
|
4.89921e-08
|
|
|
PPARGC1A
|
[NCBI]
|
4.89921e-08
|
|
|
COL4A3
|
[NCBI]
|
4.89921e-08
|
|
|
MLP
|
[NCBI]
|
4.89921e-08
|
|
|
SFRP1
|
[NCBI]
|
4.89921e-08
|
|
|
ALDH1A1
|
[NCBI]
|
4.89921e-08
|
|
|
CTSK
|
[NCBI]
|
4.89921e-08
|
|
|
PER1
|
[NCBI]
|
4.89921e-08
|
|
|
ERCC5
|
[NCBI]
|
4.78924e-08
|
|
|
MTTK
|
[NCBI]
|
4.78924e-08
|
|
|
ACCN2
|
[NCBI]
|
4.78924e-08
|
|
|
BFLS
|
[NCBI]
|
4.24819e-08
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.24819e-08
|
|
|
HIDS
|
[NCBI]
|
4.24819e-08
|
|
|
EBN1
|
[NCBI]
|
4.24819e-08
|
|
|
ACLS
|
[NCBI]
|
4.24819e-08
|
|
|
pancreatic carcinoma
|
[NCBI]
|
4.24819e-08
|
|
|
brugada syndrome 1
|
[NCBI]
|
4.24819e-08
|
|
|
bethlem myopathy
|
[NCBI]
|
4.24819e-08
|
|
|
NPHP1
|
[NCBI]
|
4.24819e-08
|
|
|
F2
|
[NCBI]
|
3.52932e-08
|
|
|
UCP3
|
[NCBI]
|
3.24649e-08
|
|
|
BMP4
|
[NCBI]
|
3.22164e-08
|
|
|
DNMT3B
|
[NCBI]
|
2.81217e-08
|
|
|
GRPR
|
[NCBI]
|
2.81217e-08
|
|
|
neuraminidase deficiency
|
[NCBI]
|
2.77903e-08
|
|
|
ATS
|
[NCBI]
|
2.77903e-08
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.77903e-08
|
|
|
IVD
|
[NCBI]
|
2.62394e-08
|
|
|
MYCN
|
[NCBI]
|
2.62394e-08
|
|
|
GAS
|
[NCBI]
|
2.62394e-08
|
|
|
TNNT2
|
[NCBI]
|
2.62394e-08
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.62394e-08
|
|
|
CD8A
|
[NCBI]
|
2.62394e-08
|
|
|
PRG4
|
[NCBI]
|
2.62394e-08
|
|
|
PPIB
|
[NCBI]
|
2.62394e-08
|
|
|
TNFRSF6B
|
[NCBI]
|
2.62394e-08
|
|
|
refsum disease
|
[NCBI]
|
2.46791e-08
|
|
|
RSMD1
|
[NCBI]
|
2.46791e-08
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
2.46791e-08
|
|
|
acromegaly
|
[NCBI]
|
2.46791e-08
|
|
|
PHA
|
[NCBI]
|
2.46791e-08
|
|
|
hyperlipoproteinemia, type i
|
[NCBI]
|
2.46791e-08
|
|
|
CORD2
|
[NCBI]
|
2.46791e-08
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
2.46791e-08
|
|
|
neuropathy, congenital hypomyelinating
|
[NCBI]
|
2.46791e-08
|
|
|
SPG2
|
[NCBI]
|
2.46791e-08
|
|
|
MVA
|
[NCBI]
|
2.46791e-08
|
|
|
SLC2A2
|
[NCBI]
|
2.16406e-08
|
|
|
TLR2
|
[NCBI]
|
2.09544e-08
|
|
|
HPRT1
|
[NCBI]
|
1.50827e-08
|
|
|
KRT5
|
[NCBI]
|
1.33534e-08
|
|
|
MTND6
|
[NCBI]
|
1.33534e-08
|
|
|
TERC
|
[NCBI]
|
1.33534e-08
|
|
|
IL8
|
[NCBI]
|
1.33534e-08
|
|
|
COL10A1
|
[NCBI]
|
1.33534e-08
|
|
|
RAC1
|
[NCBI]
|
1.33534e-08
|
|
|
BDNF
|
[NCBI]
|
1.33183e-08
|
|
|
LFNG
|
[NCBI]
|
1.08189e-08
|
|
|
TIMP1
|
[NCBI]
|
1.08189e-08
|
|
|
DLG1
|
[NCBI]
|
1.08189e-08
|
|
|
BACE1
|
[NCBI]
|
1.08189e-08
|
|
|
SLC22A6
|
[NCBI]
|
1.08189e-08
|
|
|
CD2AP
|
[NCBI]
|
1.08189e-08
|
|
|
COL17A1
|
[NCBI]
|
1.08189e-08
|
|
|
HMGA2
|
[NCBI]
|
1.08189e-08
|
|
|
KRT14
|
[NCBI]
|
1.08189e-08
|
|
|
HBFQTL2
|
[NCBI]
|
1.03175e-08
|
|
|
XLP1
|
[NCBI]
|
8.10569e-09
|
|
|
PJS
|
[NCBI]
|
7.0543e-09
|
|
|
MRD
|
[NCBI]
|
5.14984e-09
|
|
|
CDH1
|
[NCBI]
|
4.48359e-09
|
|
|
PGK1
|
[NCBI]
|
4.48359e-09
|
|
|
ASL
|
[NCBI]
|
4.48359e-09
|
|
|
MMP9
|
[NCBI]
|
4.48359e-09
|
|
|
FTL
|
[NCBI]
|
3.8908e-09
|
|
|
AK1
|
[NCBI]
|
3.8908e-09
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.8908e-09
|
|
|
MET
|
[NCBI]
|
3.8908e-09
|
|
|
CDKN1B
|
[NCBI]
|
3.8908e-09
|
|
|
ALDH3A2
|
[NCBI]
|
3.8908e-09
|
|
|
ALPL
|
[NCBI]
|
3.8908e-09
|
|
|
CRY1
|
[NCBI]
|
3.8908e-09
|
|
|
DCN
|
[NCBI]
|
3.8908e-09
|
|
|
MJD
|
[NCBI]
|
2.55108e-09
|
|
|
SPTA1
|
[NCBI]
|
2.50346e-09
|
|
|
MMP2
|
[NCBI]
|
2.50346e-09
|
|
|
CHGA
|
[NCBI]
|
2.24151e-09
|
|
|
ALDH1A2
|
[NCBI]
|
2.24151e-09
|
|
|
PROS1
|
[NCBI]
|
2.24151e-09
|
|
|
HSPB1
|
[NCBI]
|
2.24151e-09
|
|
|
PTX3
|
[NCBI]
|
2.24151e-09
|
|
|
NOS2A
|
[NCBI]
|
2.24151e-09
|
|
|
ABCC2
|
[NCBI]
|
2.07807e-09
|
|
|
CLN3
|
[NCBI]
|
1.56488e-09
|
|
|
MNS
|
[NCBI]
|
7.82247e-10
|
|
|
ABS
|
[NCBI]
|
7.82247e-10
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
7.82247e-10
|
|
|
leopard syndrome 1
|
[NCBI]
|
7.82247e-10
|
|
|
FHM2
|
[NCBI]
|
7.82247e-10
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
7.82247e-10
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
7.82247e-10
|
|
|
factor xii deficiency
|
[NCBI]
|
7.82247e-10
|
|
|
EAOH
|
[NCBI]
|
7.82247e-10
|
|
|
bladder cancer
|
[NCBI]
|
7.82247e-10
|
|
|
FTLDU
|
[NCBI]
|
7.82247e-10
|
|
|
weaver syndrome
|
[NCBI]
|
7.82247e-10
|
|
|
SCN1
|
[NCBI]
|
7.82247e-10
|
|
|
AQP4
|
[NCBI]
|
7.58643e-10
|
|
|
WT1
|
[NCBI]
|
7.58643e-10
|
|
|
KCNH2
|
[NCBI]
|
4.5922e-10
|
|
|
ACVRL1
|
[NCBI]
|
6.55509e-11
|
|
|
complement component 6 deficiency
|
[NCBI]
|
6.55509e-11
|
|
|
CD40LG
|
[NCBI]
|
6.55509e-11
|
|
|
TGFBR2
|
[NCBI]
|
6.55509e-11
|
|
|
DST
|
[NCBI]
|
6.55509e-11
|
|
|
GRIN1
|
[NCBI]
|
6.55509e-11
|
|
|
GPC3
|
[NCBI]
|
6.55509e-11
|
|
|
E2F1
|
[NCBI]
|
6.55509e-11
|
|